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Despite an explosion of knowledge regarding the molecular regulation of autophagy since its initial 
characterization in yeast in the 1990s (including the 2016 Nobel Prize in Physiology or Medicine for Dr 
Yoshinori Ohsumi), essential questions concerning its biological relevance are unanswered. Importantly, 
given autophagy’s logical links to the beneficial health effects of relative caloric restriction and exercise, 
progress is being made towards developing autophagy-inducing drugs intended to generally benefit 
human health. Although many candidates appear to have such effects in model organisms and are well-
tolerated by humans, it remains unclear whether these effects are due to autophagy specifically, as 
direct autophagy-inducing chemicals have not yet been publicly identified. This lack of precise 
autophagy-targeting chemicals amplifies and confounds the fact that the biological and physiological 
impacts of specific autophagy induction are relatively unexplored. Here, several basic cellular effects 
resulting from autophagy induction by amino acid starvation or rapamycin (mTOR inhibitor) as well as 
mitophagy induction by CCCP (depolarizes mitochondrial membranes) were examined. These effects 
were investigated in Atg7-knockdown C2C12 cells (considered to be autophagy-deficient) and those with 
Bnip3-knockout. 
 
First, previous research has examined the relationship between autophagy and senescence caused by 
various stimuli; results have shown that autophagy promotes and attenuates senescence, depending on 
the study. Although, whether autophagy induction itself causes senescence has not been examined. We 
demonstrate that repeated administration of C2C12 cells with low staurosporine (STS) doses causes 
senescence characterized by G1 cell cycle arrest, enlarged cell and nuclei size, increased senescence-
associated heterochromatic foci (SAHF), increased senescence-associated acid b–galactosidase activity 
(SA-Bgal), and myogenic differentiation impairment. However, none of these cellular features occurred 
in cells repeatedly incubated in amino acid and serum free media (HBSS), which massively induced 
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autophagy. Additionally, while senescent cells were protected from cell death caused by the DNA 
damaging agent cisplatin, HBSS-treated cells were not. When Atg7-deficient cells were intermittently 
given low dose STS, senescence did not occur, likely due to the vastly decreased ability to actually 
survive without functional autophagy. Therefore, Chapter II demonstrates that although autophagic 
activity is implicated in senescence development, massive sub-lethal autophagy induction itself does not 
cause senescence. 
 
Next, we wanted to further examine autophagy-induced stress resistance development, as some 
protection from STS-induced cell death was observed in HBSS-treated cells in Chapter II. To do this, 
normal and Atg7-deficient cells were intermittently incubated in amino acid free media or rapamycin to 
induce autophagy, and the sensitivity to cell death caused by STS, cisplatin, or hydrogen peroxide was 
examined. Results indicated that prior repeated amino acid withdrawal protected cells from STS-induced 
cell death, and this required Atg7. This effect was likely due to reduced mitochondrial-mediated caspase 
activation, as caspase-9 activity was significantly lower in amino acid starved cells and administering a 
chemical inhibitor of caspase-3 could mimic the protective effect. Surprisingly, not only were rapamycin-
treated cells not similarly protected, but they displayed increased sensitivity to cell death induced by 
hydrogen peroxide and cisplatin in an Atg7-independent manner. These cells were additionally 
characterized by greatly enlarged cell size, altered cell cycle profiles, and completely prevented 
myogenic differentiation. Therefore, Chapter III demonstrates autophagy’s potential as a cellular 
remodelling mechanism that causes context-dependent stress resistance, and highlights the significant 
differences between metabolic stimulation of autophagy and that caused by mTOR inhibition. 
 
Lastly, to investigate the relevance of mitophagy and mitochondria-specific mechanisms in mediating 
this observed autophagy-induced stress resistant phenotype, similar experiments were performed to 
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compare the effects caused by intermittently incubating cells in HBSS or CCCP. Although CCCP 
treatments did not protect from STS-induced cell death to the same extent as HBSS, both treatments 
attenuated calcium-induced mitochondrial membrane depolarization and permeability pore formation. 
In fact, this protection was abrogated in Atg7-deficient cells, demonstrating that autophagy is required 
for this adaptation. Further examination into mitochondrial function showed that previous intermittent 
amino acid starvation increased maximal ADP-stimulated cellular oxygen consumption when provided 
with complex-I and/or complex-II substrates. Additionally, not only was mitochondrial respiration 
significantly impaired in Atg7-deficient cells, but amino acid starvation did not increase oxygen 
consumption without Atg7. By generating Bnip3-deficient cells with CRISPR/Cas9, it was also shown that 
Bnip3 is dispensable for repeated amino acid starvation to cause resistance to STS-induced cell death 
and to increase maximal mitochondrial respiration. Therefore, Chapter IV demonstrates that specific 
amino acid starvation-induced autophagy causes mitochondrial remodelling resulting in increased stress 
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Cells deal with and respond to stressors in a variety of ways. Depending on a cell’s current functional 
status, stress signal integration will direct response mechanisms ultimately leading to survival or death. 
A commonly investigated method of cell death is apoptosis, where cells mediate their own destruction 
upon reaching a critical level of damage. Currently attributed with both pro-survival and pro-death 
functions, autophagy is a mechanism of intracellular protein degradation which is activated in response 
to various stimuli. Importantly, many human disease states are associated with or caused by 
dysregulation of these two fundamental biological processes. Autophagic degradation is currently 
characterized with seemingly opposing roles. On one hand, research has demonstrated that autophagy 
contributes to detrimental cellular breakdown. On the other, autophagy has displayed cyto-protective 
functions as cells are more sensitive to death-inducing insults when it is inhibited. Importantly, it is 
known that several stressors, including damaging pharmacological agents (staurosporine, doxorubicin, 
cisplatin), pathophysiological conditions (ischemia reperfusion, infection/inflammation), and even 
exercise, induce autophagy before or while cell death processes are activated. While initial assessments 
of these observations concluded that autophagy was contributing to cellular demolition and elimination, 
subsequent experiments indicate that autophagy occurs in an attempt to mitigate the encountered 
stress. Although autophagy appears to be generally benevolent, as with other biological phenomena the 
most likely answer is that an optimal level of autophagy exists, and that specific conditions of overactive 
and underactive autophagy can be pathological. However, an interesting concept can be taken from 
these studies: if a properly-regulated induction of autophagy is considered a front-line defence 
mechanism, it is possible that intermittent autophagic degradation functions to remove hazardous 
cellular contents, thereby improving the cellular environment over time. Taken one step further, if 
autophagy specifically is induced, that is, not in the context of mediating dysfunction/damage, it may 
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serve as a pro-active mechanism of stress resistance. In this way, autophagy may constitute a 
mechanism through which cell composition and function can be improved.  
 
This literature review provides an overview of the biochemical and physiological signals responsible for 
initiating and regulating both cell death and autophagy. Specifically, an emphasis will be placed on the 
autophagic removal of mitochondria, an occurrence termed mitophagy, due to the important role these 
organelles play in energy production and cell death. Furthermore, the interaction between the 
molecular signals regulating these degradative systems and their importance in maintaining tissue 
function and organ health will be considered.  
 
Cell Death Functions and Processes  
Apoptosis is a physiologically regulated cell death (RCD) mechanism responsible for eliminating 
abnormal, damaged, and/or unnecessary cells (1-3). Its activation results in cell removal by intracellular 
demolition stemming from protein cleavage, nuclei condensation, and directed packaging of cellular 
material. During development, specific cells undergo cell death in a genetically planned manner, thus 
regulating tissue shape and adult organ function (3). In adult organisms, apoptosis is responsible for 
removing cells which have lost specific functional abilities due to extra/intracellular damage or genetic 
disruption (2,3). Apoptosis represents a relatively clean method of cell death by limiting the exposure of 
potentially dangerous cellular contents to surrounding cells. In comparison, the cell death processes of 
necrosis and necroptosis elicit an immune response, which may lead to additional unwarranted tissue 
damage (4). Therefore, apoptosis allows cell removal while providing protection for the tissue and 
organism as a whole. Due to this important role, several disease states are associated with its 
dysregulation (3). For example, cancerous cells typically develop alterations which remove apoptosis-
activating sensors or result in an apoptotic-resistant phenotype (2,3). On the other hand, overactive 
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apoptosis is implicated in the development of several autoimmune disorders as well as in the tissue loss 
contributing to neurodegeneration and heart failure (2,3). The primary executioners of apoptotic cell 
death are a family of enzymes known as caspases which cleave substrates between cysteine and aspartic 
acid residues (2,3,5). Caspases are generally separated into two broad categories: initiator and effector. 
Both exist as inactive procaspases and are activated by proteolytic cleavage, removing their pro-domain 
and leaving a truncated, active form. Initiator caspases, such as caspases-8 and -9, are activated on 
large, enzyme-specific, multi-subunit scaffold platforms. Effector caspases, such as caspases-3, -6, and -
7, are activated by initiator caspases and are responsible for the cleavage of >400 cellular proteins (6). 
Cleavage of these numerous substrates results in cellular degradation, DNA fragmentation, and blebbing 
typical of cell death. The array of targeted proteins is large and includes: cytosolic and nuclear structural 
proteins such as actin and lamin; the DNArepair enzyme PARP, and the DNA-fragmenting enzyme ICAD; 
pro-death kinases MEKK and PKC; and additional pro-apoptotic effectors such as Bid (7).  
 
Cell death can be initiated by several extra- and intra-cellular mechanisms. The extracellular/extrinsic 
pathway involves activation of a formal death-receptor from the tumor necrosis factor (TNF) super-
family by the respective ligand (ie. TNF-a, Fas-L, TRAIL) (8).  These receptors contain death-domains 
(DD), and their activation stimulates assembly of protein scaffolds such as the death-inducing signalling 
complex (DISC) through interaction of regulatory molecules including TRADD/FADD and procaspase-8 
(8). This results in caspase-8 activation leading to cleavage-induced activation of caspase-3 (9). 
Intracellularly, cell death is induced by stressors sensed by the mitochondria and endoplasmic reticulum. 
Mitochondrial-mediated mechanisms are activated by toxic stimulants, growth-factor exhaustion, DNA 




Fig. 1. Overview of downstream apoptotic cell death signaling pathways. This figure illustrates the 
molecular signaling pathways of important apoptotic cell death molecular effector proteins. In response 
to various extra/intra-cellular stimuli (grey box, upper left), several signaling families (TNF, JNK) 
integrate information and activate death-associated transcription factors (p53) and effector signaling 
mechanisms (ROS) (green boxes). Cells use mitochondria as central mediators of cell death: as their 
function greatly impacts cells’ ability to produce engery and therefore live, the presence of 
mitochondrial-located proteins in the cytosol (indicating damage) act as strong proxy signals for the 
progression of cell death execution. Here, pro-death proteins (burgundy boxes) such as Bax participate 
in the permeabilization of mitochondria, causing them to release Cyt-c, Smac, and AIF, among others. 
Once release, these proteins directly damage DNA (AIF) and contribute to caspase activation (cyt-c, 
Smac). Caspases (red boxes) are proteolytic enzymes with numerous cellular targets whose activation 
ultimately leads to directed cellular demolition: these enzymes participate in amplification loops where 
their activities become unstoppable upon reaching a certain threshold. The binding of extracellular 
ligands at so-called death receptors is typically associated with caspase-8 activation through production 
of a series of highly ordered protein scaffolds. At the endoplasmic reticulum, accumulated misfolded 
proteins (brown clouds) and improper calcium handling can activate unique effectors such as CHOP, 
which promotes many aspects of cell death, and an additional family of proteolytic enzymes known as 
calpains. These pro-death signaling mechanisms are resisted by several proteins with anti-cell death 
functions (blue boxes), which provide an additional level of control. Note that significant cyclical 
redundancy exists with respect to these relationships: for example, although AIF cleaves DNA, DNA 
damage itself may initiate a similar chain of events (ie. activate p53) leading to caspase activation; 
similarly, caspase-dependent degradation of specifc targets, such as DNA or mitochondrial proteins, 
functions to amplify this response. TNF, tumor necrosis factor; JNK, c-jun N-terminal kinases; ROS, 
reactive oxygen species; casp-, caspase-; cyt-c, cytochrome c; Smac, second mitochondrial activator of 
caspases; AIF, apoptosis inducing factor; ARC, apoptosis repressor with caspase recruitment domain; 
XIAP, x-linked inhibitor of apoptosis protein; CHOP, C/EBP homologous protein; Ca2+, calcium. 
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production, alter mitochondrial membrane potential, and cause release of proteins such as cytochrome 
c, second mitochondrial activator of caspases (Smac), apoptosis-inducing factor (AIF), and endonuclease 
G (EndoG) (2,3). In the cytosol, cytochrome c joins with apoptotic protease activating factor (Apaf-1) and 
procaspase-9, forming a molecular structure known as the apoptosome (10). The apoptosome cleavage-
activates caspase-9, which in turn activates effector caspases (10). Smac release also leads to caspase 
activation by reducing the caspase-inhibiting potential of cytosolic proteins known as inhibitors of 
apoptosis (IAPs), which act on caspases-9 and -3 (11,12). AIF and EndoG, once released, can translocate 
to nuclei and cause DNA fragmentation independent of caspase activation (13,14).  
 
These processes are regulated by many accessory proteins which provide various levels of control. 
Apoptosis repressor with caspase recruitment domain (ARC) inhibits apoptosis by preventing DISC 
assembly and the association of proteins which cause mitochondrial release of pro-apoptotic factors 
(15,16). Heat shock protein 70 (Hsp70) directly inhibits caspase-9 and can bind AIF in the cytosol, thus 
impairing its nuclear translocation (17,18). An important cell death-regulating group of proteins are 
those belonging to the Bcl2 family. The Bcl2 family consists of both activators and inhibitors of cell death 
and mediate the release of pro-apoptotic factors from the mitochondria (1,2,13,19). These proteins 
share specific Bcl2 homology (BH) domains, the number of which determines their apoptotic role. The 
inhibitors (Bcl2, Bcl-xL) contain four BH domains, while the pro-apoptotic members are either missing 
the fourth BH domain (Bax, Bak) or contain only the BH3 domain (PUMA, Bid, Bad, Bnip3) (1,2). The 
BH3-only proteins exist under extensive transcriptional and post-translational control. For example, 
PUMA transcription is initiated by p53 (20), Bid becomes pro-apoptotic after proteolytic cleavage by 
caspase-8 and caspase-2 (21,22), Bad is activated by dephosphorylation during growth factor 
deprivation (23), and Bnip3 is hypoxia-inducible (24). Upon their activation, BH3-only proteins promote 
the cell death promoting roles of Bax and Bak by binding anti-apoptotic Bcl2 proteins, thus relieving 
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their inhibitory associations with Bax/Bak, and by directly interacting with Bax/Bak (1-3). Ultimately, Bax 
activation leads to a conformation change, causing its mitochondrial translocation where it oligomerizes 
in the outer mitochondrial membrane (1,2). At the mitochondria, Bax and Bak participate in the opening 
of channels in the outer mitochondrial membrane (OMM), which results in the loss of membrane 
potential and release of soluble proteins from the intermembrane space such as cytochrome c (1,2). 
Additionally, Bax and Bak may contribute to the development of mitochondrial permeability transition 
pores (mPTP). These mPMP, which are formed by reconfiguration of the F-ATP synthase and perhaps the 
additional interactions of cyclophilin D (CypD), translocator protein (TSPO), voltage dependent anion 
channel (VDAC), phosphate carrier (PiC), and adenine nucleotide transporters (ANT) allow the outflow of 
material from the mitochondria (25). The loss in membrane polarization and resulting osmotic 
imbalance causes swelling of the inner mitochondrial membrane (IMM), mitochondrial outer membrane 
permeablization (MOMP), and subsequent release of cell death activating factors into the cytosol (1,2). 
Mitochondrial permeablization, therefore, is a critical point in cell death regulation, as the loss of 
membrane potential additionally decreases the ATP generating capacity which, in itself, induces 
apoptosis (2,26).  
 
An important regulator of cell death is p53, which operates through direct protein-protein interactions 
and by acting as a transcription factor. Many cell-death inducing signals including DNA damage, elevated 
ROS, and various stress/mitogen activated protein kinases converge and depend on p53 to execute their 
apoptotic functions (2,3). As mentioned previously, p53 upregulates transcription of several pro-
apoptotic proteins including PUMA, Bax, and Bad, while simultaneously repressing transcription of Bcl2 
and ARC (20,27-29). In addition, mitochondrial p53 localization contributes to MOMP by interacting with 
Bad, Bax, Bak, Bcl2, and/or Bcl-xL, (28,30-33). Finally, p53 is able to reduce mitochondrial membrane 
potential by stimulating ROS production (34), and shuttling Fas receptor to the cell surface (35). Despite 
8 
 
the multitude of pathways through which p53 induces cell death, it also plays a primary role in 
regulating autophagy (36).  
 
In addition to the mitochondria, sufficient stress to the endoplasmic reticulum (ER) can activate cell 
death-promoting mechanisms (37). ER stress is induced by improper folding and/or the accumulation of 
misfolded proteins, resulting in activation of the unfolded protein response (UPR) (37). Here, a build-up 
of damaged proteins in the ER induces the oligomerization of eukaryotic translation initiation factor 2-
alpha kinase 3 (PERK), leading to translation inhibition in an attempt to limit the ER functional load 
(37,38). If the stress persists, continued PERK activation will stimulate the transcription factor C/EBP 
homologous protein (CHOP), thereby causing Bcl2 downregulation and translocation of Bax to the 
mitochondria (39-41). Another UPR-related factor, IRE1, will activate c-Jun N-terminal kinases (JNKs) as 
well as recruit TNF receptor-associated factor 2 (TRAF2), each of which promotes apoptosis-inducing cell 
signalling mechanisms (42,43). Furthermore, sufficient ER stress will lead to impaired Ca2+ homeostasis. 
Elevated cytosolic calcium can activate caspase-12 as well as a class of apoptosis-associated Ca2+-
induced proteases known as calpains (43-45). 
 
Regulation of Autophagy 
Autophagy is a degradative process responsible for breaking down various subcellular content (46-49). 
Unlike the other major proteolytic pathway, the ubiquitin-proteasome system (UPS), which targets 
individual substrates based on specific ligase-substrate identification, autophagy is thought to degrade 
large portions of cytoplasm in addition to entire organelles. Briefly, autophagy operates by generating 
double-membrane organelles known as autophagosomes, filling them with cellular cargo, and fusing 
these structures with lysosomes where their contents are degraded and recycled back into the cytosol 
(46,48,49). The execution of autophagy involves a highly conserved molecular signalling pathway that 
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can be induced by numerous stimuli (46-49). The primary function of autophagy seems to be the 
provision of energetic substrates during periods of starvation, thus sacrificing cellular material to enable 
adequate ATP production. In fact, systemic deletion of many autophagy-related genes is embryonically 
lethal in mice, largely due to autophagy’s ability to regulate and maintain the dramatic metabolic 
alterations which occur during development and the subsequent transition from in utero feeding (50-
55). Autophagy is additionally involved in defense, remodelling, and the removal of damaged and long-
lived proteins and organelles. Due to these functions, autophagy is considered cyto-protective, serving 
to prolong proper cellular functioning (46-49). However, the importance of proper autophagic regulation 
is emphasized during conditions of its overactivation, which can promote unnecessary degradation and 
even cell death (46,49). This is highlighted in the observation that dysfunctional autophagy is implicated 
in the pathogenesis of several diseases including cancer, neurodegeneration, and heart disease (46,49). 
Several classifications of autophagy exist; these are typically categorized based on the mechanism of 
lysosomal targeting (48,49). Autophagic degradation characterized by autophagosome-lysosome fusion 
is termed macroautophagy, but will be referred to simply as autophagy here. 
 
Autophagic degradation is carried out using well characterized molecular signalling machinery. Initially 
described in yeast, novel genes regulating autophagy were identified and termed autophagy-related 
(Atg) (46,48,49). However, many homologues have been identified in mammals and given names 
separate from their yeast “Atg” counterpart (46,48,49); the mammalian forms will be used here. 
Autophagy begins with the production of a double membrane structure known as the isolation 
membrane (yeast: phagophore). Development of the isolation membrane is controlled by two multi-
subunit kinase complexes (46,48). One such complex contains, among others, the proteins ULK1/2, 
Atg13, and FIP200, and will be referred to as the ULK complex (46-48). Under nutrient/growth factor-





Fig 2: Overview of downsteam autophagy signaling pathways. Although autophagy is acutely sensitive to 
energy/nutrient status, numerous other stimuli affect the execution of autophagic flux (grey box, upper 
left). These stimuli typically function by activating (AMPK, FoXO) and/or inhibiting (Akt, mTOR) cellular 
stress and energy/nutrient sensing molecular signaling mechanisms (green boxes). Autophagy involves 
de-novo production of an organelle called the autophagosome, principally mediated by the Beclin and 
ULK signaling complexes which modulate downstream autophagy-related (Atg) protein function. An 
important member of this developing organelle is LC3, the activated form of which (LC3II) is responsible 
for identifying appropriate targets for autophagic degradation. These potential substrates are identified 
by several means: p62 binds to aggregated and misfoled proteins (brown clouds) with ubiquitin tags, 
while mitochondria are identified by unique ubiquitin binding and complex kinase-dependent activation 
of Parkin and PINK1, which accumulates on dysfunctional mitochondria. Additional proteins such as 
Bnip3, Nix, and FUNDC1 as well as cardiolipin are also capable of interacting with LC3 and therefore 
identifying mitochondria to be degraded. Upon their complete formation, autophagosomes bind to 
lysosomes with the help of adaptor proteins such as LAMP, after which all autophagosomal contents 
(including the inner membranes) are degraded by proteolytic lysosomal enzymes (Pac-men shapes). The 
resulting peptides/amino acids are then released into the cytosol for recycling, or perhaps used for 
subsequent immunomodulation purposes. LAMP, lysosome associated membrane protein; LC3, 
microtubule associated protein light chain 3; PINK1, PTEN-induced putative kinase 1; Ub, ubiquitin. 
 
 
close association with the ULK complex (47,56). In this state, mTORC1 maintains a level of ULK1/2 and 
Atg13 hyperphosphorylation thereby inhibiting their activation (56,57). mTOR inhibition results in 
dissociation of the ULK complex from mTORC1 leading to ULK1/2 hypophosphorylation (56,57). This 
11 
 
activates ULK1/2, promoting its autophosphorylation and phosphorylation of distinct residues on other 
ULK complex members Atg13 and FIP200 (58). These phosphorylation events induce ULK complex 
activation and translocation to the site of pre-autophagosome production, leading to isolation 
membrane production as well as activation of other autophagy-related cellular machinery (56,58,59). 
Although the exact downstream targets of the active ULK complex are just being characterized (60), 
there is evidence that, in addition to stimulating phagophore production, it interacts with other 
regulators of isolation membrane development (47,61,62). The main protein members of this second 
kinase platform are Beclin1, Vps34, and Ambra1, and will be referred to as the Beclin1 complex (46,48). 
This complex functions as a class-III phosphatidylinositol 3-kinase (PI3K), and is responsible for the 
production of phosphatidylinositol 3-phosphate (PI3P) (63). The phosphatidylinositol for this reaction is 
sourced from other cellular membranes such as that of the plasma membrane (64), ER (65,66), or 
mitochondria (67), indicating that existing double membranes are required for autophagosome 
biosynthesis. In fact, it’s been demonstrated that ER-mitochondria contact sites, known as 
mitochondria-associated ER membranes (MAM), are the likely source of elongation membrane 
formation, as upstream autophagy-related proteins such as Beclin1 converge here during autophagy 
induction and whose dysfunction impairs autophagosome formation (68,69). Like ULK, the Beclin1 
complex is controlled by several mechanisms ensuring it is only activated when necessary. Primarily, due 
to the BH3 domain of Beclin1, the activity of this complex is reduced by direct binding of the anti-
apoptotic Bcl2 family members Bcl2 and Bcl-xL to Beclin1 (70). In addition, ULK-mediated Ambra1 
phosphorylation also contributes to Beclin1 complex activation (71). This event appears necessary to 
release the Beclin1 complex from a dynein light chain, thereby allowing its translocation to sites of 
membrane production (71). This, therefore, may represent a mechanism through which ULK signalling 
may aid in the sourcing of initial phagophore membrane products (71,72). Ultimately, the production of 
12 
 
PI3P induces autophagosome development by recruiting a number of adaptor proteins responsible for 
double membrane production (73,74). 
 
The pre-autophagosomal membrane produced by active ULK and Beclin1 complexes is elongated with 
the help of two ubiquitin-like conjugation systems. The first involves the assembly of a protein complex 
composed of Atg12, Atg5, and Atg16 (75,76). Here, Atg12 is activated by Atg7 in an E1-like manner and 
is ligated by the E2-like carrier Atg10 to Atg5, thus forming an Atg5-Atg12 heterodimer (77). This is 
joined by Atg16, forming the active Atg5-Atg12-Atg16 conjugated protein, which then translocates to 
the developing isolation membrane (46,48). The second ubiquitin-like conjugation system is responsible 
for activating a very important protein member of autophagosome membranes, microtubule-associated 
light chain 3 (LC3). LC3 is a cytosolic protein whose autophagic role is initiated by Atg4-dependent 
cleavage, leaving a product known as LC3I (78,79). LC3I, like Atg12, is activated by Atg7 in an E1-like 
manner and is subsequently conjugated to phosphatidylethanolamine (PE) by the E2-like carrier Atg3 
(80). The LC3I-PE conjugate, termed LC3II, is recruited by the Atg5-Atg12-Atg16 complex to the 
developing isolation membrane. Once the proper molecular machinery has been recruited, the ULK and 
Beclin1 complexes guide autophagosome elongation in association with Atg5-Atg12-Atg16, making LC3II 
a major membrane component (78,80). Here, in addition to basic structure, LC3II provides important 
functional roles. Upon completion of the autophagosome, the Atg5-Atg12-Atg16 conjugate dissociates, 
leaving LC3II embedded in the membrane. This is followed by autophagosome-lysosome fusion, 
dependent on the function of lysosomal associated membrane proteins (LAMPs), forming a structure 
known as the autolysosome (81). Finally, lysosomal hydrolases and cathepsins break down the 
autophagic cargo as well as the inner autophagosome membrane, including LC3II (46,48). Degraded 
material is released into the cytosol, where it is used for energy metabolism, protein synthesis, and 
various other tasks (46,48,49). 
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Because the biochemical products of autophagic degradation are used in a variety of cellular functions, 
and as overactive autophagy would be unnecessarily catabolic, its execution is precisely regulated. The 
mTORC1 is perhaps the most important control point for autophagy induction which, as previously 
mentioned, responds to cellular nutrient and energy status and affects ULK complex function (46-48). 
mTORC1 integrates information from several signalling pathways to regulate mRNA translation, 
subsequently impacting various cellular functions including cell cycle, differentiation, and cytoskeletal 
organization in addition to autophagy (46,47). mTORC1, composed of the subunits mTOR, raptor, 
mLST8, and PRAS40, is canonically inhibited with rapamycin, which stabilizes mTOR-raptor association 
thereby reducing the complex kinase activity (46). Active mTOR phosphorylates specific targets resulting 
in promotion of protein synthesis and prevention of autophagy; its inhibition therefore reduces mRNA 
translation and induces autophagy (46). The typical method of autophagy induction is nutrient 
deprivation, and many signals related to this phenomenon modulate mTOR function (46,47). Insulin and 
growth factor signalling inhibit autophagy through an Akt-mTOR axis. Insulin receptor activation 
stimulates phosphorylation of insulin receptor substrates (IRS), recruitment of class 1 PI3Ks, and 
production of phosphatidylinositol triphosphate (PIP3). PIP3 activates phosphoinositide dependent 
kinase 1 (PDK1) which subsequently phosphorylates and activates Akt. Activated Akt promotes 
phosphorylation of tuberous sclerosis complex components (TCS1, TSC2), thus preventing TSC2 
interaction with TSC1 and blocking formation of the TSC1/2 complex (82). TSC1/2 is the GTPase 
activating protein (GAP) for the GTP-binding protein Rheb, and its inhibition causes Rheb to exist in its 
active GTP-bound state, allowing it to directly bind and activate mTORC1 (83,84). During periods of 
amino acid availability, mTORC1 is maintained in its active, protein synthesis promoting form via the 
interaction between raptor and the Rag family of small GTPases (85,86). Reduced cellular amino acid 
concentrations caused by starvation therefore remove the Rag/Rheb-mediated sensitisation of mTOR to 
nutrient availability, releasing the brake on autophagy induction (87). Finally, nutrient unavailability 
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increases the AMP:ATP ratio, resulting in AMPK activation. AMPK inhibits mTORC1 by phosphorylating 
TSC2 in a manner similar to Akt (but on different residues), as well as downstream of TSC1/2 by directly 
phosphorylating the mTORC1 component raptor (88,89). Furthermore, AMPK can activate autophagy by 
directly phosphorylating ULK1 (90,91). 
 
Many of the autophagy-regulating mechanisms just described are additionally controlled by stress-
sensitive systems like ROS as well as elaborate kinase signalling pathways involving JNKs, mitogen-
activated protein kinases (MAPKs), and extracellular-signal regulated kinases (ERKs) (36,46,49). Although 
elevated ROS impact autophagy by causing cellular damage that autophagy attempts to mitigate, ROS 
additionally play direct roles regulating autophagy induction and execution (36,46,49). In fact, 
antioxidant administration actually depresses the level of starvation- (92) and ROS- (93,94) induced 
autophagy. Specifically, oxidation of Atg4 is partially required for autophagosome production (92), and 
ROS-induced inhibition of mTOR is dependent on AMPK (95). In this latter paper, autophagy activation in 
response to ROS also required the DNA damage sensor ataxia-telangiectasia mutated (ATM), and 
rescuing autophagy in ATM-deficient mice by administration of rapamycin reversed ROS-induced 
lymphomagenesis (95). Typically, autophagy protects from ROS-induced apoptosis (36,46). However, in 
specific cell types, suppression of autophagy-related genes actually ameliorated ROS-induced cell death 
(96), demonstrating the complexity of this relationship. Several stress-related kinases also impact 
autophagy in both mTOR-dependent and independent ways. JNK1-dependent phosphorylation of Bcl2 
decreases its inhibition of Beclin1, thereby permitting autophagy induction during starvation (97). JNK 
signalling also contributes to mitophagy specifically by inducing FoxO3a-dependent transcription of 
Bnip3 (98). Growth-factor dependent activation of Ras signalling inhibits autophagy through MAPK-
dependent activation of Akt (99). Furthermore, an amino-acid sensitive MAPK, Raf-1, impairs activation 
of downstream MAPKs MEK1/2 and ERK1/2 thereby inhibiting autophagy during nutrient excess 
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conditions (100). Likely, the integration of information processed by these complex signalling pathways 
allows cells to fine-tune their autophagic responses.  
 
As mentioned, autophagy is capable of degrading non-specific portions of sequestered cytoplasm as well 
as specific cellular targets, including whole organelles. One way in which specific substrates are 
identified is through the interaction of LC3II with p62 (46,48). P62 is a multifunctional adaptor protein 
commonly found in clusters of protein aggregates. Damaged and misfolded proteins can be tagged for 
UPS degradation with the small regulatory factor ubiquitin. In addition to the proteasome, p62 can 
identify mono- and poly-ubiquitinated proteins and directly bind to them via its ubiquitin-associated 
domain (UBA) (101,102). P62 can subsequently bind to LC3 via its LC3-interacting region (LIR), thus 
directing specific substrates for autophagic degradation (101,102). This function is vital not only for the 
clearance of accumulated proteins but for basal autophagy, and therefore p62 is commonly analyzed as 
an indicator of autophagic flux (103). A similar protein, NBR1, also contains UBA and LIR, and functions 
similar to p62 (104). NBR1 can also directly bind to p62, where together they act as receptors for 
autophagic degradation of ubiquitinated substrates. Another method of aggresome degradation 
involves the recruitment of heat-shock proteins and the E3-ligase CHIP along with the co-chaperone 
BAG3 (105,106). Here, misfolded and ubiquitinated targets are sequestered by heat-shock complexes 
and shuttled to developing autophagosomes through the interaction between BAG3, p62, and LC3 
(105,106). Lastly, several proteins participate in the identification of entire organelles for autophagic 
degradation. While autophagy appears capable of sequestering ribosomes, peroxisomes, and 
endoplasmic reticulum, the targeting of mitochondria is of particular interest given their role in energy 




Mitophagy as Targeted Autophagic Degradation 
Autophagy of mitochondrial (mitophagy) is a precisely controlled process, often regulated 
independently of the nutrient/energy/stress signals that govern basal autophagy (107). Mitophagy is 
important for the maintenance of mitochondrial morphology and function. Specifically, it appears that 
mitophagy primarily operates as a quality control mechanism, targeting and degrading dysfunctional 
mitochondria that may otherwise contribute to the activation of apoptotic signalling (107). Additionally, 
mitophagy is responsible for eliminating healthy mitochondria during the differentiation of several cell 
types (108-110). While the stimuli for induction and targeting may differ between mitophagy and “non-
specific” autophagic degradation, mitochondria are thought to be degraded by full autophagosome 
sequestration and subsequent lysosomal fusion. In this sense, mitochondria are simply treated as very 
large autophagic substrates, thereby requiring activation of the molecular machinery responsible for 
phagophore production and substrate recognition (ie. Beclin1, ULK, LC3, etc.) (107). However, due to the 
size and complexity of mitochondrial networks, specific biological events related to mitochondrial 
identification and sequestration during mitophagy do exist. 
 
Execution of mitophagy actually involves unique/additional substrate identification mechanisms. 
Notably, this typically includes the proteins Parkin and PINK1. Parkin, a cytosolic E3-ubiquitin ligase, and 
the mitochondrial phosphatase PTEN-induced kinase 1 (PINK1), were initially described due to their 
association with recessive form of parkinsonism (111,112). Specifically, this form of Parkinson’s is 
associated with PINK1/Parkin dysfunction stemming from their genetic mutation. Normally, PINK1 is 
constitutively transported into mitochondria, cleaved by the protease presenilin-associated rhomboid-
like protein (PARL), and subsequently degraded by mitochondrial proteases (113,114). When 
mitochondria become dysfunctional, PINK1 degradation by PARL is restricted and PINK1 becomes 
stabilized on the outer mitochondrial membrane (114-116). Specifically, it appears that PARL function is 
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dependent on proper mitochondrial membrane polarity, and dissipation of membrane potential reduces 
its activity resulting in PINK1 accumulation (114,117). In response, Parkin translocates to sites of 
mitochondrial damage denoted by PINK1 presence (114-116,118). Despite this widely accepted 
mechanism of mitophagy targeting and autophagic sequestration, it is unknown how exactly 
accumulation of PINK1 on mitochondrial membranes triggers Parkin recruitment (107). It is currently 
thought that mitochondrial proteins phosphorylated by PINK1 serve as Parkin docking sites or that direct 
phosphorylation of Parkin stimulates its translocation (107,119). More recently, the phosphorylation of 
ubiquitin by PINK1 and formation of specific poly-ubiquitin chains has been shown to regulate Parkin 
recruitment (120). Here, through an apparent feed-forward mechanism, mitochondrial depolarization 
and ubiquitination of mitochondrial outer membrane proteins allows PINK1-dependent phosphorylation 
of polyubiquitin as well as Parkin, both enhancing mitochondrial tethering of Parkin thereby causing 
further ubiquitination (121,122). In addition, one study has shown that the constitutively produced 
PINK1 cleavage fragment travels to the cytosol and impairs Parkin recruitment (123). Regardless, Parkin 
ubiquitinates several outer mitochondrial membrane proteins following its translocation, resulting in the 
isolation of mitochondrial fragments from the healthy population (124,125). Subsequently, these 
mitochondria are identified by ubiquitin-p62-LC3 autophagosome targeting and degraded following 
lysosomal fusion (117,118,126). However, it is important to note that several reports have indicated p62 
is required for mitochondrial clustering/fragmentation during mitophagy, but not in their degradation 
specifically (117,127,128). 
 
Several mitochondrial proteins have been identified as Parkin substrates which appear to be important 
for mitochondrial fragmentation and targeting, as well as autophagic identification. This includes the 
outer membrane fusion proteins mitofusins 1 and 2 (Mfn1/2), the translocases of the outer membrane 
(TOMs), voltage dependent anion channels (VDACs), and Miro (124,129-131). Parkin-mediated Mfn 
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ubiquitination stimulates its proteasomal degradation, and it is thought this occurs to prevent defective 
mitochondria from fusing back into the mitochondrial network (124,132). However, although Mfn 
degradation is necessary for mitophagy, this does not trigger mitophagy itself, as PINK1 and Parkin can 
initiate mitophagy in cells lacking Mfns (124,132). It was recently demonstrated that PINK1-dependent 
phosphorylation of Mfn2 was required for ubiquitination by Parkin, perhaps providing a mechanism for 
PINK1-dependent mitochondrial Parkin recruitment (133). Mfn elimination highlights the requirement 
for correct mitochondrial segregation during mitophagy.  Importantly, excessive fusion, caused by 
overexpression of optic atrophy 1 (Opa1) or dominant-negative dynamin related protein 1 (Drp1), 
inhibits autophagic degradation of mitochondria (134). In fact, rounds of fission may be necessary or 
even responsible for causing mitochondrial fragments with phenotypes appropriate for autophagic 
degradation (ie. depolarized membranes) (134). Thus, functioning mitochondrial fission/fusion 
machinery, particularly the fission-regulating protein Drp1, should be considered prerequisite for proper 
mitophagy. During mitophagy, PINK1 and Parkin also become associated with Miro, a protein that 
anchors a kinesin/microtubule motor complex to mitochondria (131). Similar to Mfn, phosphorylation by 
PINK1 and ubiquitination by Parkin stimulates proteasomal degradation of Miro, releasing mitochondria 
from the kinesin complex and reducing mitochondrial motility, perhaps providing an additional 
mitochondrial quarantine measure (131). VDACs are also required for efficient Parkin recruitment, and 
their Parkin-dependent ubiquitination is necessary for mitophagy (118,130). However, in this study, as 
long as cells expressed one of the three VDACs present in mammals, mitophagy occurred seemingly 
unimpaired (130), supporting the findings of others who concluded VDAC ubiquitination was 
dispensable for mitophagy (117). Finally, Parkin ubiquitination of several TOM isoforms during 
membrane depolarization stimulates their proteasomal degradation (129). Although the specific role 
this has on mitophagy is unclear, PINK1 associates with TOM on mitochondria with polarized 
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membranes, therefore depolarization-induced PINK1 accumulation may affect TOM degradation and 
subsequent import of PINK1 (135).  
 
Proper autophagic sequestration of mitochondria is aided by several adaptor molecules which function 
alongside and independently of PINK1 and Parkin. In yeast, the protein Atg32 functions alone in 
mitochondrial tagging, fragmentation, and identification of damaged mitochondria by autophagic 
machinery (136,137). A mammalian structural homologue, Bcl2-L-13, was recently demonstrated to be 
required for mitochondrial fragmentation and mitophagic degradation in HEK293 cells, and was 
additionally shown to mimic Atg32 in yeast (138). Here, this protein was shown to be capable of causing 
mitochondrial fragmentation independent of Drp1 through its BH domains, binding to LC3 using its LIR 
domains, and incorporation of mitochondrial fragments into lysosomes and depletion of mitochondrial 
proteins (indicating mitophagy) in the absence of Parkin. However, due to their relative complexity, 
previous research in mammalian cells has characterized a growing list of proteins which regulate 
mitophagy during various conditions (139). Two other Bcl2 family members possess autophagy 
promoting capabilities independent of their pro-apoptotic functions associated with being BH3-only 
proteins (140). Bnip3 (Bcl2/adenovirus E1B 19-kDa interacting protein 3) and its homologue Nix (Bnip3L) 
are implicated in several means of autophagy induction (141-144). Bnip3 and Nix induce autophagy by 
competitively binding to and displacing Bcl2/Bcl-xL from Beclin1, and perhaps by their ability to 
depolarize mitochondria (145). Furthermore, both interact directly with LC3 via LIR domains, and are 
therefore important for autophagosome-mitochondria targeting (142,146-148). The existence of LIR 
domains and binding of Bnip3/Nix with LC3 is the mechanism through which these proteins are thought 
to induce mitophagy independent of PINK1/Parkin. Alternatively, although PINK1- or Parkin-mediated 
exposure of Bnip3/Nix LIR domains is enticing, thus far evidence of such interactions is limited. However, 
it has been demonstrated that Bnip3 affects PINK1 function by suppressing its proteolytic cleavage thus 
20 
 
enabling PINK1-dependent mitophagy during hypoxia, and that Bnip3 overexpression suppresses muscle 
degeneration caused by PINK1 deactivation (149). In separate studies performed in cardiomyocytes, 
Bnip3 and Nix were able to trigger the translocation of Drp1 to mitochondria resulting in mitochondrial 
fission, followed by Parkin-dependent mitophagy (126,150). Another mitophagy targeting protein, 
FUNDC1, has been identified as an outer mitochondrial membrane protein involved in mitophagy (151). 
FUNDC1, similar to Bnip3/Nix, functions as an autophagosome receptor and mediates mitochondrial 
selective autophagy by interacting with LC3 through a LIR-like motif (151). Interestingly, ULK1 was 
recently shown to phosphorylate FUNDC1, enhancing its ability to bind LC3 (152). In this study, FUNDC1 
reciprocally participated in mitochondrial recruitment of ULK1. The essential mitochondrial membrane 
phospholipid cardiolipin was also observed to signal mitochondria for autophagic degradation (153). In 
response to several autophagy inducers, cardiolipin externalization occurs and is subsequently bound to 
by specific LC3 residues (153). The protein optineurin, dysfunction of which is associated with 
amyotrophic lateral sclerosis (ALS) (mutation of optineurin on its own actually causes symptoms of ALS), 
also interacts with Parkin-dependent ubiquitinated mitochondria and LC3 using its LIR (154). In fact, 
despite the array of mitophagy-related adaptors, two recent studies have identified optineurin and the 
xenophagy-related protein NDP52 as the de facto receptor proteins required for mitophagy (128,155). 
These researchers suggest these two receptors function partly redundantly to link phosphorylated 
polyubiquitin to LC3 and subsequent Parkin-dependent enhancement of mitochondrial membrane 
protein ubiquitination (128). Here, PINK1-dependent phosphorylation of ubiquitin is vital to activating 
ubiquitin, optineurin, and NDP52 irrespective of Parkin presence. Importantly, fully Parkin-independent 
execution of mitophagy has been described (156). These researchers observed that the ULK-complex 
member Ambra1 promoted mitochondrial sequestration and mitophagy in Parkin-expressing cells. 
Additionally, in the absence of Parkin and p62, Ambra1 relocated to depolarized mitochondria and 
recruited LC3, a function dependent on its LIR (156). Similar observations of Parkin- (138,157-159) and 
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PINK1-independent (160) mitophagy have also been made by others, observations typically ascribed to 
the function of alternate mitochondrial targeting mechanisms. The existence of multiple and redundant 
mitochondrial targeting mechanisms underscores the importance of accurate substrate identification in 
mitophagic degradation.  
 
Notably, the mechanisms of mitophagy induction outlined above all relate to mitochondrial segregation 
and identification by autophagosomes. Assuming that mitophagy requires autophagosome 
sequestration, an important question is: how does mitochondrial dysfunction induce autophagosome 
membrane production? In fact, recent work has demonstrated some interaction between the mitophagy 
machinery and upstream autophagy kinase complexes. First, Beclin1 has been shown to be involved 
with mitochondrial translocation of Parkin and subsequent Parkin-induced mitophagy (161). 
Importantly, following mitophagic stimuli, PINK1, Beclin1, and Parkin localize to MAM (162). Here, PINK1 
aids in recruiting Beclin1 to MAM independently of Parkin, and this interaction was required for proper 
MAM-associated autophagosome biogenesis (162). The Beclin1 complex component Ambra1 is also 
recruited to depolarized mitochondria and promotes isolation membrane production and mitochondrial 
clearance (156,163). Next, full-length PINK1, which would only accumulate during mitochondrial 
depolarization, interacts with Beclin1 to promote autophagy (164). Finally, recent evidence shows that 
phosphorylation of the mitophagy receptors NDP52 and optineurin can activate the upstream 
autophagy regulating protines ULK1, DFCP1, and WIPI1 (128). Therefore, the ultimate result of these 
interactions is that during normal cellular functioning mitochondria prepped for mitophagy are 
degraded alongside other autophagy substrates, and that this occurs to a greater extent when markers 
of dysfunction (PINK1, Parkin, ubiquitin, Bnip3, p62, etc.) are present. One consideration to make is that 
these molecular descriptions of mitophagy execution were performed after an induction of 
mitochondrial dysfunction, an experimental necessity as mitophagy occurs relatively infrequently in 
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healthy mammalian cells (107). Typically, this involved chemical interruption of membrane polarization, 
photo-irradiation of mitochondria, or specific genetic manipulation (107). While pharmacological 
mitochondrial depolarization definitely activates mitophagy, other, physiological mechanisms of 
mitophagy induction are less well characterized. Perhaps the most commonly examined biological 
stimulator is ROS. Of note, Bnip3 is hypoxia-inducible and has been implicated in the regulation of 
mitophagy during ischemia-reperfusion (IR) in the heart (140,141,143,145). 
 
Autophagy in Skeletal Muscle 
In skeletal muscle, autophagy has demonstrated divergent functions. First, autophagy participates in the 
degradation of energetic substrates in skeletal muscle tissues during nutrient deprivation (165-168). This 
function is likely vital for converting and mobilizing skeletal muscle’s large protein and glycogen stores 
into fuel for use by other tissues. In fact, it was recently shown that mice lacking skeletal muscle AMPK 
displayed hypoglycemia during fasting, a finding attributed to their inability to supply the liver with 
alanine for gluconeogenesis resulting from depressed skeletal muscle autophagy (169). However, this 
catabolic response must be properly regulated, and therefore autophagy may unnecessarily contribute 
to atrophy during specific circumstances (165). Elevated skeletal muscle autophagic activity has been 
observed in response to denervation (166,170,171), fasting (166,168,172), oxidative stress (173,174), 
chemotherapy (175), inflammation (176), glucocorticoid administration (176,177), and disuse (178,179). 
Although relatively fewer examinations regarding the specific activation of mitophagy in skeletal muscle 
have been performed, fasting has been shown to cause elevations in Bnip3 and Parkin levels (180,181), 
while indirect measurements have suggested increased mitophagy during fasting and denervation 
(170,171,180). Additionally, one study demonstrated that Parkin-deficient mice displayed delayed 
atrophy and decreased UPS activation during denervation compared to their wild-type counterparts 
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(171). Despite increased autophagic activity in skeletal muscle during these atrophic conditions, it is 
unclear whether this response contributes pathologically.  
 
Importantly, the lack of autophagy also produces a number of detrimental effects. Owing to its 
important role as a cyto-protective mechanism in post-mitotic tissues, autophagy is required for 
maintenance of adult skeletal muscle, and dysfunctions in autophagy are associated with several 
pathological conditions, including aging, chronic disease, specific myopathies, and muscular dystrophies 
(165,182-186). In fact, simply inhibiting autophagy in skeletal muscle of adult mice through genetic 
deletion of Atg7 or Atg5 results in structural and functional abnormalities (182,184). Additionally, mice 
with skeletal muscle Atg7 deficiency since birth actually display increased atrophy during denervation 
(182). Reductions in mitophagy-related factors have also been observed during aging (187). Due to the 
energy demands and stress incurred, autophagy is unsurprisingly induced in skeletal muscle during and 
after exercise (188-190). It was previously demonstrated that autophagy contributes to the provision of 
metabolic substrates during prolonged acute exercise, and mice that are unable to induce autophagy 
during exercise have decreased running capacity (189). However, others have reported no detriment in 
exercise capacity in autophagy-deficient mice (191,192). Importantly, repeated autophagy induction is 
thought to be partially responsible for the beneficial effects of exercise training (190). This stems from 
the idea that skeletal muscle undergoes dramatic remodelling in response to chronic exercise, and that 
these changes require the turnover/transformation of cellular proteins and structures (190). The 
occurrence of mitophagy has also been noted after a bout of exercise, albeit indirectly (193), a response 
which theoretically has implications regarding training-induced mitochondrial biogenesis (110). Clearly 
then, autophagy serves a number of important roles in maintaining adult skeletal muscle structure and 
function. Finally, autophagy also appears to be important for skeletal muscle formation, where it 
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contributes to energy provision (194), protects from apoptotic signalling (183), and participates in 
mitochondrial remodelling (110).  
 
In fact, investigations of autophagy’s physiological relevance are normally performed to examine its 
cyto-protective role during various conditions. Specifically, without mitophagy, accumulation of 
dysfunctional mitochondria will theoretically lead to promotion of mitochondrial-mediated apoptotic 
signaling (107). Unsurprisingly then, significant cooperation exists between mitophagy and apoptosis 
mediators. 
 
Interplay Between Autophagy and Cell Death: Molecular Signalling and Relevance 
Several molecular components with apoptosis- and autophagy-specific roles have been shown to 
regulate both mechanisms. These functions provide a further level of pathway complexity that 
translates into a greater ability to fine-tune a stress response. The molecular interactions between 
apoptosis and autophagy are characterized by proteins with directly overlapping functions, the blunting 
of apoptotic proteolysis during elevated autophagic activity, and a tendency for autophagy inhibition 
during apoptosis. 
 
As previously mentioned, the Bcl2 family of proteins are responsible for mediating apoptosis primarily 
through their roles related to mitochondrial permeablization. With respect to autophagy, the anti-
apoptotic Bcl2 members (Bcl2, Bcl-xL) inhibit Beclin1 complex PI3K activity by directly binding to 
Beclin1’s BH3 domain (70,195). Therefore, inhibiting Bcl2 through competitive binding by BH3-only 
proteins (ie. Bad, among others) and BH3 mimetics will increase Beclin1 complex activity and 
subsequently promote autophagy (195). Furthermore and as already cited, in addition to functioning as 
mitophagy receptors by interacting with LC3 (146,147), the BH3-only proteins Bnip3 and Nix interrupt 
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Beclin1-Bcl2 binding (145). Although their ability to induce apoptosis versus autophagy is not clear, the 
mitochondrial localization of Bax/Bak and BH3-only proteins may contribute to mitochondrial 
membrane depolarization and autophagosome membrane production at low activation levels, thereby 
only promoting apoptosis during prolonged/high intensity stresses. The apoptosis regulator p53 has also 
been shown to inhibit autophagy (196). Cytosolic localization of p53 protein allows its direct interaction 
with and inhibition of FIP200 (197) and Parkin (198), thereby reducing Beclin1 complex activity and 
preventing mitochondrial autophagic clearance. However, during situations of induced autophagy, p53 
is responsible for activating transcription of TSC and AMPK components, two platforms with mTOR 
inhibiting, and therefore autophagy promoting, functions (199). Another p53 transcriptional target, 
DNA-damage regulated autophagy modulator 1 (DRAM1) is additionally responsible for executing p53-
dependent autophagy during DNA damage and inhibition of mitochondrial respiration (200,201). As 
mentioned above, mitochondrial externalization of cardiolipin is required for mitochondrial targeting by 
LC3 and sequestration by autophagosomes (153).  This essential membrane phospholipid also possesses 
several functions related to apoptosis. Oxidation of cardiolipin is known to be a major mechanism 
contributing to the mitochondrial release of cytochrome c (202), cardiolipin provides an activating 
platform for caspase-8 (203), and its oxidation also promotes OMM pore formation by tBid (204). A 
number of additional proteins display overlapping but less well examined roles. Death associated 
protein kinases (DAPKs) phosphorylate Beclin1 thereby relieving binding by Bcl-xL (205), JNK-dependent 
phosphorylation of Bcl2 similarly decreases inhibition of Beclin1 (97), and Akt inhibits autophagy and 
apoptosis by phosphorylating Beclin1 and Bad, respectively (206,207). 
 
Several stressors have been shown to sequentially induce autophagy and apoptosis. Likely, this allows 
cells to mediate damage through elevated autophagic degradation before reaching a level obliging 
death (107). In fact, a recent analysis indicated that not only did cells induce autophagy and apoptosis 
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consecutively in response to several stressors, but those which mounted the most robust autophagic 
response displayed the greatest apoptotic resistance (208). This potential cyto-protective function of 
autophagy is commonly observed and is highlighted by the numerous observations that cell death 
increases when autophagy is inhibited (46,48,49) or that cell death can be attenuated by increasing 
autophagy (209,210). A quick internet/PubMed search for “autophagy and cell death” demonstrates the 
huge number and variety of situations in which this relationship is observed. Importantly, many of these 
effects are due to autophagic clearance of defective mitochondria whose continual dysfunction would 
lead to the activation of typical mitochondrial-mediated cell death mechanisms. Mitophagy was shown 
to attenuate heat-shock induced apoptosis, and chemical inhibition of the Beclin1 complex with 3-MA 
decreased mitophagy while increasing cytochrome c release and caspase-3 activity (211). Reducing 
Parkin protein levels sensitized neural cells to apoptotic cell death (212), and its overexpression 
protected cardiomyocytes during hypoxia (213). Finally, Bnip3-meidated mitophagy has also been 
shown to limit the mitochondrial amplification of apoptosis by reducing cytochrome c release capability 
(214). In addition to tempering the damage caused by dysfunctional mitochondria, other actions 
associated with mitophagy induction prevent apoptosis activation. Upon mitochondrial depolarization, 
PINK1 stabilizes the anti-apoptotic abilities of Bcl-xL by phosphorylating and preventing its cleavage 
(215). Although cytosolic p53 can bind to and inhibit mitochondrial Parkin translocation, Parkin has been 
shown to prevent p53-induced caspase-3 activation by acting as a transcriptional repressor of p53 (216). 
Additionally, specific targeting and degradation of caspase-8 during autophagy induction has been 
observed (217). In another interesting study, the proteins Bcl2 and FKBP38 were shown to selectively 
escape mitophagic degradation, and this contributed to apoptotic resistance (218). Clearly, autophagy 




When cellular stress and damage reaches a critical level however, apoptotic signalling mechanisms will 
overcome autophagy’s protective capabilities and induce cell death. In fact, part of this response 
involves caspase-dependent cleavage and inactivation of autophagy executing proteins. The Beclin1 
complex again constitutes a major site of this regulatory action. Caspase-3 can cleave Beclin1 itself 
during apoptosis induced by Bax, subsequently causing autophagy inhibition (219). Interestingly, the C-
terminal fragment of Beclin1 resulting from caspase cleavage was shown to translocate to mitochondria 
where it promoted the release of pro-apoptotic factors (219,220) Ambra1 is a substrate for both 
caspase- and calpain-mediated cleavage during staurosporine induced apoptosis, subsequently 
contributing to inhibition of autophagy (221). Similarly, the Beclin1 complex member Atg3 also 
undergoes caspase-dependent cleavage during apoptotic stress (222). Substrates for apoptosis-induced 
inactivation of autophagy apart from the Beclin1 complex have also been identified. Of note, calpain-
mediated Atg5 cleavage sensitized tumour cells to apoptotic stress, presumably due to inhibition of 
autophagic flux (223). Additionally, in several non-cancer cell lines, calpain activation produces an Atg5 
cleavage product which undergoes mitochondrial translocation, leading to cytochrome c release and 
caspase activation (223). Similarly, the product of caspase-dependent cleavage of Atg4 has apoptosis-
promoting effects (224). Finally, caspases cleave and inactivate Parkin, preventing the degradation of 
dysfunctional mitochondria and promoting a feed-forward cycle of cellular damage (225). Non caspase-
dependent cleavage mechanisms also occur. The pro-apoptotic kinase mammalian sterile 20-like kinase 
1 (Mst1) phosphorylates Beclin1, enhancing Beclin1 interaction with Bcl2/Bcl-xL, thus inhibiting 
autophagy and enhancing apoptosis (226). Furthermore, JNK phosphorylation of Mfns lead to their 
degradation during apoptosis and restricts Parkin-mediated mitophagy (227). Therefore, cells possess 
multiple redundant mechanisms which, during adequate apoptotic signalling, ensure autophagy 




Although cells normally induce autophagy to protect themselves from further damage, there are a few 
examples of autophagy-promoted cell death. Of course, unrestrained autophagy and mitophagy would 
be unnecessarily catabolic and theoretically lead to cellular mitochondrial depletion. While these are not 
commonly observed methods of cell death in mammalian cells, some autophagy machinery is involved 
in cell death execution and the induced cell death of some specific cancer cell types is known to involve 
autophagy (36). Although caspase-8 activation typically occurs on a plasma membrane-bound complex 
called the DISC, a similar platform forms on autophagosomes and is required for complete enzyme 
activation (228). Atg12 has also been shown to promote apoptosis by binding to and inhibiting Bcl2, a 
function required for full cytochrome c release during staurosporine induced apoptosis (229). 
Furthermore, autophagy inhibition prevented cell death induced by falcarindiol in breast cancer cells 
(230), by MG-2477 in neuroblastoma cells (231), and by sunitinib in prostate cancer cells (232). In a 
more general setting, an interesting study demonstrated that inhibiting mitophagy resulted in less cell 
loss during starvation (233). Here, mitochondrial fusion increased during nutrient withdrawal, 
generating mitochondria that were too big to fit into autophagosomes. While starvation stimulated 
autophagy, the impact of specific mitophagy inhibition was maintenance of ATP generating capacity. 
When fission, and therefore mitophagy, was increased, starvation resulted in more cell death (233). 
Therefore, proper regulation of mitophagy and apoptosis is clearly necessary to appropriately respond 
to a variety of stresses. 
  
Pathophysiological Implications of Autophagy 
Until this point, autophagy and cell death have mostly been considered with respect to their context on 
a molecular and/or cellular level. Importantly, these molecular and cellular consequences of 
autophagy’s impact on cellular stress resistance and function are relevant to numerous pathological 
conditions. Due to overlapping regulatory mechanisms, defective autophagy and mitophagy contribute 
29 
 
to unnecessary cell death and tissue loss, and the development of cellular pro-apoptotic environments 
can decrease the limit of survivable stress (46,48,49). 
 
An obvious example of this is cancer development. Although apparently paradoxical, as autophagy is 
typically a pro-survival process, decreased autophagic activity is suggested to contribute to 
tumourigenesis (49,234). Mechanistically, several genetic alterations, such as p53 mutations, Bcl2 
upregulation, and Beclin1 inactivation, are commonly observed in human cancers and cause cell death 
avoidance and alter cell cycle regulatory processes while additionally impairing autophagy (49,235,236). 
With respect to tumour development then, two hypotheses are generally agreed upon occurring 
(49,234,236). First, chronic/accumulated cellular stress, including that associated with oncogenesis, 
leads to genomic instability and oncogene activation in the absence of the damage-controlling relief of 
autophagy (a process that is likely mediated through p62 accumulation-induced NRF2 activation (237-
239)); and similarly, without autophagy the stress associated with tumour development causes cell 
death through less immunologically-silent mechanisms and promotes an inflammatory environment, 
thereby leading to cancer progression (240). However, it is also well established that enhanced 
autophagy promotes the growth of established cancers and definitely contributes to therapy resistance 
(234). Therefore, cells that arise with increased ability to activate autophagy will thereby resist the 
ischemic and metabolic stresses associated with cancer progression and drive tumour growth. Although 
much is known regarding how this increased level of autophagy keeps cancer cell alive (for example by 
maintaining mitochondrial function, limiting ROS production, providing energetic substrates, resisting 
acute stresses, etc.), it appears relatively unknown how and why cells with augmented autophagic 
abilities arise at the onset of oncogenesis, particularly given that the genetic links briefly listed above 
(p53, Bcl2, Beclin1) cause autophagy impairment. It would additionally be interesting to identify specific 
cellular targets degraded by autophagy that promote tumour growth. 
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Insufficient mitophagy is directly related to the development of certain forms of Parkinson’s (111,112). 
As outlined above, specific mutations in PINK1 and Parkin lead to the accumulation of protein 
aggregates and defective mitochondria thereby resulting in cell damage caused by impaired mitophagic 
flux (111,112,241,242). In fact, Parkin deficiency directly contributes to the accumulation of amyloid 
beta, a known protein aggregate associated with several neurodegenerative conditions including 
Alzheimer’s (241,243). Additionally, mutations in PINK1 lead to dopaminergic cell loss typically observed 
during neurodegenerative diseases due to mitochondrial calcium stress (242,243). Mitophagy has also 
been shown to attenuate neuronal cell loss during ischemia (157), ischemia-reperfusion (244), and in 
response to staurosporine (245). Therefore, mediation of mitochondrial-related stresses by mitophagy is 
evidently necessary for preserving neural cell number and function. Importantly, a decrease in neuron 
mitophagy additionally contributes to aging-related neurodegeneration (243). These studies 
demonstrate that ways to maintain or increase mitophagy may alleviate cognitive decline during various 
conditions. 
 
Mitophagy also plays a protective role in the heart. After myocardial infarction (MI), mitophagy and 
Parkin protein levels increase in the infarct border area (213). Not only do Park2-/- (Parkin) knockout 
mice display larger infarct areas, suggesting mitophagy prevents cell loss, they additionally show 
decreased survival (213). On the other hand, elevating mitophagy by decreasing p53 expression is 
associated with increased cardiac resistance to ischemic stress (198,246). Importantly, this was observed 
to occur through Bnip3-dependent mitophagy and not Parkin (246), demonstrating that mitophagy in 
general is protective. Although Park2-/- mice display normal cardiac and mitochondrial function at 12 
months of age (213), mitophagy is impaired in the hearts of aged mice (198). In fact, mice 
overexpressing Parkin were resistant to the age-related decline in cardiac function, and this was 
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associated with elevated mitochondrial activity, decreased ROS production, and reduced inflammation 
(198).  
 
In skeletal muscle, autophagy both and contributes to protects from specific pathological conditions 
(165). Autophagy participates in the degradation of energetic substrates in skeletal muscle tissues 
during nutrient deprivation (165-168). This function is likely vital for converting and mobilizing skeletal 
muscle’s large protein and glycogen stores into fuel for use by other tissues. In fact, it was recently 
shown that mice lacking skeletal muscle AMPK displayed hypoglycemia during fasting, a finding 
attributed to their inability to supply the liver with alanine for gluconeogenesis resulting from depressed 
skeletal muscle autophagy (169). However, this catabolic response must be properly regulated, and 
therefore autophagy may unnecessarily contribute to atrophy during specific circumstances (165). 
Elevated skeletal muscle autophagic activity has been observed in response to denervation 
(166,170,171), fasting (166,168,172), oxidative stress (173,174), chemotherapy (175), inflammation 
(176), glucocorticoid administration (176,177), and disuse (178,179). Although relatively fewer 
examinations regarding the specific activation of mitophagy in skeletal muscle have been performed, 
fasting has been shown to cause elevations in Bnip3 and Parkin levels (180,181), while indirect 
measurements have suggested increased mitophagy during fasting and denervation (170,171,180). 
Additionally, one study demonstrated that Parkin-deficient mice displayed delayed atrophy and 
decreased UPS activation during denervation compared to their wild-type counterparts (171). Despite 
increased autophagic activity in skeletal muscle during these atrophic conditions, it is unclear whether 
this response contributes pathologically. On the other hand, inadequate clearance of autophagic cargo is 
observed in a number of lysosomal myopathies (185). Danon’s disease, classically known as a glycogen 
storage disease, occurs primarily due to LAMP2 deficiency, resulting in the accumulation of autophagic 
vacuoles due to impaired autophagosome-lysosome fusion (185,247). Another glycogen storage disease, 
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Pompe’s, is due to deficiency in alpha-1,4-glucosidase and is also characterized by autophagic build-up 
in the core of myofibers (185,248). Here, in a mouse model of Pompe’s, the additional genetic inhibition 
of autophagy exacerbates the disease phenotype, suggesting autophagy is activated as a protective 
measure (248). Additionally, several studies have shown that impaired autophagic flux is a shared 
characteristic between several models of muscular dystrophy (249-251). Notably, when autophagic flux 
was promoted by feeding mdx mice a low protein diet, they displayed reversal in multiple skeletal 
muscle functional and structural abnormalities (250). Likewise, using the Col4-/- mouse model of 
muscular dystrophy, researchers showed that activation of autophagy by administration of a low protein 
diet or rapamycin, but not exercise training, dramatically decreased the level of several apoptotic 
markers and improved functional parameters (188,249). However, emphasizing the dual nature of 
autophagy, it was observed that inhibiting autophagy improved clinical symptoms of muscular dystrophy 
in a mouse model of MDC1A (laminin a2 chain deficiency) (251). Finally, it was recently demonstrated 
that skeletal muscle stem cells (satellite cells) from aged/geriatric mice displayed poorer functional 
capabilities compared to their younger counterparts and that this was related to the loss of basal 
autophagy (252). Remarkably, forced autophagy induction with rapamycin was able to restore the 
regenerative potential of these aged satellite cells (252). 
 
Various other tissues also show examples of altered mitophagy impacting their pathophysiology. 
Pancreatic beta cells display reduced mitophagy during type 1 and type 2 diabetic conditions (253). 
When mitophagy was increased with Parkin overexpression, p53-/-, or chemical p53 inhibition, beta cell 
function, marked by insulin secretion and whole-body glucose uptake, was maintained (253). In 
addition, Mst1, mentioned above to inhibit autophagy, was recently identified to be an important 
inducer of beta cell apoptosis during diabetic conditions (254). Mitophagy in kidney proximal tubule cells 
is responsible for maintaining mitochondrial function during metabolic acidosis (255), and, as in other 
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tissue types, impaired mitophagy contributes to cell damage, such as that which occurs during diabetic 
nephropathy (256). The extent of kidney injury during acute ischemia was additionally shown to be 
reduced by Bnip3-dependent mitophagy (257). Hepatitis B virus (HBV) can also affect liver cell death by 
modulating mitophagy (258). Here, instead of mitophagy impairment leading to increased apoptosis, 




Another important phenomenon with connections to pathophysiological changes as well as aging that is 
intimately linked with cell death and autophagy is the development of cellular senescence. Senescence 
was originally described as the inability for normal proliferative cells to continue dividing when 
explanted for cell culture, now famously known as the “Hayflick limit” (259,260). Despite these cells 
maintaining viability and metabolic activity, they were observed to have undergone irreversible cell 
cycle arrest after a specific number of replications. From a disease pathogenesis perspective, senescence 
is thought to be tumor suppressive, in that its occurrence may restrict the growth and propagation of 
genomically-damaged cancer cells (261,262). On the other hand, the replacement of normally operating 
cells with senescent ones is also theorized to contribute to the declining regenerative capacity and 
tissue function associated with aging (262,263). Senescence is currently viewed as a perplexing and ill-
defined occurrence, as despite efforts reconcile these seemingly opposing functions, fundamental 
information such as the triggers and prevalence of senescent cells in vivo is not presently known (264). 
 
The gaps in knowledge regarding senescence exist for two reasons: 1) it was originally defined using cell 
culture, and it is unclear whether these in vitro observations translate in vivo, and 2) although several 
markers for senescence exist, it is generally a qualitative description that cells have stopped 
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proliferating, as the biochemical indicators are not universally found (264). Although Hayflick’s initial 
experiments demonstrated that senescence naturally occurred after cells had divided a certain number 
of times (259,260), an occurrence suggested to be due to telomere shortening (265), studies performed 
since then have shown that senescence can be induced by numerous means (262,264,266). This includes 
oncogene activation/tumor suppressor loss, DNA damage, oxidative damage, overactive mitogen 
signaling, epigenetic changes (such as chromatin remodelling), and others (262,264,266). 
Experimentally, senescence stimuli are typically investigated by administering noxious chemicals or 
transcription-modifying factors to proliferative cells in culture and characterizing the molecular manner 
in which senescence develops (262,264,266). Usually, these various stressors activate the DNA damage 
response (DDR), a highly structured sequence of molecular events induced to repair double strand 
breaks which involves activating senescence-causing downstream signaling mechanisms (267). Broadly, 
these are divided into two major signaling pathways: those initially involving p53-mediated induction of 
the CDK inhibitor p21, and those involving activation of the CDK inhibitor p16 (266). Subsequent 
inactivation of retinoblastoma protein (Rb) by both signaling platforms reinforces cell cycle inhibition.  
 
In addition to cell cycle arrest, the feature which best identifies senescence cells and characterizes the 
relevance of their existence is their production of unique endocrine/paracrine signals, termed the 
senescence-associated secretory phenotype (SASP) (262,264,266). These secreted proteins most often 
include TNFa,, TGFb, IGF binding proteins (IGFBPs), IL6, IL8, matrix metalloproteinases (MMPs), 
monocyte chemoattractant protein 1 (MCP1) and others (262,264,266), and are primarily driven by 
NFkB related signaling in senescent cells (268). While these factors have numerous effects on 
neighbouring cells, it has been demonstrated that the SASP recruits immune cells, causes inflammatory 
responses in non-immune cells, reduces replication, promotes wound healing, remodels tissue 
structure, increases stem-ness, damages DNA, and actually induces senescence (269-273). Other typical 
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markers of senescence include increased number of genomic herterochromatic foci at non-telomeric 
sites (SAHF) which mark sites of DNA damage that generate molecular signals to impair cell cycle 
progression, and the development of acidic b–galactosidase activity (SA-bgal) which, despite its 
widespread use as a senescence marker, does not appear to have a senescence-relevant function and 
whose appearance is actually dispensable for senescence development (262,264,266). 
 
A central conundrum regarding senescence development is that it is often utilized as a cell culture 
surrogate for “aging” (274). Although the link between replicative senescence and “senescence causes 
aging” seems apparent, there are a number of caveats in addition to the obvious apprehension required 
to give physiological relevance to cell culture findings. Notable among them is the difference in telomere 
biology between mice and humans. Despite their significantly reduced lifespans, mice telomeres are 5-
10 times longer than humans, they display increased telomerase activity in most cell types (only stem 
cells in humans possess such activity), and telomerase knockout mice do not display a dramatic early 
aging phenotype (275). Additionally, most senescence-associated markers, including SASP, SA-bgal, p16 
expression, and telomere shortening are observed in diverse biological situations such as during 
embryonic development, wound healing, professional immune cells, HIV infection, and cancer (264,276-
280). Despite this, senescent cells do in fact increase in number during in vivo aging and two landmark 
studies demonstrate this. These researchers engineered mice to inducibly eliminate cells that expressed 
p16, thus preventing senescence development (281,282). Not only did this prevent aging-associated 
phenotypes in the adipose tissue, skeletal muscle, and eyes of a rapidly-aging mouse model, but it 





Given its role mediating cellular stress responses, many connections have been made between 
autophagy and senescence. Unsurprisingly, the relationship between autophagy and senescence is 
complex (283). While studies have concluded autophagic activity can promote senescence or that a 
positive association between their induction exists (284-286 ), an equal body of evidence suggests 
autophagy prevents senescence or that they are negatively correlated (287-291). Single-cell analyses 
showed that autophagy inhibition triggered cell death and decreased senescence induced by DNA 
damage, suggesting that autophagy promotes senescence by suppressing death signaling (292). It was 
recently demonstrated that during oxidative stress-induced senescence in mouse 3T3 fibroblasts, 
autophagy inhibition was crucial for senescence development, autophagic flux was impaired in 
senescent cells, and restoration of autophagy was able to attenuate senescence (293). Meanwhile, 
another large study showed that senescent cells display increased “general” autophagy and that 
autophagy inhibition also caused senescence (294). Here, irradiation-induced senescence of human lung 
fibroblasts was suppressed by selective autophagic degradation of the transcription factor GATA4, 
activation of which promoted Nf-KB activity and the SASP, while general autophagy supported 
senescence transition by making substrates available for the SASP (294). Additionally, GATA4 protein 
accumulation was proposed to be caused by decreased association of p62 with GATA4. Notably, this 
observation provides mechanistic explanation for the cancer versus senescence consequence of DNA 
damage: p62 accumulation can activate NRF2 thereby contributing to oncogenesis (237-239), while 
decreased p62 may contribute to senescence (294). As p62’s autophagic targeting functions depend on 
ubiquitination, these researchers also suggested altered activity of ubiquitin ligases or deubiquitinating 
enzymes for GATA4 may mediate its protein stability (294), although the factors which determine its 
expression after DNA damage are unknown. However, despite numerous examples of autophagy 
positively and negatively regulating senescence development in response to diverse stimuli, an 
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experiment testing whether autophagy induction through the strongest and most physiologically-
relevant stimuli, amino acid starvation, occurs, has not been performed. 
 
Cellular Hormesis, Preconditioning, and Autophagy 
The concept of hormesis suggests that exposure to stressors at low doses results in generally beneficial 
changes, while high doses of similar stressors have negative effects (295). In biology, this is typically 
demonstrated by showing that administration of toxins in low doses conditions cells to be relatively 
resistance to damage subsequently caused by those toxins, a corollary similar to but distinct from the 
acquisition of senescence in vitro (296,297). This notion of adaptive preconditioning is an important 
protective measure in the heart and brain (298). In these tissues, intermittent periods of ischemia 
(ischemia-reperfusion, IR) is classically known to stimulate resistance to tissue damage and cell death 
caused by subsequent larger doses (299,300). Although IR-related protection is an accepted adaptive 
process for cardiomyocytes and neurons, examples of preconditioning involving other stressors and cell 
types exist. Previous hypoxia exposure was shown to contribute to cancer-associated resistance to cell 
death caused by doxorubicin and etoposide (301). Administrating relatively low doses of hydrogen 
peroxide (H2O2) to endothelial cells protected them from apoptosis caused by serum depletion, effects 
that were partially dependent on ROS-induced activation of the redox regulating enzyme thioreductase-
1 (Trx-1) (302). Arsenite preconditioning reduced cell death and caspase-3/9 activity induced by 
ultraviolet radiation in corneal endothelial cells through activation of heat shock protein 27 (Hsp27) 
(303). It was demonstrated that 1 hour of heat shock treatment prevented H2O2-induced cell death in 
primary cardiomyocytes and C2C12 cells by attenuating mitochondrial Smac release and caspase-3/9 
activation (304). Heat shock pre-treatment was also shown to protect HeLa cells from various apoptotic 
signaling including activation of caspases-3/9, mitochondrial Bax translocation, and p53 transcriptional 
activity caused by H2O2 (305). In this study, thermotolerant HeLa cells displayed several antioxidant 
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adaptations including increased expression and activity of MnSOD and catalase, while inhibiting 
glutathione production during heat exposure prevented the development of cell death resistance (305). 
Finally, exposing primary neurons to sub-lethal concentrations of ceramide provided protection against 
cell death triggered by oxygen/glucose deprivation (306), a finding partly explained by the observation 
that ceramide administration increased Bcl2 and Bcl-xL protein expression in neural tissue in vivo (307).  
 
Despite these observations in cell culture models, the physiological relevance of hormesis is debated 
due to the complexity of biological organisms, the toxic side-effects associated with exposure to 
damaging stimuli, and the lack of specific adaptive mechanisms (295). However, on a cellular level, 
autophagy may represent an adaptive mechanism that contributes to preconditioning given its roles in 
defense and remodelling (296,297). In fact, autophagy’s role in mediating the effects of ischemic 
preconditioning (IPC) is beginning to receive attention, where it is known to be a mediator of the 
protective effects of IPC in several tissues. Numerous modes of autophagy and/or mitophagy inhibition 
during the reperfusion phase prevented IPC-induced protection during middle cerebral artery occlusion 
or oxygen deprivation of cultured cortical neurons (244). Autophagy inhibition also prevented IPC-
induced protection from subsequent liver ischemia in mice and rats (308). Similarly, the protective 
effects IPC are attenuated when autophagy is inhibited in neurons (309,310). Additionally, autophagy is 
implicated in contributing to the beneficial effects of caloric restriction and regular exercise, which can 
also be considered hormetic responses (296,311). In skeletal muscle, exercise training-induced 
mitochondrial biogenesis and running endurance were attenuated in beclin1-haploinsuffucient mice 
(191). Mice incapable of exercise-induced autophagy were also not protected from high fat diet-induced 
metabolic dysfunction applied after an exercise training regimen compared to their wild-type 




Finally, various modes of caloric restriction are known to induce longevity in model organisms (312). The 
potential involvement of autophagy in this context is clear and under intense investigation. In fact, 
studies have demonstrated that long-term administration of rapamycin increases longevity in species 
from yeast (311,313) to mice (311,314-317). Importantly, autophagy is required for the longevity 
inducing effects of caloric restriction and administration of various small molecules in yeast, worms, 
flies, and fish (311). However, the translation of these findings to non-human primates has been met 
with controversy, largely owing to the definition of what represents a “healthy” adult control (318-321) 
(This Sohal and Forster paper is interesting). Regardless, despite our vast knowledge of autophagy’s 
molecular regulatory mechanisms, significantly less is known regarding the implications of its induction.   
 
Conclusion 
This literature review highlights that the balance between cell survival and death is determined not only 
by the type and intensity of stress but also a cell’s ability to appropriately respond. Typically, surviving 
mild stresses is necessary for maintaining tissue function and is additionally associated with the 
development of advantageous cellular adaptations. Equally as important, however, is the efficient 
removal of mutated cells and those beyond repair as their accumulation is similarly dysfunctional. The 
proper interaction between stress processes is particularly salient in neural and muscle tissues, as cells 
lost here are difficult to replace and significantly contribute to their pathology. Fortunately, autophagy 
acts not only as a first or second line of defense during acute stressors, it also allows chronic stimuli to 
be sensed and responded to appropriately. This responsive remodelling function has demonstrated 
importance in such diverse cellular events as preventing cancer progression, transforming cells during 
differentiation, and mediating the exercise-induced benefits to skeletal muscle. Importantly, as progress 
is made towards conducting a human trial investigating the effects of rapamycin administration on aging 
(322), it is noteworthy that rapamycin is widely used as an immunosuppressant which also causes insulin 
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resistance, glucose intolerance, testicular degeneration, and cataracts (311). Therefore, it is likely that if 
a drug whose purpose is to activate autophagy is ever approved for human use, it will have to target 
autophagy in a more direct way.  
 
Overall Purpose 
Although the molecular mechanisms of cell death, autophagy, and mitophagy regulation are becoming 
well-characterized, many questions remain regarding their importance and relevance in specific 
physiological conditions. Amongst these are the general effects resulting from repetitive autophagy 
induction. Given its role as a cellular remodelling mechanism and potential involvement mediating the 
protective effects of preconditioning, it is possible that exclusive autophagy induction could mimic the 
effects of preconditioning without experiencing the associated toxic effects. Particularly, the abundance 
of specific targeting interactions suggests autophagy displays high level control, and is perhaps capable 
of avoiding non-discriminate degradation. Therefore, autophagy may affect cell composition by 
degrading cellular material, such as mitochondria, in a “worst is first” manner, particularly if an acute 
stress (like ischemia) is absent. However, this has yet to be shown experimentally. Therefore, the overall 
objectives of this thesis were to examine: 
1) if autophagy induction itself leads to senescence development, 
2) whether autophagy and/or mitophagy function as mechanisms of cyto-protective 
remodelling, and  
3) what specific mechanisms of stress-resistance are affected by autophagy.  
 
These objectives were examined using cell culture of C2C12 cells. These are murine/mouse skeletal 
muscle myoblasts (stem cell-like cells that spontaneously undergo characteristic skeletal muscle 
differentiation/development in culture) that is considered immortalized: current cell lines are derived 
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from a clone isolated in the 1980’s from a line of cells originally obtained in the 1970’s. These cells were 
chosen to conduct the experiments for this Thesis for several reasons: 1) the Muscle Biology and Cell 
Death Laboratory has extensive experience using this cell line and possesses robust protocols for 
culturing and analyzing them, 2) the hypothesis that autophagy generally mediates forms of cellular 
adaptation suggests this relationship should be observed regardless of the cell type used (ie. as long as it 
has autophagy, this relationship would exist in every biological system), and 3) given (2), mature skeletal 
muscle possesses a remarkable ability to adapt to stress, and some of these mechanisms might be 
conserved in myoblasts and therefore be relevant to observing the effects hypothesized here. In 
general, to examine the consquences of deliberate autophagy induction and/or the roles of its parallel 
activation on cell composition and function, the experiments contained herein were performed by 
treating/incubating/growing C2C12 cells in/with various modes of stressful stimuli. Using cell culture 
provides numerous advantages in this regard, as 1) cells can be administered an almost infinite array of 
interrogative stimuli for examining numerous specific biological phenomena, 2) genetic manipulation is 
relatively simple, and 3) cultured cells can be relevantly analyzed by varied and purposeful biological 
research techniques. Essentially, examining the effects of autophagy-dependent cellular remodelling in 
cultured mammalian cells allows the inspection of specific molecular and cellular mechanisms driving 
these relationships in an environment close to the genetic/physiological make-up of cells in vivo. Details 
regarding the general methological performance of these studies are outlined below.  
 
Methodological Considerations for Study Design 
A significant number of pilot experiments were performed to identify and optimize cell culture protocols 
that would appropriately answer the questions posed in this Thesis. As outlined, this primarily involved 
determining experimental treatment conditions that differentiated between specific autophagy 
induction and toxic stress-associated autophagy induction. Regarding the first treatment condtion, this 
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meant finding a stimulus capable of strongly inducing autophagy but avoiding the activation of cell 
death processes. This is an important consideration, as cultured cells are well known to become stress-
resistant after “rounds” of stress (likely through repeated death of the inherently weaker cells combined 
with repetitive exposure to a specific stress), and since physiologically-relevant cellular preconditioning 
is likely counterproductive if cells are lost in the process. Of course, autophagy is very sensitive to cellular 
nutrient and energy status and therefore various forms of starvation such as growth factor, amino acid, 
vitamin and other macromolecule withdrawal are commonly used alone or together to investigate 
autophagy in cell culture. With respect to proliferating C2C12 cells, it was previously observed that 
incubation in Earle’s Balanced Salt Solution (EBSS – an ionic solution (calcium chloride, magnesium 
sulphate, potassium chloride, sodium chloride, sodium phosphate, sodium bicarbonate) similar in 
osmolarity, pH, and glucose concentration to regular cell culture media), caused expected starvation-
related changes to LC3I and LC3II levels, maximal caspase-3 activation after 4 hours, DNA 
fragementation beginning at 16 hours, and increased annexin binding also beginning at 16 hours (464). 
Here, while roughly 70% of cells remained metabolically viable (possessed caclein AM activity) after 48 
hours in EBSS, a similar number of total cells displayed positive annexin binding. Based on these 
observations, I investigated the autophagy and cell death responses to a similar “starvation” media, 
Hank’s Balanced Salt Solution (HBSS), which is similar in composition to EBSS (same osmolarity, HBSS 
contains 15% of the sodium bicarbonate of EBSS and adds roughly 0.5 mM magnesium chloride and 
potassium dibasic). Effectively, incubating cells in HBSS represents amino acid and growth factor 
withdrawal. Alongside this, I additionally examined the autophagic response to several stress-inducing 
laboratory chemicals. The results of these tests are outlined in Appendix B Figure 1. Notably, HBSS 
consistently reduced p62, LC3I, and LC3II protein levels and increased Bnip3 while relatively high 
concentration staurosporine (STS) reduced p62, LC3I, and Bnip3 protein. These observations indicated 
that although HBSS and STS both induce autophagy, these responses are phenotypically different. As the 
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activation of cell death during EBSS incubation was previously observed to increase with time, I assessed 
autophagy induction during shorter time periods of HBSS incubation. Remarkably, HBSS-induced 
autophagic flux analyses proved to be almost impossible due to the strength of the autophagic 
response. This assay is performed by incubating cells with/without the selected treatment with/without 
an inhibitor of autophagy and then measuring p62/LC3 with immunoblotting; however, extremely high 
concentrations of lysosomal inhibiting compounds were required to prevent HBSS-induced LC3II and p62 
degradation and this was only possible at relatively short time points (Appendix B Fig. 3). Importantly, it 
was frequently found that incubating C2C12 cells in HBSS up to 5-6 hours did not significantly induce cell 
death, as indicated by caspase-3 activity and pH2AX protein expression (Chapter II Fig. 1, Chapter IV Fig. 
2, Appendix B Fig. 9). Based on these observations, I concluded that HBSS treatments up to 6 hours 
satisfied a treatment condition characterized by “autophagy induction without cell death”. Because 
autophagy also appeared to be induced by STS, traditionally an apoptosis-causing stimulus, it was 
examined for its suitability as a “toxic sress-associated autophagy” treatment. We typically use STS to 
induce cell death at concentrations between 1-2 µM for 3-4 hours, which constitutes a severe stress 
(>50% cell death). To decrease the stress level and allow more cell survival (again, the intention is to 
examine how cells respond to different stresses, therefore I don’t necessarily want them to be 
eliminated), lower concentrations of STS were examined that would be time-synchronized with HBSS 
treaments. The results of these tests are largely presented in Chapter II Figures 1 & 2. However, the 
initial test in this experiment is not presented. To begin, proliferative C2C12 cells were separately 
incubated with 12 different concentrations of STS for 6 hours and visually examined 24 hours later. Of 
these concentrations, two were used for subsequent analyses: a relatively low dose which did not affect 
cell numbers but did give them an abnormal appearance, and a very low dose in which cells appeared 
normal the following day. Including two concentration groups was intended to further explore the 
relationship between stress, autophagy, cell death, and cellular adaptation by altering the stress dosage. 
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A similar search for mitophagy-inducing stimuli was conducted alongside these pilot experiments. Initial 
research outlining the functional relationship between PINK1, Parkin, and mitophagy performed in the 
Youle laboratory utilized FCCP/CCCP (cyanide) to cause mitochondrial depolarization, which was 
discovered to cause widespread autophagy-dependent degradation of mitochondria in Parkin-
expressing cells (114-117). More recent studies involve combinations of oligomycin and antimycin a 
(122, 128, 155) to examine molecular mitophagy machinery. In fact, CCCP was previously shown to 
qualitatively increase overlap of LC3-GFP punta with mitochondria in C2C12 cells using fluorescent 
microscopy (439). In-house testing with CCCP exposure indicated that our C2C12 cells did not display 
significant cell death with concentrations up to 30 µM for 4-6 hours (Appendix B Fig. 8 & 9; Chapter IV 
Fig. 2). Similar to the previous studies, CCCP administration induced LC3II formation, puncate 
mitochondrial morphology, and degradation of mitochondria-specific proteins in my C2C12 cells 
(Appendix B Fig. 2, 3, 4, & 7; Chapter IV Fig. 1). Not shown in Appendix Figures are experiments involving 
oligomycin/antimycin a administration: the mitophagic response to these chemicals in C2C12 cells was 
less robust compared to CCCP, likey for the reasons explained in the following paragraph. Regardless, as 
with HBSS-induced autophagy, I found that incubating C2C12 cells in growth media with 30 µM CCCP for 
4-6 hours induced mitophagy and did not significantly activate cell death processes. A final important 
step was determining a protocol for intermittently treating cells with these various autophagy and/or 
cell death inducing stimuli to examine the potential adaptations and mechanisms caused by their 
repeated administration. Importantly, as C2C12 cells will spontaneously differentiate into myotubes 
upon reaching confluence in culture (and as this process is associated with a myriad of cellular changes) 
it was paramount for cells in different treatment groups to be of similar confluence at the end of the 
treatment protocol. It can be seen in pilot experiments that some groups experienced such 
unintentional premature differentiation (Appendix B Fig. 10). Therefore, throughout the expeirments in 
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this Thesis, each specific intermittent treatment protocol was always performed to ensure equal cell 
confluence after 3 days of treatments (Appendix B Figs. 8, 10, & 11). 
 
Another methodological consideration was selecting the specific targets of genetic manipulation used 
herein. Due to its complexity and importance, a myriad of cellular actors are known to impact 
autophagy. Although many of these roles are somewhat accessory and therefore deemed redundant in 
various situations, even so-called “autophagy-genes” (Atg’s) have been shown to be unnecessary for 
actual execution of autophagy. In effect, due to their downstream and relatively specific-to-autophagy 
actions, two Atg’s are typically manipulated in order to generate models of “autophagy deficiency”: 
Atg5, which helps construct autophagosome membranes, or Atg7, which activates LC3 and Atg5-12 
(103). For the experiments in this Thesis, C2C12 cells with negligible Atg7 protein content were created 
and examined. Importantly, the incorporation of these autophagy-deficient cells allows the impacts of 
the models of autophagy induction just described to be attributed to autophagy specifically. Again, 
although amino acid and serum starvation is a strong stimulus for autophagy activation, this stress alters 
many cellular processes: examining the differences observed between Atg7-possessing and Atg7-lacking 
cells allows these findings to be specifically credited to autophagic degradation. In separate 
experiments, C2C12 cells with CRISPR-mediated knockout of Bnip3 are also investigated. Preliminary 
experiments suggested mitophagy can be induced in C2C12 cells using oft-cited chemical perturbations 
(outlined above), and that these manipulations significantly alter Bnip3 expression. As Bnip3 is 
implicated with autophagy and specific mitophagy regulation, additional studies were conducted in 
Chapter IV to investigate such a role in C2C12 cells. 
 
A final aspect of deliberate study design in which additional troubleshooting expeirments were 
performed was selecting modes of cell death induction. Chapters III and IV focus on the effect of forced 
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intermittent autophagy on stress resistance development. In these studies, cell death was induced by 
administering one of three compounds: staurosporine (STS), cisplatin (CisPL), or hydrogen peroxide 
(H2O2). These three chemicals were chosen due to the different effector mechanisms through which 
each executes cell death. In our hands, STS causes classic apoptotic cell death characterized by 
phosphatidyl serine exposure, cell permeablization, DNA damage, robust caspase-9 and -3 activation, 
and release of several mitochondrial pro-death factors (369, 388). CisPL (or other platinum-containing 
compounds) is a frequently-used chemotherapeutic that functions by binding and therefore interfering 
with DNA replication, causing widespread DNA damage thereby targeting quickly-dividing cells. C2C12 
cells given CisPL are characterized by strong upregulation of p53, dramatically decreased Bcl2, activation 
of caspases and significant DNA damage (357). Finally, H2O2 administration is an oxidative stress that 
causes cell permeabilization, DNA damage, and release of mitochondrial AIF (388). Including these 
various forms of cell death activation was intended to examine potential specific phenotypes and 












CHAPTER II: Autophagy induction through intermittent amino acid starvation does not cause 























Project Rationale and Hypotheses 
Although cellular senescence was initially observed in vitro (and even considered an artifact of it), it is 
currently acknowledged that senescent cells in fact exist in vivo and that they increase in number 
throughout human lifespan. These cells are characterized by lacking tissue-specific functions, 
significantly reduced or arrested cell cycle progression, and altered paracrine/endocrine signaling. While 
the physiological purpose of these cells is debated and under extensive examination, their 
biological/genetic induction is suggested to be anti-oncogenic and their accumulation is thought to 
contribute to aging. Because their first observation was described in the context of exhaustive 
replication, some theorize that aging itself is the primary (and perhaps only) driver of senescence 
development. However, several cellular stressors induce a senescence-like phenotype in cell culture, 
and the most widely-held theory is that chronic/additive damaging stresses interact with the changing 
cellular environment which occurs during normal aging that leads to senescence in vivo. Given its role in 
stress response adaptation and cell death, autophagy’s role in senescence development is frequently 
investigated. Typically, this involves determining: 1) whether autophagy is altered during senescence 
caused by “intervention X”, and 2) if this response facilitates or functions to attenuate senescence. 
Importantly, this relationship remains cloudy partly because whether autophagy induction itself affects 
senescence is relatively unexplored.  
 
Another growing body of literature aims to give scientific credence to the adage “what doesn’t kill you 
makes you stronger”, specifically by testing the hypothesis that autophagy mediates the health and 
longevity benefits of relative/intermittent caloric restriction and regular exercise. Although, despite 
strong evidence that autophagy provides such a role in model organisms (yeast, flies, worms, and fish) 
and extensive epidemiological evidence that healthy diets and exercise are beneficial to human health, 
translating the “autophagy induction promotes health and longevity” theory to mammals and non-
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human primates has yet to occur. Despite this, significant effort is being directed towards using or 
designing a drug for human use that would benefit health by systemically inducing autophagy. 
Importantly, despite robust understanding of the molecular control and execution of autophagy, some 
fundamental effects of autophagy induction remain relatively unexplored. Notably, it is unknown if 
chronic/repeated autophagy induction through the strongest and most physiologically relevant 
autophagic stimulus, starvation, causes senescence.  
 
Therefore, the purpose of Chapter II was to investigate precisely this: does starvation-induced 
autophagy cause senescence in vitro? This was tested by repeatedly culturing C2C12 cells in amino acid- 
and serum-free media and examining several phenotypic alterations consistent with senescence 
development. This was compared to toxic stress-induced senescence, and the mechanisms which 
differentiate or are shared by these conditions were investigated. Finally, the contribution of autophagy 
to toxic stress-induced senescence was determined by examining senescence development in 
autophagy-deficient cells by knocking down Atg7 expression. 
 
The hypotheses for this Project were: 
1. Repeated autophagy induction through amino acid starvation will not cause senescence. 








These experiments contribute to our knowledge of autophagy and senescence by demonstrating that 
although robust autophagy induction through amino acid and serum withdrawal does not cause 
senescence, toxic stress-induced senescence is attenuated in autophagy-deficient cells.  
 
Abbreviations 
CisPL, cisplatin; HBSS, Hank’s Balanced/Buffered Saline/Salt solution; NAC, N-acetyl-L-cysteine; pH2AX, 
phosphorylated histone H2AX; SA-Bgal, senescence-associated b–galactosidase activity; SAHF, 




Cellular adaptation to survivable stressors has wide-ranging outcomes from the acquirement of 
beneficial stress-resistance to senescence and cancer. The mechanisms that regulate these responses 
are complex. In this study, we investigated the effects of repeated amino acid and serum withdrawal 
(HBSS) on the development of senescence in vitro and compared these to the effects caused by 
repeated toxic stress (staurosporine, STS). We found that intermittent STS administration caused cell 
cycle arrest, development of enlarged and misshapen cells/nuclei, increased senescence-associated 
heterochromatic foci and senescence-associated b–galactosidase activity, and prevented myogenic 
differentiation in C2C12 cells. These features were not observed in HBSS-treated cells. While STS-treated 
cells displayed less DNA damage (pH2AX content) and caspase activity when administered cisplatin, 
amino acid starved cells were protected from STS. Additionally, STS-induced senescence was attenuated 
in Atg7-deficient cells. These results demonstrate that repeated nutrient withdrawal did not cause 




Upon sensing a critical threshold of damage, cells can remove themselves by activating cell death 
processes such as apoptosis and programmed necrosis (2-4). Cellular elimination functions to remove 
potential sources of damage and allow their replacement; however, it is equally important to avoid the 
unnecessary removal of cells which could survive and continue functioning normally. In fact, neural and 
muscle tissues do not regenerate by simply replacing lost cells; maintenance of them depends on 
preventing and removing damage which could lead to cell death and tissue loss (36,49). 
Correspondingly, numerous pathological conditions are associated with cell death in these tissues, 
including: neurodegenerative diseases (323-330), stroke (331), myocardial infarction (332-335), dilated 
cardiomyopathy (336,337), and skeletal muscle myopathies (338-340). In fact, the degree of tissue loss is 
an important clinical consideration and therapeutic benefit is often observed with cell death inhibition 
(327,329,330,332,334,337,340). An important stress resistance mechanism in neural tissues and cardiac 
muscle is ischemic preconditioning (298). Here, intermittent ischemia induces resistance to tissue 
damage and cell death caused by subsequent ischemia, suggesting these cells possess an inherent ability 
to beneficially adapt to stress (300,341). This has been shown to involve autophagy, which is thought to 
be required to attenuate stress and allow cellular remodelling (244,342-344). 
 
However, cells do not always adapt to stress in physiologically advantageous ways. Although initially 
described as a state of permanent cell cycle arrest directly related to cellular divisions and telomere 
length (260,265), senescence occurs during several disturbances including oncogene or tumour 
suppressor loss, DNA damage, oxidative damage, overactive mitogen signaling and others (264,266,345). 
These stressors commonly invoke senescence through shared molecular pathways including the DNA 
damage response (DDR) and subsequent p53-mediated induction of p21 and/or p16 activation along 
with retinoblastoma protein inactivation (264,266,345). Regardless, senescence cells are characterized 
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by significantly reduced replicative capacity, the secretion of specific paracrine signals, and resistance to 
cell death (264,266,345). The result is the appearance of cells which lack tissue-relevant function, like 
cancerous cells, but don’t divide or die while maintaining the ability to respond to and regulate their 
environment. The biological purpose for this response is unclear, but the acquisition of damage-induced 
senescence is considered anti-oncogenic (264,266,345). Despite this, the number of senescent cells 
increases with age and is thought to contribute to tissue dysfunction and perhaps even aging itself 
(266,281,282). 
 
Many questions regarding the mechanisms and relevance of senescence development remain. 
Unsurprisingly, the interaction between autophagy and senescence is complex (283,293,294). In specific 
situations, it’s been demonstrated that autophagy promotes senescence, (284-286,292), prevents 
senescence (287-291,293), or both (294). These conclusions are typically explained by autophagy’s 
modulation of cell death signaling, as senescence occurs when the incurred stress is strong enough to 
cause oxidative stress and activate the DDR and p53, but not strong enough to cause complete cell 
death. Additionally, targeted degradation of specific senescence-regulating factors and the generation 
of amino acids required for maintaining cell viability and secretory factor production are also suggested 
to be autophagy-dependent mechanisms related to senescence development (294).   
 
Previous studies examining the relationship between senescence and autophagy have typically involved 
assessing whether autophagic degradation mediates senescence development caused by known stimuli 
or how chemical autophagy modifiers affect this response. Importantly, very limited evidence exists 
regarding senescence development caused by the strongest and most physiologically-relevant mode of 
autophagy induction: relative starvation. Therefore, the purpose of this study was to investigate the 
effect of repeated amino acid withdrawal on senescence development in vitro. We compared these 
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changes to those associated with repeated toxic stress, a known senescence-inducing insult. In doing so, 
we attempted to gain insight regarding the differences between adaptations caused by starvation and 
those typically associated with dysfunction. 
 
Results 
Short term amino acid and serum withdrawal induces massive autophagy and low concentration STS 
slightly activates cell death signaling in C2C12 cells 
Importantly, our intention was to compare the effects of non-lethal nutrient withdrawal to those caused 
by repeated toxic stress, as prolonged starvation would be unnecessarily stressful. We began by 
determining the cell death and autophagy response to Hank’s Buffered/Balanced Salt/Saline Solution 
(HBSS) which contains no amino acids or added serum, as well as low doses (15 nM and 125 nM) of 
staurosporine (STS) in regular growth media (GM). Incubation in HBSS for up to 8 hours only modestly 
increased (p<0.05) caspase-3 activity (Fig. 1A) and did not change protein expression of phosphorylated 
histone H2AX (pH2AX) (Fig. 1C & 1D) compared to cells in GM, indicating that cell death mechanisms 
were not highly activated in this context. However, 15 nM and 125 nM STS elevated (p<0.05) caspase-3 
activity by 3.9-fold and 6.2 fold and pH2AX expression by 3.0-fold and 5.5-fold, respectively, after 8 
hours (Fig. 1A, 1C & 1D). 125 nM STS exposure also increased (p<0.05) caspase-3 activity by 3.4-fold and 
pH2AX content by 4.2-fold at the 4 hour time point. These magnitudes were far less than those triggered 
by 3 hours of 2.0 µM STS, which caused 15- and 11-fold elevations (p<0.05) in caspase-3 and pH2AX 
levels, respectively (Fig. 1A, 1C & 1D). As expected, HBSS caused time-dependent reductions (p<0.05) in 
p62 and LC3II protein levels compared to GM (Fig. 1E, 1F & 1G). Low concentration STS treatment also 
reduced (p<0.05) p62 protein levels, although to a lesser degree than HBSS, and altered LC3 expression 
(Fig. 1E, 1F, & 1G). Although consistent changes to Beclin1 and Atg7 did not occur, Bnip3 protein content 




Fig. 1. Cell death and autophagy induced by starvation (HBSS) and low-concentration toxic stress (STS). 
(A-G) C2C12 cells were incubated in HBSS or culture media containing 15/125 nM STS for 1-8 hours and 
assessed for changes to caspase-3 (A) and cathepsin (B) activity or Bcl2, Bax, pH2AX (C & D), Atg7, p62, 
Beclin1, Atg4B, Bnip3, and LC3 protein content (E, F & G). (H & I) LC3 and p62 protein expression in cells 
treated as indicated for 4 hours with or without a combination of chloroquine and leupeptin (Cq+Leu). 
Actin is shown as a loading control. In all graphs, dashed line represents cells which remained in GM, 
arbitrarily given a value of 1.0 for comparison purposes. Significant differences from GM-receiving cells 
as calculated using T-tests are indicated with asterisks (*), where p<0.05 and n=3. 
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To measure autophagic flux, cells were treated for 4 hours with or without the addition of 50 µM 
chloroquine (Cq) and 250 µM leupeptin (Leu) (Fig. 1H & 1I). 15 nM and 125 nM STS increased (p<0.05) 
the LC3II/I ratio 3.5-fold and 2.5-fold more, respectively, than cells which remained in GM when 
administered Cq/Leu, demonstrating increased autophagic flux (Fig. 1 H, lower right panel). Notably, it 
appears that HBSS-induced autophagy was not fully inhibited by Cq+Leu, as p62 and LC3II protein levels 
are lower in HBSS/Cq+Leu cells compared to CTRL/Cq+Leu cells (Fig. 1H & 1I). This is likely due to the 
massive autophagy induction caused by HBSS and the extended time of the assay (103). 
 
Next, we characterized recovery from HBSS/STS treatments by replacing fresh GM after 4 hour 
treatment (Fig. 2). Caspase-3 activity (Fig. 2A) and pH2AX protein expression (Fig. 2C & 2E) were not 
increased in HBSS-treated cells during the recovery period. In cells given 15 nM STS, these two markers 
were highest (p<0.05) after 3 hours of recovery but dropped after 6 hours (Fig. 2A, 2C & 2E). Cells given 
125 nM STS did not recover, as caspase-3 and pH2AX remained elevated (p<0.05) during the recovery 
period (Fig. 2A, 2C & 2E). As p62 and LC3I protein levels in HBSS and 15 nM STS treated cells were not 
different (p>0.05) from untreated cells after 6 hours of recovery, this indicates recovery of autophagic 
activity (Fig. 2D & 2E). However, the sustained decrease (p<0.05) in p62 protein content in cells given 
125 nM STS suggests these cells were unable to fully recover (Fig. 2D & 2F). 
 
Repeated STS administration, but not HBSS, causes a senescence-like phenotype 
Next, the effect of repeated amino acid and serum withdrawal or toxic stress on senescence was 
evaluated by incubating C2C12 cells in HBSS, 15 nM STS in GM, or 125 nM STS in GM for 4 hours per day 
for 3 consecutive days. Additional cells were left in GM and served as controls (CTRL). 20 hours following 
the final treatment, cells were analyzed for changes to cell morphology, cell cycle, differentiation, and 




Fig. 2. Recovery from HBSS and STS treatments. C2C12 cells were incubated in HBSS, 15 nM STS, or 125 
nM STS for 4 hours and allowed to recovery in fresh GM for 3 or 6 hours. (A) Caspase-3 and (B) cathepsin 
activity. (C) pH2AX, (D) p62, and (E) LC3 protein levels. (F) Representative immunoblots. Actin is shown 
as a loading control. Dashed line represents cells which remained in GM, arbitrarily given a value of 1.0 
for comparison purposes. Significant differences from GM-receiving cells as calculated using T-tests are 
indicated with asterisks (*), where p<0.05 and n=3. 
 
 
size or shape, as measured on cells immunostained for actin and DAPI (Fig. 3A – 3E). However, STS 
caused concentration-dependent increases (p<0.05) in cell and nuclear size (Fig. 3A & 3B), as well as 
altered nuclear shape (Fig. 3D). Importantly, these morphological indicators are consistent with the 
development of senescence in vitro (264). Additionally, there was no difference between CTRL and 
those given HBSS on cell cycle, as 60% of cells in both groups appeared in G0/G1, 20% in M/G2, and 20% 
in S phase (Fig. 3E). However, cell cycle was arrested in cells repeatedly administered STS, as significantly 
more (p<0.05) cells existed in G0/G1 (90%) and less (p<0.05) in M/G2 (7%) and S (3%) phases compared 




Fig. 3. Repeated STS exposure, but not HBSS treatment, alters cell morphology and causes growth arrest. 
Cells were incubated in HBSS or culture media with 15 or 125 nM STS for 4 hours per day for 3 
consecutive days. (A) Cells were then immunolabelled with an anti-actin antibody (green) and 
counterstained with DAPI (blue) and analyzed for total cell area (B), nuclear area (C), nuclear length to 
width aspect ratio (D), and nuclear circularity (E). (F) Cell cycle analyses on similarly treated cells. For 
morphological measurements, n=3 where at least 100 cells were analyzed per group per experiment. 
For cell cycle analysis, n=5. Groups were compared with 1-way ANOVAs and significant differences 
(p<0.05) are indicated with lower case letters, where bars with different letters are significantly different 
than each other. Scale bar represents 50 µm. 
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Giemsa staining was also performed to assess cell morphology. Intermittent STS dramatically altered cell 
morphology, growth pattern characteristics, and apparent organelle shape (Fig. 4A). STS-treated cells 
also demonstrated increased (p<0.05) number of nuclear foci per cell (SAHF) as measured on Giemsa-
stained images compared to CTRL and HBSS (Fig. 4B). HBSS caused no obvious morphological changes 
(Fig. 4A) or affected the number of nuclear foci compared to CTRL (Fig. 4B). Analysis of another typical 
senescence-associated phenomenon, the acquisition of b–galactosidase activity at pH 6.0 (SA-Bgal) 
(263), was also conducted; only STS-treated cells displayed strong X-gal staining (Fig. 4C). Lastly, as 
C2C12s are capable of myogenic differentiation, additional cells were induced to differentiate by placing 
them in low-serum media for 4 days. While HBSS-treated cells differentiated similar to CTRL as 
demonstrated by similar myosin induction and transient myogenin expression, neither STS-treated 
group produced detectable levels of myosin and both displayed very low myogenin content (Fig. 4D). 
Both STS groups also displayed altered Pax7 and p21 protein expression (Fig. 4D & 4E). Therefore, it 
appears that repeated low concentration STS administration induced a senescence-like state in C2C12 
cells. 
 
Intermittent nutrient withdrawal and STS exposure uniquely alter cell death induction 
We next compared the effects of repeated nutrient withdrawal or senescence on subsequent cell death 
resistance. Cells were intermittently administered HBSS or STS for 4 hours per day for 3 consecutive 
days as done previously and given either 0.5 µM STS for 4 hours, 50 µM cisplatin (CisPL) for 18 hours, or 
nothing (vehicle, Veh) the day following the third treatment. In CTRL, STS caused a 25.7% drop in the 
number of healthy cells, compared to a 38.8% drop (p>0.05) in cells given 15 nM STS and a 43.0% 
decrease (p<0.05) in cells given 125 nM STS (Fig. 5A). HBSS-treated cells experienced a 16.4% decrease 
in the number of healthy cells, although this was not statistically different from CTRL (Fig. 5A). Similar 




Fig. 4. Repeated STS exposure, but not HBSS treatment, induces features of senescence and prevents 
myogenic differentiation of C2C12 cells. Cells were incubated in HBSS or culture media with 15 or 125 
nM STS for 4 hours per day for 3 consecutive days. (A & B) Giemsa staining was used to analyze the 
number of nuclear foci number per cell. (C) b-galactosidase activity staining at pH 6.0. MCF7 cells are 
included as a positive control. (D & E) Separate cells were differentiated by switching to low serum 
media and collected after the indicated number of days; Day 0 refers the time other cells were first 
given differentiation media. (E) Pax7 and p21 protein content. Actin and histone are shown as loading 
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controls. Groups were compared with 1-way ANOVAs and significant differences (p<0.05) are indicated 
with lower case letters, where bars with different letters are significantly different than each other. For 
foci counting n=3 where at least 100 cells were analyzed per group per experiment, for immunoblotting 
n=4. Scale bars represent 20 µm. 
 
 
In response to CisPL, no effect of previous HBSS incubation was observed, as the number of healthy and 
dying cells was not different (p>0.05) compared to CTRL (Fig. 5). However, while CisPL caused a 45.6% 
reduction in healthy cells (Fig. 5A) and a 26.6% increase in early-apoptotic cells (Fig. 5B) in CTRL, the 
number of healthy cells decreased by 7.4% (Fig. 5A) and the number of early apoptotic cells only 
increased by 4.6% (Fig. 5B) in the group repeatedly given 15 nM STS. 
 
 
Fig. 5. Intermittent HBSS and STS exposure causes unique responses to cell death induction. After 
repeated treatments, cells were given 0.5 µM STS for 4 hours or 50 µM cisplatin (CisPL) for 18 hours to 
induce cell death or did not receive a death-inducing insult (vehicle, Veh). (A) Number of healthy cells 
demonstrating negative staining for both annexin and PI. (B) Number of cells undergoing early stages of 
cell death that are positive for annexin but negative for PI. (C) Number of cells in late stages of cell death 
which are positive for both annexin and PI. Groups were compared with 1-way ANOVAs and significant 
differences (p<0.05) are indicated with lower case letters, where bars with different letters are 
significantly different than each other. N=5. 
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Unique mechanisms of cell death are altered by previous intermittent HBSS and STS treatment 
To examine the mechanisms of STS- and CisPL-induced cell death modulated by prior starvation and 
toxic stress, enzyme activities and protein expressions were assessed. First, measuring the DNA 
fragmentation marker pH2AX closely mirrored annexin/PI data: repeated HBSS reduced (p<0.05) pH2AX 
expression compared to CTRL during STS-mediated death and senescent cells displayed dramatically 
lower (p<0.05) pH2AX expression compared to CTRL and HBSS cells after CisPL administration (Fig. 6A). 
Additionally, repeated HBSS treatments decreased (p<0.05) caspase-3 (Fig. 6B) and caspase-9 (Fig. 6C) 
activities by 44% and 33%, respectively, compared to CTRL after 0.5 µM STS administration. To support 
this, protein expression of cleaved caspase-3 in cells given 0.5 µM STS was also 55% lower (p<0.05) in 
HBSS-treated cells compared to CTRL (Fig 6D). While HBSS did not reduce (p>0.05) caspase activity in 
response to CisPL, senescent cells displayed a complete lack of caspase activation (Fig. 6B & 6C) and 
cleaved caspase-3 expression (Fig. 6D) from CisPL. Both STS-treated groups also displayed significantly 
reduced (p<0.05) Bax:Bcl2 ratios compared to CTRL and HBSS-treated cells with or without cell death 
triggers (Fig. 6G). In fact, Bcl2 was 50% higher (p<0.05) in cells given 15 nM STS compared to CTRL 
without being intentionally killed, and 1.9-fold higher after cell death induction with CisPL (Fig. 6F). 
 
Autophagy is altered during senescence 
P62 protein content in STS-treated cells was noticeably reduced (p<0.05) 90-95% compared to CTRL and 
HBSS (Fig. 7A). However, when expressed as a percentage change, senescent cells did experience 
relative p62 accumulation when administered Cq+Leu and p62 degradation during HBSS at levels similar 




Fig. 6. Mechanisms of cell death execution are altered by intermittent HBSS and STS administration. 
After repeated treatments, cells were given 0.5 µM STS for 4 hours or 50 µM cisplatin (CisPL) for 18 
hours to induce cell death, or did not receive a death-inducing insult (vehicle, Veh). (A) pH2AX, (D) 
cleaved caspase-3, and (F) Bcl2 protein contents with Bax/Bcl2 ratio (G). (B) Caspase-3, (C) caspase-9, 
and  (E) and calpains enzyme activity. (H) Representative immunoblots. Results are presented relative to 
Veh CTRL, arbitrarily given a value of 1.0. Actin and histone are shown as loading controls. Groups were 
compared with 1-way ANOVAs and significant differences (p<0.05) are indicated with lower case letters, 




far greater in CTRL and HBSS). There was additionally no difference (p>0.05) in p62 levels during the flux 
assay between CTRL and HBSS-treated cells (Fig. 7A & 7B). Despite the large change in p62 content, LC3 
protein levels in senescent cells were much closer to CTRL; although LC3I content was lower (p<0.05) in 
both STS groups (Fig. 7C). Similar to p62, the relative change in LC3II protein levels was similar between 
groups during the autophagic flux assay (Fig. 7D).  
 
STS-induced senescence is partly mediated by oxidative stress 
As oxidative stress is known to cause senescence, the contribution of reactive oxygen species (ROS) to 
STS-induced senescence was examined (Fig. 8). 15 and 125 nM STS increased (p<0.05) ROS production 
to a greater extent than untreated and HBSS-treated cells as measured by detecting DCF fluorescence 
(Fig. 8A). Additionally, the antioxidants N-acetyl-L-cysteine (NAC) and 4,5-dihydroxy-1,3-
benzenedisulfonic acid (tiron) each reduced (p<0.05) STS-induced ROS when administered with STS at 
specific concentrations (Fig. 8A). Next, cells were treated with 15 nM STS for 4 hours per day for 3 
consecutive days with or without 20 µM NAC and several senescence markers were analyzed. Co-
treatment with NAC slightly prevented STS-induced cell cycle arrest as fewer (p<0.05) cells were present 
in G0/G1 compared to STS alone (Fig. 8B). NAC administration also attenuated STS-induced alterations to 
nuclear shape (Fig. 8C & 8D) and SAHF number (Fig. 8E & 8F). Importantly, NAC also prevented SA-bgal 
caused by repeated STS exposure (Fig. 8G).  
 
Loss of Atg7 attenuates STS-induced senescence 
Finally, to determine if increased autophagy (Fig. 1H) was relevant to STS-induced senescence, C2C12 
cells with stable Atg7 knockdown were generated (Fig. 9A). Similar to previous experiments, control 
(SCR) and Atg7-deficient (shAtg7, clone #1) cells were administered 15 or 125 nM STS for 4 hours per 
day for 3 consecutive days and analyzed for senescence markers. While STS caused cell cycle arrest in 




Fig 7. Autophagic flux is altered in senescent cells. Autophagic flux assay performed on cells 
intermittently treated with HBSS, 15 nM STS, or 125 nM STS. (A) p62 protein expression in GM flux cells. 
(B) Change in p62 induced by Cq+Leu and HBSS. (C) LC3 protein expression in GM flux cells. (D) Change 
in LC3II induced by Cq+Leu and HBSS. (E) Representative immunoblots, where p62 is shown at low (top) 
and high (bottom) exposures. Groups were compared with 1-way ANOVAs and significant differences 
(p<0.05) are indicated with lower case letters, where bars with different letters are significantly different 
than each other. N=4-5. 
 
 
CTRL, the number of STS-treated shAtg7 in each cell cycle phase was not different (p>0.05) from CTRL or 
SCR CTRL (Fig. 9B). Notably, shAtg7 treated with 125 nM STS are absent in these analyses: in fact, 
regardless of how many cells were seeded, no shAtg7 remained after 3 days of receiving 125 nM STS. 
SCR demonstrated similar senescence-associated changes to cell morphology as unmodified C2C12 cells 
in previous experiments (Fig. 3 & Fig. 4), as intermittent STS increased (p<0.05) SAHF, nuclear size, and 
nuclear aspect ratio compared to CTRL (Fig. 9C – 9G). However, shAtg7 did not display (p>0.05) 
increased SAHF, nuclear size, or nuclear aspect ratio in response to repeated STS (Fig. 9C – 9G). These 




Fig. 8. STS-induced senescence is partly mediated by oxidative stress. (A) ROS production in cells treated 
with HBSS, 15 nM STS, or 125 nM STS with or without NAC or Tiron for 4 hours. Dashed line represents 
cells in GM, arbitrarily given a value of 1.0. (B-G) Cells were administered 15 nM STS with or without 20 
µM NAC for 4 hours per day for 3 consecutive days. (B) Cell cycle analyses. (C & D) Nuclei size and shape 
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assessed on actin- and DAPI-labelled cells. (E & F) Cells stained with Giemsa solution were analyzed for 
the number of nuclear foci per cell. (G) SA-Bgal staining. Groups were compared with 1-way ANOVAs 
and significant differences (p<0.05) are indicated with lower case letters, where bars with different 
letters are significantly different than each other. In (A), asterisk (*) represents difference (p<0.05) from 
treatment-specific groups that did not receive antioxidant calculated with T-tests. For cell cycle and ROS 
analyses n=4. For morphological and foci counting measurements, n=3 where at least 100 cells were 
analyzed per group per experiment. Scale bars represent 50 µm. 
 
 
displayed significantly reduced (p<0.05) cell counts 24 hours following a single STS treatment (Fig. 9H), 
this conclusion is complicated by the increased sensitivity of shAtg7 to STS-induced cell death.  
 
Discussion 
These results demonstrate some mechanisms that differentiate cellular remodelling caused by repeated 
nutrient withdrawal versus toxic stress in proliferative C2C12 cells. Although initially appearing 
paradoxical, stress-induced stress resistance is an exceptionally important physiological phenomenon. 
This induced resistance to stress is most commonly observed after ischemia/reperfusion (IR) of neural 
and cardiac tissues (298,300,341), although this process also occurs in skeletal muscle (346) and has 
shown potential clinical relevance during liver, kidney, lung, and stem cell transplants (347,348). 
Classically, IR causes significant resistance to subsequent ischemic insults 1-2 hours following IR 
administration and delayed protection for 1-4 days (341). The mechanisms which mediate tissue 
protection are diverse, but those most often implicated are related to MAPK/ERK signaling pathways, 
activation of Akt and protein kinase C, Hif-1a and oxidative defence, heat shock proteins, and anti-cell 
death factors (298,300,341). The search for mimetics of IR-induced preconditioning has demonstrated 
that preconditioning mechanisms are observed with other types of stressors. Perhaps the most often 
examined is oxidative stress; notably, ROS signaling is required for cardiac IR preconditioning (349) and 
antioxidant administration attenuates the metabolic enhancements caused by exercise training in 







Fig. 9. Loss of Atg7 attenuates STS-induced senescence. (A) Immunoblot demonstrating Atg7 expression 
in control (SCR) and Atg7-deficient (shAtg7) C2C12 cells. Subsequent experiments were conducted on 
knockdown clone #1. (B-G) SCR and shAtg7 were administered 15 nM or 125 nM STS for 4 hours per day 
for 3 consecutive days. (B) Cell cycle analyses. (C & D) Cells stained with Giemsa solution were analyzed 
for the number of nuclear foci per cell. (E-G) Nuclei size and shape assessed on actin- and DAPI-labelled 
cells. (H) Cell counts conducted 24 hours after treating SCR and shAtg7 with 15 nM or 125 nM STS for 4 
hours or left in GM. Counts are expressed relative to the number of cells in culture wells prior to 
treatments, arbitrarily given a value of 1.0 and represented by dashed line. Groups were compared with 
1-way ANOVAs and significant differences (p<0.05) are indicated with lower case letters, where bars 
with different letters are significantly different than each other. In (H), asterisk (*) represents significant 
difference (p<0.05) between SCR and shAtg7 compared using a T-test. For cell cycle analyses n=4, for 
morphological and foci counting measurements, n=3 where at least 100 cells were analyzed per group 
per experiment. In (C), scale bar represents 20 µm; in (E) scale bar represents 50 µm. 
 
 
and experiments have shown that: hydrogen peroxide-induced preconditioning was partly mediated by 
the antioxidant enzyme thioredoxin-1 (302); arsenite-induced preconditioning was mediated by Hsp27 
(303); heat shock-induced preconditioning involved Hsp70, reduced release of mitochondrial pro-death 
factors (304,305), and the antioxidants MnSOD and catalase (305); and hypoxia-induced preconditioning 
was mediated by Hif-1a (301), Bcl2 and erythropoietin (347), Hif-1a and erythropoietin (351), and 
p38/MAPK (352). These studies demonstrate that a wide variety of stresses can cause protective cellular 
phenotypes and suggest that a common set of cellular mechanisms may mediate this response. 
Evidently, these systems respond to a diverse array of stimuli and their shared activation appears 
essential to providing proactive cellular protection.  
 
Increasing evidence shows that forms of caloric restriction have beneficial effects on health and/or 
longevity. Like the preconditioning stimuli just mentioned, the mild stress associated with relative or 
intermittent starvation is thought to produce cellular adaptations that cause the development of stress 
resistance and subsequent health benefits (353,354). However, it is unclear whether caloric restriction 
can be considered a hormetic stress or if it is a separate phenomenon with distinct biological mediators 
(354). Interestingly, the cellular response to stress is highly variable: while preconditioning represents a 
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physiologically beneficial adaptation, cancer and/or senescence development represent pathological 
outcomes. Notably, the cellular mechanisms that differentiate these responses are complex and 
unknown. In fact, despite the accepted longevity/health benefits of mild caloric restriction, the actual 
cellular consequences induced by relative nutrient deficiency are highly tissue dependent (355). The 
results of this study showed that repeated amino acid and serum withdrawal caused stress resistance 
that was phenotypically different than that caused by repeated toxic stress in C2C12 cells. While cells 
intermittently incubated in HBSS displayed resistance to cell death caused by STS, cells repeatedly 
administered nanomolar STS were resistant to CisPL-induced death. We also found that protection from 
STS-induced death caused by repeated nutrient withdrawal was mediated by reduced caspase 
activation. A number of mechanisms can explain these observations as amino acid starvation can alter a 
variety of cellular processes (355). Although this could be an exhaustive list, those related to beneficial 
cellular adaptations include insulin/Akt and mTOR signaling, which are nutrient-sensitive; AMPK and 
sirtuins, which are energy-sensitive; and antioxidants, which are ROS-sensitive (353-356). Importantly, 
these signaling platforms are implicated during many models of increased longevity, and are thought to 
function partly through their shared induction of relative stress resistance. Of course, autophagy is an 
essential cellular remodelling mechanism implicated in longevity which is induced by nutrient 
withdrawal (311). Experiments in model organisms have shown that functional autophagy is required to 
observe the longevity-inducing effects of various interventions (311). As a result, it is enticing to 
hypothesize that autophagy mediates the beneficial effects of caloric restriction by acting as a cellular 
recycling mechanism through its targeting of damaged/dysfunctional proteins and organelles. However, 
data precisely showing the improvement of specific cellular contents or modulation of particular 
signaling mechanisms by autophagy is lacking. It is also possible that forced nutrient withdrawal 
promotes the expression of protective cellular proteins. However, HBSS-treated cells did not possess 
increased protein content of Bcl2 (Fig. 6F) or the antioxidant MnSOD (Fig. 4D) and did not display altered 
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autophagic activity (Fig. 7) compared to controls. Potentially, nutrient withdrawal may target and 
thereby modulate upstream signaling platforms responsible for sensing and integrating stress signals. 
Although nanomolar STS treatments were expected to cause resistance to STS-induced death in a 
hormesis-like manner, analyses indicated these cells were actually more sensitive to STS-induced death 
and were protected from CisPL (Fig. 5). CisPL is a common chemotherapeutic because it directly causes 
DNA damage, making quickly proliferating cells more sensitive to it. As STS-treated cells were growth 
arrested (Fig. 3), it is not surprising that they were relatively resistant to CisPL. These cells also displayed 
increased Bcl2 protein content, which likely contributed to CisPL resistance given the massive reduction 
in Bcl2 that CisPL causes (357). 
 
Staurosporine functions as a non-specific kinase inhibitor by competing for ATP-binding sites of enzymes 
(358). Its use has been instrumental in determining the mechanisms of programmed cell death 
execution (19,359-362). The cellular response to STS is characterized by increased ROS production 
(363,364), elevated cytosolic calcium (363,364), release of mitochondrial pro-death factors (19,361), 
caspase activation (359,362,363,365), and DNA damage (359,360,362). Importantly, many of these 
features are similar to known causes of senescence including telomere attrition, which induces 
replicative senescence, as well as forms of stress-induced senescence such as oxidative stress and 
oncogene activation (264,266,345). Despite some differences in signaling mechanisms, it appears that 
DNA damage and the resultant activation of the DNA damage response (DDR) is the most integral 
component of senescence induction (264,266,345). Because STS exposure causes these effects, its 
administration has previously been shown to cause senescence (366). In the present study, nanomolar 
concentrations of STS elevated caspase-3 activity and caused DNA damage, indicated by pH2AX content 
(Fig. 1 & 2). After repeated treatments with STS, cells and their nuclei appeared large and mis-shapen, 
proliferation was halted, cells displayed increased senescent-associated heterochromatic foci (SAHF) 
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and senescence-associated b–galactosidase activity (SA-Bgal), and myogenic differentiation was 
completely prevented (Fig. 3 & 4). Notably, we did not detect p16 protein expression in any treatment 
condition. Although the current unavailability of the most commonly used p16 antibody (252,367,368) 
hindered our ability to assess this marker, the lack of molecular data questions whether the cellular 
phenotype we observed can be considered “senescence”. The growing complexity of senescence 
biomarkers and confusion regarding their interpretation further affirms that additional research on 
senescence is warranted (264,266). Regardless, the senescence-associated changes to cell morphology 
observed in STS-treated cells were absent in intermittently starved cells. Therefore, despite the 
repeated stress of nutrient deficiency, these cells appeared to function normally. 
 
The relationship between autophagy and senescence is complex (283). While studies have concluded 
autophagic activity can promote senescence or that a positive association between their induction exists 
(284-286), an equal body of evidence suggests autophagy prevents senescence or that they are 
negatively correlated (287-291). Single-cell analyses showed that autophagy inhibition triggered cell 
death and decreased senescence induced by DNA damage, suggesting that autophagy promotes 
senescence by suppressing death signaling (292). It was recently demonstrated that during oxidative 
stress-induced senescence in mouse 3T3 fibroblasts, autophagy inhibition was crucial for senescence 
development, autophagic flux was impaired in senescent cells, and restoration of autophagy was able to 
attenuate senescence (293). Meanwhile, another large study showed that senescent cells display 
increased “general” autophagy and that autophagy inhibition also caused senescence (294). Here, 
irradiation-induced senescence of human lung fibroblasts was suppressed by selective autophagic 
degradation of the transcription factor GATA4, activation of which promoted Nf-KB activity and the 
SASP, while general autophagy supported senescence transition by making substrates available for the 
SASP (294). Of relevance to the present study is that GATA4 protein accumulation was proposed to be 
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caused by decreased association of p62 with GATA4; therefore, our observed reduction in p62 protein 
content associated with repeated STS administration (Fig. 7A) provides additional explanation for STS-
induced senescence. As p62’s autophagic targeting functions depend on ubiquitination, these 
researchers also suggested altered activity of ubiquitin ligases or deubiquitinating enzymes for GATA4 
may mediate its protein stability (294). Several observations in this study contribute to our knowledge 
regarding the relationship between autophagy and senescence: 1) repeated nutrient withdrawal, which 
induces massive autophagy, did not cause morphological and functional features of senescence; 2) 
levels of p62 and LC3 were altered in STS-treated cells, although the relative change in protein content 
was similar during an evaluation of flux; 3) nanomolar STS concentrations induced autophagy, thereby 
implicating autophagic activity in regulating senescence development; 4) senescence was attenuated in 
Atg7-deficient cells, although this is likely due to their decreased ability to survive STS treatments; and 5) 
while both nutrient withdrawal and nanomolar STS administration activated autophagy, senescence was 
associated with repeated STS-induced cell death signaling. 
 
The physiological purpose of senescence is incompletely understood. The most widely acknowledged 
theory for its continued presence in humans is its role as a “less bad” response to DNA damage 
compared to cancer (264,266,345). It is also suggested that the cellular acquisition of senescence is not 
genetically regulated and exists as an unintentional response to stress, the increased accumulation of 
which contributes to tissue dysfunction during aging and even aging itself (264,266,345). This is likely 
due to the replacement of healthy/functioning cells with senescent ones and the inflammatory impact 
of SASP-related molecules (264,266,345). Either way, an important feature of senescent cells is their 
relative resistance to cell death induction leading to their prolonged existence. This permanence 
amplifies their effects and as a result strategies to remove senescent cells have been investigated to 
study their impact on aging. In fact, it’s been demonstrated that selective elimination of p16-positive 
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cells in mice attenuates the aging phenotypes of several tissues and may even increase longevity 
(281,282). In this sense, the development of stress resistance in senescent cells could be considered 
pathological. This contrasts the typical link made between cellular stress resistance and aging, where 
increased stress resistance is shared between several models of increased longevity (353,354). In fact, 
the mechanisms that cause senescence-associated stress resistance are likely different than those which 
mediate the forms of stress resistance associated with reduced tissue dysfunction and aging. The results 
here show that different stresses produce different adaptations: not only did the form of stress 
resistance depend on the type of incurred stress, but the mechanisms behind these stress-resistance 
profiles were specific. Although it would be conjecture to comment on the physiological implications of 
being resistant to staurosporine versus cisplatin, these chemicals do simulate the insults cells regularly 
deal with. Even more complex is the relationship between autophagy and senescence. While we 
observed reduced senescence development in Atg7-deficient cells, thereby suggesting that autophagy 
contributes to senescence, this came at the expense of increased cell death and division. Importantly, 
this raises the question whether it is physiologically/functionally preferable for a tissue’s cells to display 
increased sensitivity to stress, die, and have to be replaced, or for those cells to continue functioning 
and perhaps become senescent. Although the answer to this question is highly complex and likely 
depends on numerous contextual factors, recent evidence suggests the accumulation of senescent cells 
is pathological in some tissues (281). Interestingly, forced autophagy induction through starvation was 
not associated with senescence, but it did cause resistance to STS-induced cell death signaling 
mechanisms. Regardless, it is notable that these findings resulted from an in vitro experiment lasting 
only a few days, further emphasizing cellular capacity for remodelling and how easily this can be 
manipulated, particularly given the relatively slow rate that senescence develops and aging occurs. 




This study demonstrates the similarities and differences between the mechanisms of cellular adaptation 
caused by intermittent nutrient withdrawal or toxic stress in proliferative C2C12 cells. Notably, these 
results show that repeated and robust autophagy induction through amino acid and serum withdrawal 
did not lead to senescence development. Furthermore, although repeated starvation caused a cyto-
protective response, the specific changes implicated in this adaptation are unknown. Understanding the 
molecular regulators that respond to and mediate these changes could be relevant to the fields of 
caloric restriction, exercise, and aging. Importantly, this includes the specific involvement of autophagy 
and/or mitophagy as inducible mechanisms of beneficial cellular remodelling. Finally, while autophagy 
deficiency attenuated the senescence phenotype observed in these experiments, the physiological 
implications regarding this relationship are complex and warrant further study. As our understanding of 
senescence grows, it will also be important to define and differentiate the morphological features and 
molecular factors therein related, which may lead to the identification of currently overlooked cellular 
phenotypes. 
 
Materials and Methods 
Materials 
Cells were treated as indicated with: Hank’s Balanced Salt Solution (HBSS; Gibco formulation: 140mg/L 
CaCl2, 100mg/L MgCl2-6H2O, 100mg/L MgSO4-7H2O, 400mg/L KCl, 60mg/L KH2PO4, 350mg/L NaHCO3, 
8.0g/L NaCl, 48mg/L Na2HPO4, 1.0g/L D-glucose, with 1% penicillin/streptomycin), chloroquine (Cq, 30 
µM; Sigma-Aldrich), leupeptin (Leu, 250 µM; Sigma Aldrich), staurosporine (STS, 15 nM, 125 nM, 0.5  µM 
or 2.0 µM; Enzo Life Sciences), cisplatin (CisPL, 25 µM; Enzo Life Sciences), N-acetyl-L-cysteine (NAC, 10, 
20, or 50 µM; Sigma Aldrich), tiron (1, 2, or 5 mM; Sigma Aldrich), and 2',7'-dichlorodihydrofluorescein 





C2C12 mouse skeletal myoblasts (ATCC) were cultured in growth media (GM) consisting of low-glucose 
Dulbecco’s Modified Eagles Medium (DMEM; Hyclone, ThermoFisher) containing 10% fetal bovine 
serum (FBS; ThermoFisher) and 1% penicillin/streptomycin (ThermoFisher) on polystyrene culture dishes 
(BD Biosciences), as previously performed (357,369). Differentiation was induced by switching 90% 
confluent cells to differentiation media (DM) consisting of low-glucose DMEM containing 2% horse 
serum and 1% penicillin/streptomycin. For microscopy experiments, cells were grown on Cultrex- (R&D 
Systems) coated glass coverslips. When necessary, cells were isolated via trypsinization after washing in 
warmed PBS and centrifuged at 1000g. For all cell death experiments culture media and PBS were 
collected to include non-adhered cells and debris. 
 
Atg7 Knockdown 
C2C12 cells grown in 12-well plates were transfected with vectors encoding either an shRNA against 
Atg7 (Gene ID 74244, Origene TG504956) or a scramble control sequence (Origene TR30013) using 
Lipofectamine 2000 (ThermoFisher) at a DNA:lipofectamine ratio of 1 µg: 3 µL as previously performed 
(183). Cells with stable incorporation of each vector were selected using 2 µg/mL puromycin (Sigma). 
Surviving clones were individually isolated and assessed for Atg7 protein expression using 
immunoblotting. Two Atg7-deficient cell lines were obtained, termed shAtg7 in Figure 7; clone #1 was 
used for subsequent experiments.  
 
Immunoblotting 
Immunoblotting was performed as previously described (357,369). Whole-cell lysates were generated 
by adding ice-cold lysis buffer (LB, pH 7.4;  20mM HEPES, 10mM NaCl, 1.5mM MgCl2, 1 mM DTT, 20% 
glycerol, and 0.1% Triton-X100, Sigma Aldrich) with protease inhibitors (Complete Cocktail; Roche) to 
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cell pellets followed by sonication for 12 seconds. Protein content was measured using the BCA protein 
assay method. Briefly, equal amounts of protein were loaded into and separated using 10-12% SDS-
PAGE, transferred onto PVDF membranes (Bio-Rad Laboratories), and blocked for 1 hr at room 
temperature with 5% non-fat dry milk in TBS-T. Membranes were then probed with primary antibodies 
against Bcl2 (sc-7382, 1:200), Bax (sc-493, 1:1000), p21 (sc-397, 1:1000), phosphorylated histone H2AX 
(pH2AX, sc-101696, 1:1000; Santa Cruz), Atg7 (8558, 1:1000), Atg4B (5299, 1:1000), Beclin1 (3738, 
1:1000), LC3 (2775, 1:1000; Cell Signalling), histone H2B (07-371, 1:2000; Millipore), MnSOD (SOD-110, 
1:4000; Enzo Life Sciences), actin (A-2066, 1:2000), Bnip3 (B7931, 1:1000), cleaved caspase-3 (C8487, 
1:1000; Sigma Aldrich), myosin (MF-20, 1:2000), myogenin (F5D, 1:200), Pax7 (PAX7, 1:200; 
Developmental Studies Hybridoma Bank), or p62 (PM045, 1:2000; MBL) overnight at 4oC. Membranes 
were then incubated with the appropriate horseradish peroxidase- (HRP) conjugated secondary 
antibody (anti-rabbit: sc-2004, anti-mouse: sc-2005; Santa Cruz), and bands visualized using ECL 
immunoblotting substrates (BioVision) or Clarity ECL substrates (Bio-Rad) and the ChemiGenius 2 Bio-
Imaging System (Syngene). The approximate molecular weight for each protein was estimated using 
Precision Plus Protein WesternC Standards and Precision Protein Strep-Tactin HRP Conjugate (Bio-Rad 
Laboratories).  
 
Proteolytic Enzyme Activity 
Enzymatic activity of caspases-3  and caspase-9 was determined using the substrates Ac-DEVD-AFC and 
Ac-LEHD-AMC (Enzo Life Sciences), respectively, as previously performed (357,369). Calpain activity was 
determined similarly, using the substrate Suc-LLVY-AMC. To account for proteasomal cleavage of this 
substrate, each sample was also analyzed with 25 µM of the calpain inhibitor Z-LL-CHO and the 
difference in fluorescence was taken as calpain activity. Cell lysates were prepared using lysis buffer 
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without addition of protease inhibitors and incubated in duplicate with 20 µM of the appropriate 
fluorogenic substrate in assay buffer (20 mM HEPES, 10 mM DTT, and 10% glycerol). 
 
Lysosomal enzyme activity was measured using the substrate z-FR-AFC (Enzo Life Sciences), generally 
considered to indicate the activities of cathepsins L and B (357,369). Cell lysates were prepared similar 
to caspase/calpain assays and analyzed in duplicate with 25 µM of z-FR-AFC in a buffer containing 50 
mM sodium acetate, 8 mM DTT, 4 mM EDTA, and 1 mM Pefabloc at pH 5.0. For all enzyme activities, 
fluorescence was measured at 30oC using a Synergy H1 microplate reader (BioTek) with excitation and 
emission wavelengths of 360 nm and 440 nm for AMC substrates, and 400 nm and 505 nm for AFC 
substrates, respectively. All enzyme activities are presented normalized to total protein content and 




Annexin-V/PI staining was performed to assess the degree and type of cell death occurring after various 
stressors. For these measurements, culture media and one PBS wash were collected along with the 
adherent cells in order to include dying/detached cells. After treatment, cells were removed from 
culture dishes and suspended in Annexin Binding Buffer (10 mM HEPES/NaOH, 150 mM NaCl, 1.8 mM 
CaCl2, pH 7.4) and incubated with 1 µL of Annexin V-FITC (Life Technologies) and 1 µL of 500 µg/mL 
propidium iodide (PI). Cells were incubated for 20 min at room temperature, after which they were 
washed and suspended in HBSS.   
Cell Cycle 
After collection, cells were fixed by slowly suspending them in ice-cold 70% ethanol in PBS. Following at 
least 24 hr fixation, cells were washed with PBS and suspended in PI staining solution containing 40 
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µg/mL PI, 0.1% Triton-X, and 20 µg/mL RNAse in PBS for 30 minutes at room temperature. All flow 
cytometry analyses were performed on a BD FACSCalibur flow cytometer equipped with Cell Quest Pro 




Cell morphology was visualized using Giemsa staining, as previously performed (357). Briefly, after fixing 
in ice-cold methanol for 10 min and air-drying, cells were incubated with 1:20 dilution of 0.45 µm 
filtered Giemsa staining solution (Sigma Aldrich) in PBS (pH 6.0) for 45 min at room temperature. Cells 
were then washed with distilled water and mounted with Permount (ThermoFisher). 
 
Immunofluorescence 
Cell and nuclear morphology was also determined using immunofluorescent identification of actin and 
DAPI. After fixing in 4% formaldehyde and permeabilizing in 0.5% Triton-X 100 in PBS, cells were blocked 
in 5% goat serum for 1 hr and incubated with an anti-actin antibody (A-2066, 1:200; Sigma Aldrich) 
overnight at room temperature. Cells were then incubated with anti-rabbit AlexaFluor 488 secondary 
antibody for 1 hr, counterstained in 300 nM DAPI (ThermoFisher), and mounted with Prolong Gold 
(ThermoFisher). ImageJ was used to analyze cell and nuclear shape parameters. After masking nuclei by 
colour threshold, Area and Shape Descriptors measurements were performed. Calculations of these 
measurements can be found under the Analyze heading of the ImageJ user guide. 
 
b-galactosidase Staining 
Senescence-associated b-galactosidase activity staining (SA-Bgal) was performed as previously indicated 
by others (263). After washing with PBS, cells were fixed in 2% formaldehyde for 5 min at room 
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temperature, washed again with PBS, and then incubated at 37oC for 48 hours in the staining solution 
consisting of PBS with 1 mg/mL X-gal, 40 mM citric acid, 5 mM potassium ferrocyanide, 5 mM potassium 
ferricyanide, 150 mM NaCl, and 2 mM MgCl2 at pH 6.0. For all microscopy experiments, cells were grown 
on Cultrex- (R&D Systems) coated glass coverslips. Fluorescent microscopy was performed using a Zeiss 
Laser Scanning Microscope (LSM) 780. Brightfield images were acquired with a Nikon microscope 
equipped with a PixeLink digital camera. 
 
ROS Measurement 
ROS production was assessed by measuring DCF fluorescence. 20,000 cells were plated in each well of a 
black-walled 96-well plate and 24 hours later cells were pre-loaded with dye by incubating them in HBSS 
with 25 µM H2DCFDA (ThermoFisher) for 45 minutes at 37
oC/5% CO2. Cells were then washed twice with 
warmed PBS and treated as indicated for 4 hours. After washing again in PBS, HBSS was added to all 
wells and fluorescence was measured at 37oC using a Synergy H1 microplate reader (BioTek) with 
excitation and emission wavelengths of 395 nm and 528 nm, respectively. Data is reported as arbitrary 
fluorescence and corrected for background fluorescence.  
 
Cell Counting 
A Beckman-Coulter Z2 particle analyzer was used to assess cell numbers. Events from 12-23 µm were 
counted as cells. 
 
Statistics 
Results are presented as means ± SEM, where n=3-6 independent experiments. Time- and/or 
concentration-dependent single treatment effects were determined with T-tests (performed using 
Microsoft Excel) by comparing individual treatment conditions to untreated cells or to those which 
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remained in growth media. Effects between intermittently HBSS- or STS-treated groups were 
determined with 1-way ANOVA analyses and Tukey post-hoc tests and calculated using GraphPad Prism. 
Statistical significance is indicated when p<0.05.  
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Project Rationale and Hypotheses 
In Chapter II, it was found that C2C12 cells repeatedly grown in amino acid and serum free media were 
protected from subsequent cell death induction by staurosporine, suggesting that autophagy caused 
cellular remodelling that led to stress resistance. While autophagy is widely thought of as an on-demand 
mechanism of mediating stress and preventing cell death, relatively less is known regarding its role as a 
remodelling mechanism in the absence of additional stress. In neural and cardiac tissues, ischemic 
preconditioning (IPC) is well established as a protective measure that reduces the damaging impact of 
subsequent ischemic insults. Interestingly, some have reported that autophagy is required for the 
beneficial effects of preconditioning. Importantly, this involves actual execution of autophagic flux, 
implying that IPC doesn’t simply prime autophagic signaling (as is the case with our understanding of 
classical preconditioning), but that its degradative activity is necessary for this response. Additionally, 
autophagy is required for the dramatic cellular remodelling that occurs during skeletal muscle, 
adipocyte, and red blood cell differentiation, and demonstrates importance during the adaptations that 
occur in skeletal muscle during exercise training. Despite this, the general effects resulting from specific 
autophagy induction are relatively unknown. 
 
Therefore, the purpose of this Project was to examine the importance of autophagy in mediating the 
development of stress resistance caused by repeated amino acid withdrawal observed in Chapter II. This 
was performed by intermittently incubating unmodified and Atg7-deficient cells in amino acid-free 
media (HBSS) and subsequently determining the sensitivity to cell death induced by staurosporine, 
hydrogen peroxide, or cisplatin. Additionally, this effect was compared to repeated rapamycin 
administration, which induces autophagy by inhibiting mTOR. 
 
The hypotheses for Chapter III were: 
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1. Repeated autophagy induction would prevent cell death caused by various stressors 
2. Rapamycin would cause stress resistance similar to amino acid starvation 
3. Without Atg7, the protective effect of intermittent autophagy induction would be lost 
 
Abstract 
Autophagy is an important stress response mechanism that mediates cellular remodelling, adaptation, 
and death. Despite regulatory links to numerous stimuli, the consequences of specific autophagy 
induction are relatively unknown. In this study, we tested the hypothesis that repeated autophagy 
would cause stress resistance in vitro. Intermittent amino acid withdrawal protected unmodified, but 
not Atg7-deficient, cells from subsequent cell death induced with staurosporine (STS) and this was 
characterized by reduced DNA damage and caspase-3 and -9 activation. Adenoviral recovery of Atg7 
content restored the amino acid starvation-induced protection from STS. However, previous repeated 
rapamycin administration increased sensitivity to cell death induced by hydrogen peroxide and cisplatin 
regardless of Atg7 content. Additionally, rapamycin treatments altered cell cycle parameters, greatly 
increased cell and nuclear size, and prevented myogenic differentiation of C2C12 cells. These results 
show that resistance to specific stressors can be achieved through metabolic autophagy induction, but 
the autophagy-independent effects of rapamycin increased cell death sensitivity and impaired growth 
and differentiation patterns. 
 
Introduction 
The cellular response to stress is highly complex, but the ultimate consequence is whether to live or die. 
Several programmed cell death (PCD) pathways, such as apoptosis, necroptosis, and necrosis, ensure 
that cells beyond repair are removed, allowing their replacement accordingly (2,4,36,370). However, 
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numerous tissues display reduced self-regenerative abilities and their healthy operation therefore 
depends on maintaining the proper function of existing cells. 
 
The degradation mechanism autophagy is suggested to play such a role. Autophagy is best characterized 
as a starvation-induced response that turns cellular structures into energetically-useful material during 
times of nutrient deficiency (36,49). Despite its degradative nature, autophagy involves sophisticated 
substrate identification machinery that can selectively target damaged proteins and organelles (36,49). 
Consequently, the induction of autophagy during stress is normally considered a defensive measure 
used to mitigate cellular dysfunction (36,46,49). This cyto-protective function of autophagy is commonly 
observed in experiments where cell death caused by various means is blocked by its induction 
(36,46,49,157,209,210,371-374) or promoted by its inhibition (36,46,49,375-379). Apart from these 
numerous pharmacological stressors, autophagy displays protective roles during physiologically-
regulated cell death (380), such as during the differentiation and development of neural tissues (381), 
skeletal muscle (183), adipocytes (382), lymphocytes (383), and erythroid cells (384). These studies 
highlight autophagy’s function as a cellular remodeller, where it allows the removal and replacement of 
proteins and structures as cells evolve. Importantly, autophagy likely provides similar functions during 
less dramatic forms of transformation. 
 
In fact, autophagy mediates the protective effects of ischemic preconditioning (IPC) in neural and 
cardiac tissues (244,342,385). Numerous modes of autophagy and/or mitophagy inhibition during the 
reperfusion phase prevented IPC-induced protection during middle cerebral artery occlusion or oxygen 
deprivation of cultured cortical neurons (244). In another study, autophagy inhibition with bafilomycin 
or 3-MA reduced infarct volume, while rapamycin pre-treatment mimicked the protective effects of IPC 
during permanent focal ischemia (342). In the heart, autophagy and mitophagy inhibition similarly 
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prevented the protective effects of IPC (343,344), and this effect could be mimicked with rapamycin 
(386). Autophagy-dependent IPC has also been observed during hepatic ischemia (308). Additionally, 
autophagy is required for the cellular remodelling responsible for the beneficial effects of exercise 
training on skeletal muscle (189,191). Here, autophagy-deficient mice did not experience functional 
adaptations (191) or were protected from subsequent metabolic stress (189) compared to their wild-
type counterparts.  In fact, autophagy is thought to mediate the health effects of caloric restriction and 
regular exercise through the development of general stress resistance (296,311). Importantly, studies 
have demonstrated that long-term administration of rapamycin increases longevity in species from 
yeast to mice (311,314,315,317). Therefore, in addition to providing protective functions during stressful 
conditions, autophagy is likely a vital mediator required by cells to adapt and acquire resistance to 
stress. 
 
Despite the well accepted acute anti-stress functions of autophagy, the specific mechanisms and targets 
which mediate autophagy’s protective effects are relatively unknown. Furthermore, knowledge is 
limited regarding its role as a pro-active mechanism of stress-resistance, such as during its induction in 
response to stimuli which are not specifically toxic or lethal. Therefore, the purpose of this study was to 
investigate the remodelling effects of repeated autophagy induction and to examine the potential 
impact on subsequent stress resistance. This was performed by intermittently inducing autophagy in 






Starvation-and rapamycin-induced autophagy in C2C12 cells 
Autophagy-deficient C2C12 cells were obtained by transfecting vectors coding for shRNA against Atg7 or 
a scramble control sequence (SCR) and selecting puromycin-resistant colonies as previously performed 
(183). Cell lines with 97% (shAtg7 #1), 96% (shAtg7 #2), and 98% (shAtg7 #3) lower protein expression of 
Atg7 compared to unmodified C2C12 and SCR were achieved (Fig. 1A). In Chapter II, amino acid and 
serum withdrawal using Hank’s Balanced/Buffered Salt/Saline Solution (HBSS) caused massive 
autophagy that was detectable in 1 hour but did not increase caspase-3 activity or cause DNA damage 
up to 8 hours in C2C12 cells (Chapter II Fig. 1). Unsurprisingly, shAtg7 #1 and #2 displayed significantly 
more (p<0.05) caspase-3 activity during 4 hour HBSS than C2C12 cells and SCR (Fig. 1B). To avoid cell 
loss, media formulations were tested that induced autophagy but not cell death (Fig. 1B). It was found 
that 1.5 hours in HBSS supplemented with 1% FBS (HB+F) induced autophagy in SCR and limited caspase-
3 activation in shAtg7 #1 and #2 (Fig. 1B & 1C). To examine how cells recovered from this treatment 
condition, HB+F was replaced with GM and cells were collected 3 and 6 hours later (Fig. 1D – 1H). This 
recovery experiment indicated: 1) Atg7 and p62 protein levels displayed temporary post-treatment 
increases (p<0.05) in SCR, 2) shAtg7 were unable to induce LC3II formation (p>0.05) or p62 degradation 
(p>0.05), 3) autophagy-related protein contents in SCR were normalized after 6 hours in regular culture 
media, and 4) HB+F did not increase caspase-3 activity in SCR but temporarily increased (p<0.05) it by 
30% in shAtg7, although this amount was dramatically less than that caused by 2.0 µM STS for 3 hours 
(Fig. 1D – 1G).  
 
We also wanted to examine the effects of rapamycin- (Rap) induced autophagy. Rap-induced autophagic 
flux was assessed by administering 0.5 – 10 µM Rap in GM to C2C12 cells with or without the lysosomal 




Fig. 1. Inducing autophagy with amino acid and serum withdrawal in Atg7-deficient C2C12 cells. (A) Atg7 
and LC3 protein content in C2C12, 3 shAtg7 clones, and SCR cells. (B & C) Cells were incubated in the 
indicated media formulations and assessed for caspase-3 activity (B) and LC3 and p62 protein content 
(C). GM = growth media, DM = DMEM, HB = HBSS, GM/HB = 1:1 mixture of GM and HBSS, DM/HB = 1:1 
mixture of DMEM and HBSS, 1/5% refers to FBS concentration. STD represents a loading standard. (D - 
H) Cells were left untreated (GM) or incubated in HBSS with 1% FBS (HB+F) for 1.5 hours and collected 
immediately or after spending 3 (+3 hr) or 6 (+6 hr) hours in GM. Assessment of Atg7 (E), p62 (F) and LC3 
(G) immunoblotting. (H) Caspase-3 activity, with C2C12 cells administered 2.0 µM STS for 3 hours 
included for comparison. In (B), “*” denotes significant difference (p<0.05) from clone-specific GM 
calculated using a T-test. In (E-H), groups were compared with 1-way ANOVAs and significant differences 
(p<0.05) are indicated with lower case letters, where bars with different letters are significantly different 
than each other. N=3-4. 
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formation, 1.0 µM was the lowest concentration that consistently increased (p<0.05) the LC3II/I ratio 
compared to cells given Cq alone (Fig. 2B & 2C). Therefore, all subsequent experiments involving Rap 
were performed with 1.0 µM. The potential toxicity of this dose was tested by measuring caspase-3 
activity in SCR and shAtg7 after 2 hr, 4 hr, and 8 hr incubations; caspase-3 activity was lower (p<0.05) at 
the 2 hr and 4 hr time points compared to untreated cells in both groups (Fig. 2D). Importantly, Cq-
induced p62 accumulation is significantly lower (p<0.05) in shAtg7 #1 and #2 compared to SCR (Fig. 2E), 
and Rap-induced LC3 lipidation is severely restricted (p<0.05) in both knockdown lines (Fig. 2F), 
demonstrating that Atg7 deficiency reduces autophagic flux and rapamycin-induced LC3II formation. 
 
Repeated autophagy induction by amino acid starvation or rapamycin causes diverse responses to cell 
death 
To examine the effect of previous autophagy induction on stress-resistance, SCR and shAtg7 #1 were 
incubated in HB+F for 1.5 hours twice per day (cells spent 6 hours in GM between treatments) or 
administered 1.0 µM Rap in GM for 8 hours per day for 3 consecutive days or remained in GM (CTRL). 20 
hours following the final treatment, cell death was induced using staurosporine (STS, 0.5 µM for 3 
hours), hydrogen peroxide (H2O2, 2.5 mM for 5 hours), or cisplatin (CisPL, 25 µM for 18 hours). 
Additional cells not administered a death-inducing chemical (vehicle/Veh) were also analyzed. shAtg7 
displayed significantly less (p<0.05) healthy cells and significantly more (p<0.05) dead/dying cells when 
administered STS (Fig. 3D – 3F) or CisPL (Fig. 3J – 3L). Additionally, Rap treatments increased sensitivity 
to H2O2- and CisPL-induced cell death, where Rap-receiving groups displayed less (p<0.05) healthy and 
more (p<0.05) late-apoptotic cells with both death-inducing chemicals regardless of Atg7 expression 
(Fig. 3G – 3L). To demonstrate and compare the potential autophagy-dependent effects of repeated 
HB+F and Rap, the “healthy” data is also presented as a change from CTRL (Fig. 3M – 3O). Although 





Fig. 2. Inducing autophagy with rapamycin in C2C12 cells and effect of Atg7 knockdown. (A-C) C2C12 
cells were treated with the indicated concentrations of rapamycin (Rap) and/or chloroquine (Cq) and 
immunoblotted for LC3. In (B), 1.0 µM was the lowest concentration that consistently increased the 
LC3II/I ratio compared to untreated (GM + Cq) cells (dotted line). (D) Caspase-3 activity in SCR and 
shAtg7 #1 treated with 1.0 µM Rap for the indicated time periods or left in GM. (E-G) SCR and 2 shAtg7 
clones were treated as indicated with/without Cq and 1.0 µM Rap for 8 hours and immunoblotted for 
p62 and LC3. In (G), +3hr indicates cells administered Rap and switched to GM containing Cq for 3 
subsequent hours. In (B), “*” denotes significant difference (p<0.05) from untreated (GM + Cq) 
calculated using a T-test. In (D-F), groups were compared with 1-way ANOVAs and significant differences 
(p<0.05) are indicated with lower case letters, where bars with different letters are significantly different 





Fig. 3. Repeated autophagy induction by starvation or rapamycin causes diverse responses to cell death. 
SCR and shAtg7 #1 were intermittently incubated in HB+F or administered 1.0 µM Rap for 3 consecutive 
days or remained in GM (CTRL) and 20 hours following the final treatment cell death was induced. (A-C) 
Cells not administered a cell death-inducer. (D-F) Cells administered 0.5 µM STS for 3 hours. (G-I) Cells 
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administered 2.5 mM H2O2 for 5 hours. (J-L) Cells administered 25 µM CisPL for 18 hours. (M-O) Change 
in the percent of healthy cells compared to CTRL groups. In (A-L), groups were compared using 2-way 
ANOVAs: pound signs (#) denote a significant (p<0.05) main effect difference between SCR and shAtg7, 
and ampersands (&) indicate a significant (p<0.05) main effect of Rap compared to CTRL and HB+F. In 
(M-O), SCR and shAtg7 were compared at individual treatment conditions and significance (p<0.05) 
indicated with asterisks (*). N=5-6.  
 
 
when death was induced by H2O2 or CisPL (Fig. 3N & 3O), HB+F treatments resulted in 17% more healthy 
SCR cells with STS administration and this was significantly more (p<0.05) than the number of additional 
healthy shAtg7 cells, demonstrating that Atg7 was required for this protective effect (Fig. 3M). 
 
Repeated autophagy induction reduces caspase activity and DNA damage associated with subsequent 
cell death induction by STS 
Similarly-treated cells were evaluated for changes to death-related enzyme activities and protein 
contents to examine the mechanisms of cell death execution assessed in Fig. 3. In agreement with 
annexin/PI data, shAtg7 displayed higher (p<0.05) caspase-3 activity compared to SCR when cell death 
was induced with STS or CisPL (Fig. 4A), and higher (p<0.05) caspase-9 activity when cell death was 
induced with STS (Fig. 4C). Rap treatments reduced (p<0.05) the activities of both enzymes during STS- 
and CisPL-mediated cell death while HB+F reduced (p<0.05) both enzyme activities during STS-induced 
cell death regardless of Atg7 content (Fig. 4A & 4C). However, activities of both enzymes were lower 
(p<0.05) in Rap-treated Veh groups compared to CTRL (Fig. 3A & 3C), suggesting Rap altered the basal 
capacity/content of these two caspases. When expressed as a change from CTRL, HB+F and Rap 
treatments reduced STS-associated caspase-3 (Fig. 4B) and caspase-9 (Fig. 4D) activities to a larger 
extent (p<0.05) in SCR compared to shAtg7, indicating that autophagic degradation specifically is 




Fig. 4. Intermittent starvation- and rapamycin-induced autophagy reduces caspase activity associated 
with STS and CisPL exposure. Cells were administered 0.5 µM STS or 25 µM CisPL after 3 days of 
repeated HB+F or Rap treatments and assessed for caspase-3 (A & B) and caspase-9 (C &D) activities. In 
(A & C), data is presented relative to SCR CTRL Veh, arbitrarily given a value of 1.0. In (A & C), individual 
cell death groups were compared using 2-way ANOVAs: pound signs (#) denote a significant (p<0.05) 
main effect difference between SCR and shAtg7, and ampersands (&) indicate a significant (p<0.05) main 
effect of Rap compared to CTRL and HB+F. In (B & D), SCR and shAtg7 were compared at individual 
treatment conditions with T-tests and significance (p<0.05) indicated with asterisks (*). N=5-6. 
 
 
As another measure of cell death, the DNA damage marker pH2AX was examined. Although treatment- 
and Atg7-dependent effects were not observed in H2O2- and CisPL-killed cells, shAtg7 displayed 
increased (p<0.05) pH2AX content compared to SCR during STS administration regardless of treatment 
condition (Fig. 5A – 5C). When expressed as a change from CTRL, the reduction in pH2AX content caused 
by previous HB+F treatments was significantly greater (p<0.05) in SCR compared to shAtg7 (Fig. 5G), 




Fig. 5. Cell death related signaling is altered by previous autophagy induction. SCR and shAtg7 cells were 
administered 0.5 µM STS, 2.5 mM H2O2, or 25 µM CisPL after 3 days of repeated HB+F or Rap treatments 
and immunoblotted for pH2AX (A-C), Bax, and Bcl2 (D-F). (H) Assessment of Bax, Bcl2, and XIAP 
immunoblotting of cells not administered a death-inducing chemical. (I-L) Representative immunoblots. 
In (A-F & H), data is presented relative to SCR CTRL Veh, arbitrarily given a value of 1.0 and represented 
by a dotted line in (A-F). In (A-F & H), groups were compared using 2-way ANOVAs: pound signs (#) 
denote a significant (p<0.05) main effect difference between SCR and shAtg7, and ampersands (&) 
indicate a significant (p<0.05) main effect of Rap compared to CTRL and HB+F and dollar signs ($) 
indicate a significant (p<0.05) main effect of Rap compared to CTRL. In (G), SCR and shAtg7 were 
compared at individual treatment conditions with T-tests and significance (p<0.05) indicated with 
asterisks (*). N=5-6. 
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also quantitatively analyzed. No Atg7- or HB+F-dependent differences in the Bax:Bcl2 ratios in killed cells 
(Fig. 5D – 5F) or changes to Bax, Bcl2, and XIAP levels in Veh cells (Fig. 5H) were observed. However, Rap 
treatments decreased (p<0.05) Bax and XIAP and increased (p<0.05) Bcl2 protein levels compared to 
CTRL and HB+F in vehicle cells regardless of Atg7 expression (Fig. 5H). 
 
Recovering Atg7 expression restores amino acid starvation-induced protection from STS-mediated cell 
death 
To further confirm these findings, adenovirus encoding human Atg7 protein (adAtg7) was used to 
restore Atg7 expression in shAtg7. Appropriate titrations of two adAtg7 batches correctly re-established 
Atg7 and LC3II proteins in shAtg7 to the levels observed in SCR, while a control adGFP construct had no 
effect (Fig. 6A). SCR and shAtg7 with adGFP or adAtg7 were then treated with HB+F twice per day for 
three consecutive days and then given STS as in previous experiments. While HB+F treatments 
decreased (p<0.05) STS-induced caspase-3 activity in SCR and had no effects in shAtg7 infected with 
adGFP, adAtg7 recovered the HB+F-mediated caspase-3 lowering (p<0.05) effect in shAtg7 (Fig. 6B). This 
finding was echoed by pH2AX content analysis (Fig. 6C). These observations provide strong evidence 
that HB+F-mediated protection from STS-induced cell death is autophagy-dependent. Additionally, the 
dependence of HB+F-induced protection from STS-induced cell death on prevention of caspase 
activation was determined by administering the broad-spectrum caspase inhibitor z-FAD-FMK to CTRL 
SCR during STS (Fig. 6E & 6F). Here, STS-induced pH2AX expression could be decreased (p<0.05) with 




Fig. 6. Recovering Atg7 expression restores autophagy-induced protection from STS mediated cell death. 
(A) Immunoblotting of LC3 and p62 in cells administered adGFP or separate adAtg7 batches. (B-D) SCR, 
shAtg7 with adGFP, and shAtg7 with adAtg7 were intermittently incubated in HB+F for 3 consecutive 
days and subsequently administered STS. (B) Caspase-3 activity and (C) pH2AX protein content 
expressed relative to Veh arbitrarily given a value of 1.0 and represented by the dotted line. (E-F) SCR 
repeatedly given HB+F or remained in GM were administered 0.5 µM STS for 3 hours with or without Z-
FAD-FMK and immunoblotted for pH2AX. Asterisks (*) denote significant difference between SCR and 
shAtg7 (p<0.05) calculated using a T-test. In (E), groups were compared with 1-way ANOVAs and 
significant differences (p<0.05) are indicated with lower case letters, where bars with different letters 





Repeated rapamycin exposure alters cell cycle and morphology and impairs C2C12 myogenic 
differentiation  
In addition to the diverse observations regarding intermittent Rap and stress-resistance (more cell death 
as measured using annexin/PI, less caspase activity, altered stress-related protein contents), it was 
apparent that Rap treatments were affecting cell morphology. Cell cycle assessment using flow 
cytometry showed that repeated Rap increased (p<0.05) the number of cells in S phase and decreased 
(p<0.05) the number of cells in M/G2 compared to CTRL and HB-F in both SCR and shAtg7 (Fig. 7A). 
Morphological measurements performed on cells immunofluorescently-labelled with an anti-actin 
antibody and stained with DAPI demonstrated that shAtg7 were larger (p<0.05) than SCR and that Rap 
dramatically increased (p<0.05) cell area compared to CTRL and HB+F regardless of Atg7 content (Fig. 7B 
& 7D). Nuclear area of Rap-treated cells was also larger (p<0.05) compared to CTRL and HB+F (Fig. 7C). 
Rap-treated cells also possessed highly-developed actin structures, as ordered assembly of 
fibers/filaments is very apparent (Fig. 7D). Qualitative morphological observations of Giemsa-stained 
cells indicate general similarities between SCR and shAtg7 in CTRL and HB+F conditions, increased cell 
and nuclear size with Rap, and accumulation of vacuole-like structures in shAtg7 given Rap (Fig. 7E). 
 
We previously reported that senescent C2C12 cells are incapable of myogenic differentiation and that 
repeated incubation in HBSS does not affect this process. Given the alterations to cell cycle and 
morphology in Rap-treated cells, we also examined the effects on differentiation. Unexpectedly, Rap 
treatments completely prevented myogenesis as cells possessed undetectable levels of myosin protein 
after 4 days of differentiation (Fig. 8A). While normal C2C12 differentiation is characterized by 
temporarily increased myogenin and p21 (both of which occurred in SCR CTRL and HB+F groups), Rap-
treated cells displayed reduced (p<0.05) myogenin and p21 protein contents during both differentiation 







Fig. 7. Changes to cell cycle and morphology with Atg7 deficiency and repeated autophagy induction. 
SCR and shAtg7 were intermittently treated with HB+F or Rap for 3 consecutive days. (A) Assessment of 
cell cycle using flow cytometry detection of PI fluorescence. (B-D) Morphological analyses of cell area (B) 
and nuclear shape parameters (C) on cells immunolabelled with an anti-actin antibody (green) and 
counterstained with DAPI (blue) (D). (E) Representative images of Giemsa-stained cells. Groups were 
compared using 2-way ANOVAs: pound signs (#) denote a significant (p<0.05) main effect difference 
between SCR and shAtg7, and ampersands (&) indicate a significant (p<0.05) main effect of Rap 
compared to CTRL and HB+F. In (D), scale bar represents 50 µm. In (E), scale bar represents 50 µm. In (A) 
n=4, in (B & C) n=3. 
 
 
(p>0.05) between groups on day 2 of differentiation but were significantly higher (p<0.05) in Rap-
treated cells on day 4, perhaps identifying a location for the observed differentiation obstruction (Fig. 
8D). Although shAtg7 were included in this experiment, we previously demonstrated that autophagy is 
required for C2C12 differentiation (183), and as a result statistical comparisons between SCR and shAtg7 
were not performed here. Despite this, it is clear that differentiation is prevented or delayed in shAtg7 
compared to SCR, and the use of completely different cell clones in the present experiment confirms the 
findings of our previous study. 
 
Discussion 
These findings demonstrate the diverse cellular adaptations caused by two different autophagy inducing 
stimuli. While amino acid starvation increased resistance to cell death caused by STS, repeated 
rapamycin treatments actually increased sensitivity to cell death caused by oxidative stress and DNA 
damage. Additionally, rapamycin induced a cellular phenotype characterized by altered cell cycle, 
greatly enlarged cell size, and differentiation impairment.  
 
Autophagy primarily functions to provide cells with energetic substrates during times of nutrient 
deficiency. However, due to numerous specific targeting interactions, autophagy additionally regulates 





Fig. 8. Myogenic differentiation is prevented by previous rapamycin exposure. After 3 days of 
intermittent HB+F or Rap treatments, differentiation was induced and cells collected at various time 
points during the differentiation process. Quantification of myosin (A), myogenin (B), p21 (C) and Pax7 
(D) immunoblotting analyses. (E & F) Representative immunoblots of SCR (E) and shAtg7 (F). Groups 
were compared with 1-way ANOVAs at individual time points and significant differences (p<0.05) are 
indicated with lower case letters, where bars with different letters are significantly different than each 





demand mechanism of stress resistance (49,380,387). Because of this, dysregulated autophagy is 
implicated in the development of numerous diseases including cancer, neurodegeneration, and skeletal 
and cardiac muscle myopathies (49). In fact, autophagy is so essential that individual genetic deletion of 
numerous autophagy-associated genes is lethal in mice and induced deficiency of autophagy in 
adulthood causes dysfunction in several tissues. Furthermore, it is suggested that autophagy induction 
throughout life may have beneficial health effects through intermittent “recycling” of cellular material, 
and is a mechanism through which regular exercise and proper nutrition affect human health (49,311). 
However, relative caloric restriction and exercise impact innumerable processes that contribute to 
cellular adaptation (such as antioxidant defence) and although a link between these and autophagy is 
beginning to be established, specific autophagy-dependent effects remain largely unknown. Considering 
our first observation, that repeated amino acid starvation protected from subsequent STS-induced DNA 
damage and cell death, several findings can help explain this response. 
 
Notably, caspase-3 and -9 activities were significantly reduced in HB+F-treated cells, and this reduction 
was partially abrogated with Atg7-deficiency (Fig. 4). Given the role these proteolytic enzymes provide in 
executing cell death through protein and DNA cleavage, their reduced activities likely explain the 
protective effect of repeated autophagy induction. In fact, protection from STS-induced DNA damage 
could be mimicked with a chemical caspase-3 inhibitor (Fig. 6). Specifically, these observations suggest 
that STS-induced mitochondrial-mediated cell death signaling was attenuated. Of course, mitochondria 
are essential regulators of cell death execution (2). We previously demonstrated that a modest increase 
in mitochondrial content protected from cell death induced by STS and this was also associated with 
decreased caspase-3 activity (388). Forced/overexpression of PGC1a is also well-known to protect cells 
from oxidative stress-induced cell death, suggesting that mitochondria can adapt to become stress 
resistant (389,390). Specifically preventing STS-induced cell death, and not that caused by hydrogen 
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peroxide or cisplatin, further supports our conclusion that autophagy induction caused stress-resistance 
by attenuating mitochondrial-mediated caspase activation. Cisplatin is a widely-used chemotherapeutic 
because it damages DNA thereby preferentially causing cell death in quickly dividing cells (391); in 
C2C12s it induces p53, dramatically reduces Bcl2 levels, and increases caspase-3 activity (357). While 
oxidative stress causes cell death through a variety of mechanisms, in our hands hydrogen peroxide 
does not activate caspases (which is why such data is absent from Fig. 4), but causes mitochondrial AIF 
release and DNA damage (Fig. 5, 388). Therefore, it appears that repeated autophagy induction affected 
a specific aspect of STS-induced cell death activation. Importantly, we did not detect HB+F-induced 
changes to Bcl2 or XIAP protein expression, indicating that neither of these cell death inhibiting proteins 
were likely involved with the observed protective phenotype. We therefore suggest that protection 
from STS occurred by maintaining mitochondrial integrity. However, as numerous cellular pathways 
affect cell death execution, it is possible that an unidentified factor is involved here. It is also noteworthy 
that Atg7-deficiency had independent effects on cell death sensitivity. In response to all three toxic 
chemicals investigated, less healthy shAtg7 compared to SCR cells were observed (Fig. 3), while STS and 
CisPL also increased caspase activity significantly more in shAtg7 than SCR cells (Fig. 4). This supports 
autophagy’s role as an on-demand mediator of stress resistance or indicates the development of a 
relatively stress-sensitive environment in the absence of autophagy. Given the aforementioned 
potential adaptations relevant to stress-resistance, the question is how does forced autophagy induction 
cause these changes? Importantly, although the specific cellular aspects targeted by autophagy are 
relatively unknown and highly context-dependent, some autophagy-related interactions can explain 
these adaptations. 
  
Notably, autophagy preferentially targets dysfunctional and damaged proteins and organelles. Due to 
interactions between ubiquitin and the LC3 receptors p62 and NBR1, abundance of direct cargo 
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receptors, and existence of autophagy-specific chaperone mechanisms, misfolded and aggregated 
proteins are preferentially degraded by autophagy (101,104,105,392-394). Autophagy similarly targets 
depolarized and ROS-producing mitochondria as well as endoplasmic reticulum with accumulated 
misfolded proteins and dysregulated calcium signaling (134,395-397). In fact, this ability for autophagy 
to selectivity target damaged cellular material drove our hypothesis that its forced induction would pro-
actively “clean” cells thereby reducing their basal stress levels and increasing their resistance to cell 
death. In addition to these impacts on immediate sources of cellular damage, autophagy degrades other 
specific targets that potentially influence stress resistance. A direct example of such targets is caspase-8, 
which has been shown to be degraded by autophagy thereby attenuating TRAIL- and hydrogen 
peroxide-induced cell death (217,398). P62 accumulation itself can also lead to cellular dysfunction by 
affecting ROS and NRF2 signaling (237,239,291,399). Additionally, selective autophagic degradation of 
diverse proteins such as Notch1 (400), AIM2 (401), NLRP3, pro-caspase-1 (402), Chk1 (403), and IKKb 
(404) suggests its induction may modulate complex cellular signaling pathways. Furthermore, NFkB 
transcriptionally promotes Beclin1, Atg5, and LC3 expression (405,406), and HBSS-induced NFkB 
activation requires Atg5 and Atg7 (407). This possibly explains an adaptable feedback mechanism 
leading to increased stress resistance through elevated autophagy activation in response to subsequent 
stress. In fact, this explanation that resistance to cell death from STS is due to starvation-induced 
“priming” of autophagy, is supported by the numerous post-translational means through which 
autophagy is regulated (408). Cumulatively, it is clear that autophagy’s ability to turn 
unnecessary/dysfunctional and specific un-damaged proteins into cellular building blocks emphasizes its 
potential role as an inducible cellular remodelling mechanism, and our observation that repeated 




Interestingly, not only did rapamycin treatments not similarly protect cells from STS, but rapamycin-
treated cells were actually sensitized to cell death caused by hydrogen peroxide and cisplatin, regardless 
of Atg7 content (Fig. 3). As healthy cell counts were similarly reduced in SCR and Atg7-deficient cells 
when administered these death inducing chemicals (Fig 3N & 3O) and HB+F treatments did not alter 
sensitivity to H2O2 or CisPL-induced cell death (Fig. 3), the autophagy-independent actions of rapamycin 
likely caused these effects. Although rapamycin’s ability to activate autophagy is intensely researched, 
its main use is as a non-steroidal immunosuppressant widely administered during organ transplants and 
synthetic material implamts. This is due to its ability to potently arrest cell cycle at G1 by inhibiting 
TOR1/TOR2 in yeast and mTOR in mammalian cells (409-411) thereby significantly impairing T-cell 
expansion (411,412). Importantly, mTOR regulates numerous cellular processes which are still being 
fully unravelled. Interestingly, although we observe G0/G1 arrest in C2C12 cells upon differentiation 
induction (Boonstra et al, accepted August 2017) and senescence (Bloemberg and Quadrilatero, 
unpublished), repeated rapamycin treatments arrested cells in S phase here (Fig. 7) and actively mitotic 
cells were qualitatively very rare during microscopy analyses. We also found that prior rapamycin 
treatments completely prevented subsequent myogenic differentiation (Fig. 8). It is established that 
rapamycin prevents myogenic differentiation when administered in differentiation-promoting culture 
media to C2C12 and other myogenic cell types (413-418). In these experiments, rapamycin prevented 
p21 induction (416,418) similar to our observations (Fig. 8). However, the specific mTOR effectors 
implicated are complex, as these studies demonstrated that rapamycin’s effects: are mTOR dependent 
(417), involve PI3K and S6K activity (416), are mTORC2 dependent (413), do not require mTOR’s kinase 
activity (417), do require mTOR’s kinase activity (414), and are NFkB dependent (415). These 
observations suggest mTOR is intricately regulated during muscle differentiation. However, in our 
experimental protocol cells did not receive rapamycin during differentiation, suggesting its repeated 
effects pre-emptively induced an anti-differentiation state. Notably, we report sustained Pax7 
104 
 
expression in rapamycin-treated cells compared to those grown in GM alone or those intermittently 
starved of amino acids, not only implying that these cells were capable of entering the initial myogenic 
stages, but also indicating a mechanistic location for differentiation obstruction (Fig. 8C). Interestingly, 
treating isolated aged mouse satellite cells with rapamycin restored their proliferation defects, reduced 
senescence markers, and rescued their regenerative potential when transplanted after injury; effects 
that were abrogated by Atg7-deficiency (252). Rapamycin furthermore reduced mitochondrial ROS 
production, removed protein aggregates, and reverted the senescent phenotype in aged human satellite 
cells (252). Perhaps, differences between C2C12 cells and primary muscle/satellite cells account for 
these discrepant findings. It is also important to note the difference between the cellular phenotype we 
observed here with rapamycin treatments and that of toxic stress-induced senescence (Bloemberg and 
Quadrilatero, unpublished). We previously showed that senescent C2C12 cells are arrested in G1 and 
display resistance to CisPL (Bloemberg and Quadrilatero, unpublished). Despite the significantly enlarged 
and flattened appearance of rapamycin-treated C2C12 cells and their differentiation impairment, they 
were arrested in S phase and were not resistant to CisPL, suggesting this phenotype is separate from 
senescence. Additionally, although we chose 1.0 µM rapamycin based on measurements of autophagy 
induction, this is 10 times more concentrated than that used to restore the regenerative abilities of aged 
satellite cells (252). However, rapamycin typically demonstrates proliferation obstruction and myogenic 
differentiation impairment between 10-100 nM (411-414,416-418).  
 
Although the reason for increased sensitivity to cell death by oxidative stress and DNA damage after 
repeated rapamycin treatments is unknown, interestingly, CisPL reduced the number of healthy cells by 
60% in untreated Atg7-expressing cells and by 85% in rapamycin-treated Atg7-deficient cells (Fig. 3A & 
3J). Therefore, the dual insults of autophagy deficiency and previous rapamycin administration greatly 
increased the sensitivity to cell death caused by this chemotherapeutic. Similarly, hydrogen peroxide 
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exposure resulted in 30% less healthy cells in rapamycin-treated shAtg7 compared to SCR controls (Fig. 
3A & 3G). This suggests chronic rapamycin exposure actually increases the cellular sensitivity to specific 
stressors, an effect amplified by autophagy-deficiency. Whether this finding (rapamycin-induced cell 
death sensitivity) could partly explain its effects on healthy aging and longevity is unknown; however, it 
would be interesting to demonstrate this phenomenon in other/human cell lines and test this 
hypothesis in vivo. Particularly, given the observation that transplant recipients receiving rapamycin 
show decreased cancer risk (419) and the use of rapamycin/mTOR inhibitors in several combination 
chemotherapy regimens (420,421), it is likely that its effects on cell death sensitivity are involved and 
perhaps unrelated to autophagy. Regardless, these findings suggest that several exceptions and caveats 
exist regarding the “autophagy protects cells” theory, particularly autophagy induced by rapamycin. At 
the very least, it is clear that more-specific chemical modifiers of autophagy are required to answer and 
potentially solve these complicated physiological and clinical questions (422,423). 
 
We report here that repeated autophagy induction by amino acid starvation pro-actively increased 
stress resistance in vitro, as demonstrated by protection from staurosporine-induced cell death. While 
this possibility is often hypothesized to be responsible for the beneficial health and longevity effects of 
relative caloric restriction and exercise, it is seldomly demonstrated explicitly. We additionally show this 
is likely due to decreased mitochondrial-mediate caspase activation. Unexpectedly, similar experiments 
performed with rapamycin administration instead of amino acid starvation showed that rapamycin 
increased the sensitivity to cell death induced by oxidative stress and DNA damage. Repeated rapamycin 
treatments also greatly increased cell size, altered cell cycle, and prevented myogenic differentiation. 
These findings validate the ability of autophagy to function as an inducible mechanism of cellular 
remodelling and suggest further investigation into the physiological effects of chronic rapamycin 
exposure is warranted. 
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Materials and Methods 
Cell Culture  
C2C12 mouse skeletal myoblasts (ATCC) and HEK 293A cells were cultured in growth media (GM) 
consisting of low-glucose Dulbecco’s Modified Eagles Medium (DMEM; Hyclone, ThermoFisher) 
containing 10% fetal bovine serum (FBS; ThermoFisher) and 1% penicillin/streptomycin (ThermoFisher) 
on polystyrene culture dishes (BD Biosciences), as previously performed (357,369). C2C12 differentiation 
was induced by switching 90% confluent cells to differentiation media (DM) consisting of low-glucose 
DMEM containing 2% horse serum and 1% penicillin/streptomycin. For microscopy experiments, cells 
were grown on Cultrex- (R&D Systems) coated glass coverslips. When necessary, cells were isolated via 
trypsinization after washing in warmed PBS and centrifuged at 1000g. Note that for all cell death 
experiments culture media and PBS were collected to include non-adhered cells and debris. 
 
Materials 
Cells were treated as indicated with various chemicals/solutions to induce or measure cell stress. These 
include: Hank’s Balanced Salt Solution (HBSS; Gibco formulation: 140mg/L CaCl2, 100mg/L MgCl2-6H2O, 
100mg/L MgSO4-7H2O, 400mg/L KCl, 60mg/L KH2PO4, 350mg/L NaHCO3, 8.0g/L NaCl, 48mg/L Na2HPO4, 
1.0g/L D-glucose, with 1% penicillin/streptomycin), HBSS with 1% FBS and 1% penicillin/streptomycin 
(HB+F), rapamycin (Rap, 0.5 – 10.0 µM; Enzo Life Sciences), chloroquine (Cq, 50 µM; Sigma-Aldrich), 
staurosporine (STS, 0.5  µM or 2.0 µM; Enzo Life Sciences), cisplatin (CisPL, 25 µM; Enzo Life Sciences), 
hydrogen peroxide (H2O2, 2.5 mM; Sigma Aldrich), and the caspase inhibitor z-VAD-FMK (10 or 25 M 





C2C12 cells grown in 12-well plates were transfected with vectors encoding either an shRNA against 
Atg7 (Gene ID 74244, Origene TG504956) or a scramble control sequence (Origene TR30013) using 
Lipofectamine 2000 (ThermoFisher) as previously performed (183). Cells with stable incorporation of 
each vector were selected using 2 µg/mL puromycin (Sigma). Surviving clones were individually isolated 
and assessed for Atg7 protein expression using immunoblotting. When not otherwise indicated, 
experiments were performed with Atg7-deficient cell clone (shAtg7) number 1.  
 
Adenoviral Atg7 Expression 
Adenovirus coding for human Atg7 protein (adAtg7) was generously provided by Dr. Gokhan S. 
Hotamisligil, Department of Genetics and Complex Diseases, T.H. Chan School of Public Health, Harvard 
(424). An adenoviral construct encoding GFP (adAVH6/adGFP) was a generous gift from Dr. Robin Parks, 
Ottawa Hospital Research Institute (425). Virus were amplified using HEK 293A cells (generously 
provided by Dr. Robin Duncan, Department of Kinesiology, University of Waterloo) and viral particles 
were isolated/concentrated through repeated freeze-thaw cycles as indicated in the ViraPower 
Adenoviral Expression System protocol (Life Technologies). AdAtg7 stock volumes were titred to recover 
Atg7 protein content in Atg7-deficient cells to the levels observed in control/SCR cells. 
 
Immunoblotting 
Immunoblotting was performed as previously described (357,369). Whole-cell lysates were generated 
by adding ice-cold lysis buffer (LB, pH 7.4;  20mM HEPES, 10mM NaCl, 1.5mM MgCl2, 1 mM DTT, 20% 
glycerol, and 0.1% Triton-X100, Sigma Aldrich) with protease inhibitors (Complete Cocktail; Roche) to 
cell pellets followed by sonication for 12 seconds. Protein content was measured using the BCA protein 
assay method. Briefly, equal amounts of protein were loaded into and separated using 10-12% SDS-
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PAGE, transferred onto PVDF membranes (Bio-Rad Laboratories), and blocked for 1 hr at room 
temperature with 5% non-fat dry milk in TBS-T. Membranes were then probed with primary antibodies 
against Bcl2 (sc-7382, 1:200), Bax (sc-493, 1:1000), p21 (sc-397, 1:1000), phosphorylated histone H2AX 
(pH2AX, sc-101696, 1:1000; Santa Cruz), Atg7 (8558, 1:1000), LC3 (2775, 1:1000; Cell Signalling), actin 
(A-2066, 1:2000), myosin (MF-20, 1:2000), myogenin (F5D, 1:200), Pax7 (PAX7, 1:200; Developmental 
Studies Hybridoma Bank), p62 (PM045, 1:2000; MBL), or XIAP (ADI-AAM-050, 1:1000; Enzo Life Sciences) 
overnight at 4oC. Membranes were then incubated with the appropriate horseradish peroxidase-(HRP) 
conjugated secondary antibody (anti-rabbit: sc-2004, anti-mouse: sc-2005; Santa Cruz), and bands 
visualized using ECL immunoblotting substrates (BioVision) or Clarity ECL substrates (Bio-Rad) and the 
ChemiGenius 2 Bio-Imaging System (Syngene). The approximate molecular weight for each protein was 
estimated using Precision Plus Protein WesternC Standards and Precision Protein Strep-Tactin HRP 
Conjugate (Bio-Rad Laboratories).  
 
Proteolytic Enzyme Activity 
Enzymatic activity of caspases-3  and -9 was determined using the substrates Ac-DEVD-AFC and Ac-
LEHD-AMC (Enzo Life Sciences), respectively, as previously performed (357,369). Cell lysates were 
prepared using lysis buffer without addition of protease inhibitors and incubated in duplicate with 20 
µM of the appropriate fluorogenic substrate. Caspase activity measurements were performed in an 
assay buffer of 20 mM HEPES, 10 mM DTT, and 10% glycerol. For all activities, fluorescence was 
measured at 30oC using a Synergy H1 microplate reader (BioTek) with excitation and emission 
wavelengths of 360 nm and 440 nm for AMC substrates, and 400 nm and 505 nm for AFC substrates, 
respectively. All enzyme activities are presented normalized to total protein content measured using 






Annexin-V/PI staining was performed to assess the degree and type of cell death occurring after various 
stressors. For these measurements, culture media and one PBS wash were collected along with the 
adherent cells in order to include dying/detached cells. After treatment, cells were removed from 
culture dishes and suspended in Annexin Binding Buffer (10 mM HEPES/NaOH, 150 mM NaCl, 1.8 mM 
CaCl2, pH 7.4) and incubated with 1 µL of Annexin V-FITC (Life Technologies) and 1 µL of 500 µg/mL 
propidium iodide (PI). Cells were incubated for 20 min at room temperature, after which they were 
washed and suspended in HBSS. Cells negative for both annexin and PI were classified as healthy, those 
positive for annexin and negative for PI were considered to be in early stages of cell death, and those 
positive for both annexin and PI were considered to be in late stages of cell death. 
 
Cell Cycle 
After collection, cells were fixed by slowly suspending them in ice-cold 70% ethanol in PBS. Following at 
least 24 hr fixation, cells were washed with PBS and suspended in PI staining solution containing 40 
µg/mL PI, 0.1% Triton-X, and 20 µg/mL RNAse in PBS for 30 minutes at room temperature. All flow 
cytometry analyses were performed on a BD FACSCalibur flow cytometer equipped with Cell Quest Pro 




Cell morphology was visualized using Giemsa staining, as previously performed (357). Briefly, after fixing 
in ice-cold methanol for 10 min and air-drying, cells were incubated with 1:20 dilution of 0.45 µm 
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filtered Giemsa staining solution (Sigma Aldrich) in PBS (pH 6.0) for 45 min at room temperature. Cells 
were then washed with distilled water and mounted with Permount (ThermoFisher). 
 
Immunofluorescence 
Cell and nuclear morphology was also determined using immunofluorescent identification of actin and 
DAPI. After fixing in 4% formaldehyde and permeabilizing in 0.5% Triton-X 100 in PBS, cells were blocked 
in 5% goat serum for 1 hr and incubated with an anti-actin antibody (A-2066, 1:200; Sigma Aldrich) 
overnight at room temperature. Cells were then incubated with anti-rabbit AlexaFluor 488 secondary 
antibody for 1 hr, counterstained in 300 nM DAPI (ThermoFisher), and mounted with Prolong Gold 
(ThermoFisher). ImageJ was used to analyze cell and nuclear shape parameters, with at least 100 cells 
measured per trial. After masking nuclei by colour threshold, Area and Shape Descriptors measurements 
were performed. Calculations of these measurements can be found under the Analyze heading of the 
ImageJ user guide. All fluorescent microscopy was performed using a Zeiss Laser Scanning Microscope 




Results are presented as means ± SEM, where n=3-6 independent experiments. GraphPad Prism was 
used to perform 1- and 2-way ANOVA analyses and Tukey post-hoc tests where appropriate with 
significance indicated when p<0.05. Microsoft Excel was used to perform T-tests with significance 
indicated when p<0.05. Specifics regarding the statistical comparisons made can be found in figure 
captions. In figures, 1-way ANOVA significant differences are denoted with lowercase “a, b, c” characters 
and 2-way ANOVA main effect differences are denoted with pound signs (#) and ampersands (&). T-test 
significance is denoted with asterisks (*). 
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CHAPTER IV: Autophagy and mitophagy as inducible regulators of mitochondrial stress 























Project Rationale and Hypotheses 
Despite the well accepted anti-stress functions of autophagy, relatively less is known regarding 
autophagy and mitophagy’s roles as pro-active mechanisms of stress-resistance. Additionally, although it 
contributes to attenuated-aging phenotypes in model organisms, the specific mechanisms through 
which autophagy remodels cells as well as the aspects of the cellular environment that autophagy 
potentially changes are not known. Therefore, the purpose of this study was to examine the 
mitochondrial mechanisms involved in mediating the protective effects of repeated autophagy and 
mitophagy induction.  
 
This was performed by investigating the specific mitochondrial changes and mechanisms involved in 
autophagy- and mitophagy-mediated development of stress resistance in proliferative C2C12 cells by 
measuring factors which facilitate cell death, as well as by testing the stress-resistance of these systems. 
The dependence of these changes on autophagy specifically were illustrated by performing experiments 
in Atg7-deficient cells. Finally, a specific mitophagy regulating protein, Bnip3, was examined for its role 
in mediating Parkin-independent mitophagy and the adaptive effects of autophagy induction, as 
preliminary observations have indicated it may be important for autophagy/mitophagy in C2C12 cells. 
 
The hypotheses for Chapter IV were: 
1. Repeated mitophagy induction causes general cellular stress resistance. 
2. Repeated autophagy or mitophagy induction increases the specific stress resistance of mitochondria, 
and this does not occur in the absence of Atg7. 
3. Repeated autophagy or mitophagy induction increases mitochondrial content and function, and this 
does not occur in the absence of Atg7. 
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4. Bnip3 is required for proper autophagy and mitophagy induced by amino acid and serum withdrawal 
and mitochondrial membrane depolarization, respectively, in C2C12 cells. 
5.  Autophagy/mitophagy-induced stress resistance development requires Bnip3. 






















Autophagy and mitophagy are important regulators of diverse cellular functions, but relatively limited 
data exists regarding the effects of their exclusive induction or the specific cellular components 
involved. In this study, we examined the impact of previous autophagy or mitophagy induction on stress 
resistance development and mitochondrial function. Intermittent mitophagy, induced with CCCP, and 
autophagy, induced with amino acid starvation (HBSS), protected C2C12 cells from death caused by 
staurosporine (STS). Of the mechanisms investigated, this involved decreased caspase-9 activation. 
Mitochondrial stress resistance, tested with flow cytometry detection of calcein and JC-1, was 
specifically increased in CCCP- and HBSS-treated cells and this effect was abolished in Atg7-deficient 
cells. Repeated amino acid starvation also increased maximal mitochondrial oxygen consumption, while 
Atg7-deficient cells demonstrated severe impairments in mitochondrial respiration and did not display 
starvation-induced adaptations. As C2C12 cells possessed undetectable levels of Parkin protein, we also 
investigated the importance of Bnip3 in these findings. Although HBSS and CCCP differentially altered 
Bnip3 content, HBSS-induced stress resistance development and mitochondrial functional increases 
occurred in Bnip3-CRISPR cells. These results demonstrate the independent roles of autophagy and 
mitophagy in cellular remodelling, emphasizing their importance during situations of altered activity. 
 
Introduction 
Cells possess numerous mechanisms through which to resist acute stress. Existing proteins such as 
antioxidants absorb damaging stimuli like reactive oxygen species (ROS), post-translational 
modifications activate other protective proteins (Hsp’s, IAPs, sirtuins) and alter stress signalling 
mechanisms (ERK, MAPK, Akt), and ubiquitin and molecular chaperones identify and promote 
degradation of damage sources (298). However, unsurvivable stressors cause cells to remove 
themselves by activating cell death mechanisms such as apoptosis and/or programmed necrosis (2-4). 
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Although these two cell death processes occur for distinct reasons and are regulated by specific and 
differing mechanisms, they are linked through their mutual involvement of mitochondrial dysfunction 
and/or signaling (2-4). 
 
In addition to their roles in energy production and transfer, mitochondria are important sensors, 
resistors, and mediators of stress- and death-related signaling (2). Proper execution of these functions is 
so essential that mitochondrial dysfunction is generally thought to contribute to disease pathogenesis 
and aging (426). These abilities are facilitated through numerous mechanisms, including: 1) 
physiologically-regulated signal transduction by mediators such as mitochondrial anti-viral signaling 
(MAVS) (427), 2) intra-cellular stress indicators and effectors like ROS and mtDNA (427), 3) storage and 
maintenance of cellular Ca2+ concentrations (428), 4) release of pro-death factors such as cytochrome c, 
Smac, AIF, and EndoG (10,11,13,14), and 5) the extra-cellular effects of mitochondrial damage 
associated molecular patterns (DAMPs) (429). Unsurprisingly then, the biological status of mitochondria 
greatly impacts the cellular response to stressors (2). In fact, a modest elevation in mitochondrial 
content was shown to protect cultured L6 cells from caspase-dependent and independent cell death 
(388). Furthermore, the physiological relevance of mitochondrial health is commonly demonstrated by 
the adaptive effects of exercise training on skeletal muscle (338), a phenomenon that induces several 
mitochondrial adaptations. 
 
Another important mediator of the cellular stress response is autophagy. Although autophagy primarily 
functions as a catabolic means of energy provision, it is sensitive to numerous stimuli and in most 
scenarios contributes to preventing unnecessary cell removal (36,46,49). This cyto-protective role is 
typically observed in experiments where cell death is prevented by inducing autophagy 
(157,209,210,371,372), or where the sensitivity to cell death is increased by inhibiting autophagy 
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(36,49,183,245,372,430-433). Autophagy’s protective functions occur partly because it involves 
sophisticated substrate identification machinery that can selectively target damaged cellular material 
(36,46,49). Although microautophagy, chaperone-mediated autophagy, and chaperone-assisted 
selective autophagy (CASA) are known as substrate-specific responses, it is becoming increasingly 
apparent that degradation through macroautophagy-related mechanisms is also highly targeted. 
Importantly, this includes the specific degradation of mitochondria, an occurrence termed mitophagy 
(107). Research indicates that mitophagy targets metabolically impaired mitochondria (434,435) and 
those with decreased membrane potential (134), suggesting a preference for the removal of 
dysfunctional mitochondrial fragments/proteins (436). Biochemically, this process is primarily mediated 
by the proteins PINK1 and Parkin, which participate with mitochondrial fission machinery to segregate 
appropriate mitochondrial fragments and mark them for elimination (115,116). However, the Atg8-like 
autophagosome structural proteins LC3 and/or GABARAP identify a growing list of proteins including 
p62, NBR1, Bnip3, Nix, FUNDC1, cardiolipin, Bcl2-L-13, TAX1BP1, NDP52, optineurin, TBK1, and FKBP8 
which help mark damaged cellular cargo for elimination (104,128,138,142,147,151,153,155,159,392), 
demonstrating significant redundancy in mitophagic cargo selection. Due to the important cellular roles 
mitochondria play, mitophagy is a mechanism through which autophagy influences stress resistance 
(2,36,46,49). Cumulatively, these specific targeting interactions suggest autophagy displays high level 
control, and is perhaps capable of avoiding non-discriminate degradation. In this way, mitophagy 
specifically has important implications regarding cellular defense and remodelling.  
 
Therefore, autophagy may affect cell composition by degrading cellular material, such as mitochondria, 
in a “worst is first” manner. In fact, autophagy and mitophagy have been shown to contribute to the 
protective preconditioning effects of ischemia-reperfusion (IR) in the brain (244,342) and heart 
(343,437,438). However, the specific cellular aspects targeted by autophagy are largely unknown. We 
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previously demonstrated that autophagy is required for the development of stress resistance caused by 
repeated amino acid withdrawal. In this study, data is presented demonstrating that repeated 
autophagy or mitophagy induction causes resistance to specific stresses, particularly those related to 




CCCP, but not HBSS, induces mitophagy in C2C12 cells 
It was previously demonstrated that CCCP administration qualitatively increased the number of 
mitochondria colocalized with LC3 puncta in C2C12 cells (439). To more specifically investigate this 
process, the autophagic and mitophagic response to 30 µM CCCP was assessed and compared to that 
caused by amino acid and serum withdrawal (HBSS) (Fig. 1). Immunoblotting analyses indicated that 
CCCP: 1) increased LC3II in whole cell fractions, 2) decreased Bnip3 in whole cell fractions, 3) decreased 
LC3I in cytosolic subcellular fractions, 4) increased LC3II dramatically in mitochondrial-enriched 
subcellular fractions, and 5) increased PINK1 in mitochondrial-enriched subcellular fractions (Fig. 1A & 
1B). To determine whether CCCP affects general autophagic flux, C2C12 cells were treated with CCCP or 
HBSS with/without 50 µM chloroquine (Cq) for 6 hours (Fig. 1C & 1D). CCCP alone did not reduce p62 
protein levels but did increase (p<0.05) the LC3II/I ratio compared to GM and CCCP+Cq elevated 
(p<0.05) the LC3II/I ratio above that caused by Cq alone (Fig. 1C & 1D). These results alone suggest CCCP 
induces the beginning biochemical features of autophagy (such as LC3 lipidation), but may not increase 
autophagic flux activity (degradation of target material). However, the contents of several mitochondrial 
proteins were 20-30% lower (p<0.05) in cells administered CCCP for 6 hours compared to those which 
remained in GM (Fig. 1E & 1F). Therefore, it appears that CCCP in fact specifically causes mitophagy in 





Fig. 1. CCCP, but not HBSS, Induces mitophagy in C2C12 cells. (A) Cells incubated in HBSS or 30 µM CCCP 
in GM for 3 or 6 hours were immunoblotted for autophagy markers. (B) Immunoblotting of autophagy 
markers in cells treated for 6 hours and separated into subcellular fractions; 5Y represents SH-SY5Y 
lysate, included as Parkin positive control. (C & D) Assessment of p62 and LC3 immunoblotting in cells 
treated for 6 hours with or without 50 µM Cq. (E & F) Assessment of mitochondria-specific protein 
contents in whole cell lysates. Asterisks (*) indicate difference (p<0.05) from GM and plus-signs (+) 









Fig. 2. Cell death signaling during mitophagy- and autophagy-inducing treatments. C2C12 cells incubated 
in HBSS or 30 µM CCCP in GM were assessed for caspase-3 activity (A), cathepsin activity (B), and pH2AX 
protein expression (C & D). Data is expressed relative to cells which remained in GM, arbitrarily assigned 
a value of 1.0 and represented by the dotted line. Asterisks (*) indicate significant statistical difference 
from GM cells (p<0.05), calculated using T-tests. N=3. 
 
 
To examine if these autophagy/mitophagy induction modes affected cell death, C2C12 cells were 
incubated in HBSS or given 30 µM CCCP in GM and evaluated for caspase-3 activity and DNA damage 
(Fig. 2). While HBSS increased (p<0.05) capsase-3 activity by almost 2-fold at longer time points, this was 
far less than that caused by 2.0 µM STS (Fig. 2A), and this level of caspase activation did not cause DNA 
damage as indicated by pH2AX protein content (Fig. 2C). Additionally, CCCP did not elevate (p>0.05) 
caspase-3 activity or pH2AX expression above the levels observed in cells which remained in GM. 
 
Recovery from CCCP and HBSS is characterized by dramatic p62 and PGC1a induction 
As we were interested if removing CCCP would allow progression of autophagic flux, additional cells 





Fig. 3. Recovery from CCCP and HBSS is characterized by dramatic p62 and PGC1a induction. C2C12 cells 
incubated in HBSS or 30 µM CCCP in GM for 6 hours were washed in PBS and collected after spending an 
additional 3 or 6 hours in GM. Assessment of LC3 (A), p62 (B), PGC1a (C), and mitochondria-specific 
protein (D) immunoblotting. (E) Representative immunoblots. Data is expressed relative to cells which 
remained in GM, arbitrarily assigned a value of 1.0 and represented by the dotted line. Asterisks (*) 




(Fig. 3). After 6 hours in GM, the CCCP- and HBSS-induced changes to LC3 had recovered, as LC3I content 
and the LC3II/I ratio were not different (p>0.05) from cells which remained in GM (Fig. 3A). However, 
p62 protein levels were elevated (p<0.05) during recovery; this was particularly dramatic in CCCP-
treated cells where p62 was 13-fold higher (p<0.05) at the 3 hour recovery time point compared to GM 
(Fig. 3B). CCCP and HBSS also increased (p<0.05) PGC1a protein levels 15- and 7-fold, respectively, at the 
6 hour recovery time point (Fig. 3C). This was accompanied by 70% and 55% increased (p<0.05) 




Fig. 4. Repeated CCCP affects subsequent cell death induction differently than HBSS. C2C12 cells were 
incubated in HBSS or 30 µM CCCP in GM for 6 hours per day for 3 consecutive days or remained in GM 
(CTRL), and given 0.5 µM staurosporine (STS), 2.5 mM hydrogen peroxide (H2O2), 25 µM cisplatin (CisPL). 
Cells which remained in GM and not administered a death inducing chemical are included as 
negative/healthy controls (vehicle, Veh). Flow cytometry assessment of annexin/PI staining was used to 
classify cells given STS (A), H2O2 (B), and CisPL (C) into specific cell death stages. (D & E) Similarly-
treated cells were immunoblotted for pH2AX. In (E), data is expressed relative to Veh, arbitrarily 
assigned a value of 1.0 and represented by the dotted line. Groups were compared using 1-way ANOVAs 
and statistically significant differences are denoted with lowercase letters, where groups with different 




Repeated CCCP affects subsequent cell death induction differently than repeated HBSS  
The effect of prior CCCP or HBSS on cell death sensitivity was then tested by incubating cells in HBSS, 30 
µM CCCP in GM, or GM alone (CTRL) for 6 hours per day for 3 consecutive days. 20 hours following the 
third treatment, cell death was induced by administering 0.5 µM staurosporine (STS) for 3 hours, 2.5 
mM hydrogen peroxide (H2O2) for 5 hours, or 25 µM cisplatin (CisPL) for 18 hours. Cells which remained 
in GM and not administered a cell death inducing chemical served as negative/healthy controls, denoted 
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as vehicle (Veh) or depicted as dotted lines in Figures 4-6. Flow cytometry analysis of annexin/PI staining 
indicated that there were significantly more (p<0.05) healthy and less (p<0.05) late-apoptotic cells in 
HBSS-treated cells compared to CTRL (Fig. 4A). Previous CCCP administration similarly increased (p<0.05) 
the number of healthy cells and decreased (p<0.05) the number of late stage cells during H2O2 exposure 
(Fig. 4B). However, neither intermittent autophagy nor mitophagy affected subsequent cell death 
induced by CisPL (Fig 4C). pH2AX immunoblotting mirrored the annexin/PI data: intermittent HBSS 
treatments decreased (p<0.05) DNA damage caused by STS, and previous CCCP treatments decreased 
(p<0.05) DNA damage caused by H2O2. 
 
Intermittent HBSS-induced protection from STS is characterized by decreased caspase activation 
Additional cells were similarly incubated in HBSS or CCCP for 3 days, administered death-inducing 
stimuli, and analyzed for cell death related enzyme activities and protein contents (Fig. 5 & Fig. 6). HBSS 
treatments dramatically decreased (p<0.05) caspase-3 and -9 activities during STS-induced cell death 
compared to CTRL (Fig. 5A). These observations are supported by significantly reduced (p<0.05) protein 
levels of cleaved caspase-3 and a lower (p<0.05) cleaved :full-length PARP ratio in HBSS-treated cells 
compared to CTRL (Fig. 5D & 5G). Previous HBSS had similar but modest effects on these markers during 
CisPL-induced cell death (Fig. 5C, 5F & 5G). The effects of previous CCCP treatments were not as 
consistent, although cleaved caspase-3 protein content was lower (p<0.05) than CTRL during STS 
exposure (Fig. 5D). Interestingly, H2O2–mediated cell death did not involve caspase activation. 
 
The contents of several other cell death-related proteins were also analyzed to identify potential 
mechanisms which mediated autophagy-induced stress resistance development (Fig. 6). Only two 





Fig. 5. Intermittent autophagy-induced protection from STS is characterized by decreased caspase 
activation. After repeated HBSS or CCCP treatments, cells were administered STS, H2O2, or CisPL. (A – C) 
Caspase-3 and caspase-9 activities. (D – F) Immunoblotting of PARP cleavage and cleaved caspase-3. (G) 
Representative immunoblots. Data is expressed relative to cells which remained in GM and not given a 
death inducing chemical, arbitrarily assigned a value of 1.0 and represented by the dotted line. Groups 
were compared using 1-way ANOVAs and statistically significant differences are denoted with lowercase 








Bax:Bcl2 ratio compared to CTRL during STS-induced cell death (Fig. 6A & 6B), and 2) p53 content was 
lower (p<0.05) in HBSS-treated cells compared to CTRL during CisPL-induced cell death (Fig. 6E & 6F).  
 
Repeated autophagy and mitophagy cause mitochondrial-specific stress resistance 
We have consistently observed that previous HBSS treatments attenuate STS-induced cell death, and 
that this is characterized by decreased caspase-9 activity (Fig. 5A). To test mitochondria stress resistance 
specifically, we performed flow cytometry analyses of calcein and JC-1 fluorescence, which indicate 
mitochondrial permeability transition pore (mPTP) formation and mitochondrial membrane potential, 
respectively, after inducing calcium (Ca2+) stress with the calcium ionophore A23187. Similar to previous 
experiments, C2C12 cells were intermittently incubated in HBSS or 30 µM CCCP or remained in GM 
(CTRL). Subsequently incubating cells for 30 minutes in A23187 led to progressive drops in calcein 
fluorescence (Fig. 7A) and the JC-1 red:green fluorescence ratio (Fig. 7B), indicating mPTP formation and 
membrane depolarization, respectively. Previous HBSS and CCCP treatments attenuated (p<0.05) the 
reduction in calcein fluorescence at specific A23187 concentrations compared to CTRL (Fig. 7A), 
suggesting increased resistance to Ca2+ stress. Similarly, cells given HBSS and CCCP experienced a smaller 
(p<0.05) decrease in the JC-1 red:green fluorescence ratio when incubated with 5 µM A23187 compared 
to CTRL (Fig. 7B). Performing a similar experiment Atg7-deficient (shAtg7) and control (SCR) cells showed 
that previous incubation in HB+F and CCCP decreased (p<0.05) the reduction in calcein fluorescence 
caused by 5 µM A23187 in SCR, but not shAtg7 (Fig. 7C). When presented as a change from CTRL, it is 
apparent that both HB+F and CCCP decreased the reduction in calcein fluorescence by 40% in SCR, and 





Fig. 6. Cell death signaling proteins are largely unaltered by previous repeated CCCP or HBSS. After 
repeated HBSS or CCCP treatments, cells were administered STS, H2O2, or CisPL. (A & B) Assessment of 
cell death related protein contents in cells administered STS. (C & D) Assessment of cell death related 
protein contents in cells administered H2O2. (E & F) Assessment of cell death related protein contents in 
cells administered CisPL. Data is expressed relative to negative/healthy control cells which remained in 
GM and were not administered a death inducing chemical, arbitrarily assigned a value of 1.0 and 
represented by the dotted line. Groups were compared using 1-way ANOVAs and statistically significant 
differences are denoted with lowercase letters, where groups with different letters are significantly 






Fig. 7. Repeated autophagy and mitophagy increase mitochondrial stress resistance. (A & B) After 
repeated HBSS or CCCP treatments, C2C12 cells were assessed for calcium-induced mitochondrial 
permeability transition pore (mPTP) formation (A) or membrane depolarization (B). (C & D) Atg7-
deficient (shAtg7) and control (SCR) cells were intermittently incubated in HB+F or 30 µM CCCP in GM 
and similarly assessed for calcium-induced mPTP formation caused by 5 µM A23187. Data in (A – C) is 
expressed as a change from cells which did not receive A23187. In (A & B), groups at individual A23187 
concentrations were compared using 1-way ANOVAs and statistically significant differences denoted 
with lowercase letters, where groups with different letters are significantly different (p<0.05) than each 
other. In (C), data was compared by 2-way ANOVA: this revealed a main effect of shAtg7 compared to 
SCR, a main effect of HB+F compared to CTRL, and interaction effects where CCCP and HB+F are lower 
than CTRL in SCR (%) and CCCP is higher than CTRL in shAtg7. In (D), T-tests were used to compare 





Repeated amino acid and serum withdrawal increases mitochondrial respiration and this requires 
Atg7 
Next, to examine if mitochondrial stress resistance was associated with altered mitochondrial function, 
SCR and shAtg7 cells were repeatedly incubated in HB+F or 30 µM CCCP for 3 consecutive days, after 
which high-resolution respirometry (using the O2k by Oroboros) was used to measure several oxygen 
consumption metrics (Fig. 8). In general, shAtg7 displayed dramatically decreased oxygen consumption 
rates (OCR) in various conditions and HB+F treatments increased OCR only in SCR. Specifically, we first 
determined the sensitivity and maximal response to complex I-supported ADP-stimulated respiration by 
performing an ADP titration (Fig. 8A). Here, both Vmax and EC50 were significantly (p<0.05) lower in 
shAtg7 compared to SCR, and HB+F increased (p<0.05) Vmax by 28% compared to CTRL only in SCR (Fig. 
8B & 8C). Maximal (at 1.0 mM ADP) complex I+II-supported OCR was similarly increased (p<0.05) by 
previous HB+F and was notably lower (p<0.05) in shAtg7 compared to SCR (Fig. 8D). To confirm integrity 
of the mitochondrial membrane during experimental preparations, cytochrome c (cyt-c) is added at the 
end of the protocol. While this increased OCR 5-10% in SCR, shAtg7 experienced a significantly greater 
(p<0.05) 2.5-3.5-fold increase in OCR (Fig. 8E). To determine if shAtg7 possessed altered mitochondrial 
content and if HB+F caused mitochondrial biogenesis in SCR, immunoblotting of mitochondria specific 
proteins was also performed. Although HB+F did not generally increase these in SCR, CCCP increased 





Fig. 8. Repeated amino acid and serum withdrawal increases mitochondrial respiration and this requires 
Atg7. SCR and shAtg7 intermittently incubated in HB+F, CCCP in GM, or GM alone (CTRL) were assessed 
for mitochondrial respiration kinetics. (A – C) Complex I-supported ADP-stimulated oxygen consumption 
rate (OCR). (A) Average of titration curves with calculation of Vmax (B) and EC50 (C) values. (D) Maximal 
129 
 
OCR (at 1.0 mM ADP) with complex I substrates, complex I and II substrates, and cytochrome c (cyt-c). 
(E) Change in OCR caused by cyt-c. (F & G) Assessment of mitochondria-specific protein contents. 
Groups were compared using 2-way ANOVAs: pound signs (#) denote significant (p<0.05) main effect 
differences between SCR and shAtg7, ampersands (&) indicate significant (p<0.05) main effect of HB+F 
compared to CTRL and CCCP, percentage sign (%) represents interaction effect where HB+F is different 
(p<0.05) than CTRL only in SCR, (@) denotes interaction where HB+F and CCCP are different (p<0.05) 
than CTRL only in shAtg7, and (x) represents interaction effect where CCCP is different (p<0.05) than 




Role of Bnip3 in autophagy and mitophagy induction 
Individual CCCP and HBSS treatments significantly decreased and increased Bnip3 protein content, 
respectively, in C2C12 cells (Fig. 1A). Additionally, C2C12 cells were found to possess undetectable levels 
of Parkin protein (Fig. 1B). Therefore, we next examined the importance of Bnip3 in HBSS-induced 
autophagy and CCCP-induced mitophagy as well as the stress resistant phenotype and mitochondrial 
functional increases caused by HBSS. CRISPR/Cas9 was used to generate C2C12 cells deficient in Bnip3; a 
vector containing a non-targeting scramble gRNA sequence was used to generate control cells (SCR) (Fig. 
9A). SCR and Bnip3-KO were then incubated in HB+F or 30 µM CCCP and assessed for autophagy and 
mitophagy markers, with some allowed to recover in GM for 6 hours after a 6 hour treatment (Rec). 
Unlike Atg7-deficient cells, caspase-3 activity was slightly lower in Bnip3-KO during HB+F and CCCP 
treatments compared to SCR (Fig. 9B). No differences (p>0.05) were observed in p62 or LC3 protein 
levels between SCR and Bnip3-KO with HB+F (Fig. 9C & 9E). During CCCP administration, p62 levels were 
also not different (p>0.05) between groups, although Bnip3-KO did experience significantly increased 
(p<0.05) LC3II/I ratios (Fig. 9D & 9F). Additionally, mitochondrial protein contents were similarly 
decreased (p>0.05) between SCR and Bnip3-KO during 6 hour CCCP; ANT is quantitatively shown as a 
representative (Fig. 9G & 9H). However, PCG1a protein content was significantly reduced (p<0.05) in 




Fig. 9. Role of Bnip3 in autophagy and mitophagy induction. (A) Bnip3 protein content in control (SCR) 
and Bnip3-CRISPR (Bnip3-KO) C2C12 cells. Assessment of caspase-3 activity (B) and p62 and LC3 
immunoblotting (C & D) in cells incubated in HB+F or CCCP. Recovery (Rec) represents cells treated for 6 
hours and collected after spending 6 additional hours in GM. (E & F) Representative immunoblots. (G & 
H) Mitochondria-related protein content. T-tests were used to compare between SCR and Bnip3-KO and 
asterisks (*) denote a statistically significant difference (p<0.05). N=3. 
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Autophagy-induced protection from STS is not altered by Bnip3 deficiency 
To determine if Bnip3 contributed to autophagy-induced resistance to STS-mediated cell death, SCR and 
Bnip3-KO were incubated in HB+F, 30 µM CCCP in GM, or GM alone (CTRL) for 6 hours per day for 3 
consecutive days before being administered 0.5 µM STS as previously performed. Similar to previous 
findings, intermittent HB+F decreased (p<0.05) caspase-3 activity during subsequent STS exposure (Fig. 
10A). However, this reduction was not different (p>0.05) between SCR and Bnip3-KO. Similarly, previous 
HB+F and CCCP treatments decreased (p<0.05) pH2AX protein contents compared to CTRL during STS-
induced cell death (Fig. 10C); although this effect was not affected by Bnip3 deficiency (Fig. 10D). 
 
Bnip3-deficient cells display decreased maximal mitochondrial respiration but previous intermittent 
amino acid starvation still increases oxygen consumption 
Finally, we tested whether Bnip3 was required for HBSS-induced elevations in mitochondrial respiration 
(Fig. 8). Although maximal (at 1.0 mM ADP) complex I-supported, complex I+II-supported, and complex 
I+II+cyt-c-supported OCR was lower (p<0.05) in Bnip3-KO compared to SCR (Fig. 11A), HB+F treatments 






Fig. 10. Autophagy-induced protection from STS is not altered by Bnip3 deficiency. SCR and Bnip3-KO 
cells were intermittently incubated in HBSS or 30 µM CCCP in GM, or GM alone (CTRL) and administered 
STS. (A & B) Caspase-3 activity. (C - E) Assessment of pH2AX immunoblotting. In (A & C), data is 
expressed relative to cells which remained in GM and not administered STS, arbitrarily assigned a value 
of 1.0 and represented by the dotted line. In (A & C), groups were compared using 2-way ANOVAs: 
ampersands (&) indicate significant (p<0.05) main effect compared to all other groups and dollar signs 
($) indicate significant (p<0.05) main effect of HB+F compared to CTRL. In (B & D), T-tests were used to 






Fig. 11. Bnip3-deficient cells display decreased maximal mitochondrial respiration but previous 
intermittent starvation still increases oxygen consumption. (A) Maximal (at 1.0 mM ADP) oxygen 
consumption (OCR) with complex I substrates, complex I and II substrates, and cytochrome c (cyt-c) in 
cells repeatedly incubated in HBSS, CCCP, or GM alone (CTRL). (B) Change in OCR caused by repeated 
HB+F treatments expressed relative to CTRL. In (A), groups were compared using 2-way ANOVAs: pound 
signs (#) denote significant (p<0.05) main effect differences between SCR and shAtg7 and ampersands 
(&) indicate significant (p<0.05) main effect of HB+F compared to CTRL and CCCP. Groups in (B) were 









We previously demonstrated that prior repeated amino acid withdrawal partially protected cells from 
staurosporine (STS)-induced cell death and that this required Atg7. In that study, we observed less STS-
induced caspase-9 activity in cells intermittently starved of amino acids compared to those grown in 
regular culture media. Here, we empirically tested the hypothesis that these findings were due to 
mitochondrial remodelling specifically by repeatedly inducing mitophagy and subsequently evaluating 
cellular stress resistance. While intermittent CCCP did not protect cells from STS to the same extent as 
HBSS, mitochondrial resistance to calcium stress was similarly increased by both treatments and was not 
observed in Atg7-deficient cells. However, as increased maximal mitochondrial respiration kinetics were 
only observed after HB+F and not CCCP treatments, this further suggests the effects of amino acid 
starvation are phenotypically separate from and may be unrelated to mitochondrial autophagy. 
 
Notably, we were interested in examining the mitophagy-specific effects of our previous experiments 
involving intermittent amino acid starvation by conducting additional experiments with CCCP. While 
CCCP-induced mitochondrial fragmentation and overlap of mitoDsRed with LC3 has been previously 
observed in C2C12 cells (439), we expand on this finding by demonstrating CCCP-induced conversion of 
LC3I to LC3II, enrichment of LC3II in mitochondrial subcellular fractions, and 20-25% decrease in 
mitochondria-specific protein contents (Fig. 1). However, similar mitophagy-specific biochemical 
changes were not observed with amino acid starvation (HBSS), suggesting this does not actually induce 
mitophagy in C2C12 cells. Previously, HBSS reduced mitochondria-specific protein contents in MEFs 
(440) and increased mitoDsRed and LC3-GFP overlap in HeLa cells (441), thereby implying mitophagy 
induction. However, others have shown that HBSS does not deplete mitochondria-specific proteins in 
MEFs (442) or cause overlap of mitochondrial structures with LC3 in rat kidney cells (67). Furthermore, 
engulfment of mitochondria into autophagosomes did not occur with various starvation modes but did 
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with typical mitophagy activators (67), HBSS-induced overlap of mitoDsRed and LC3-GFP was less than 
that caused by rotenone (441), and HBSS incubation for 5 hours reduced mitochondria-specific protein 
contents only in cells incapable of mitochondrial fusion (233). In fact, several studies have demonstrated 
that various cell types hyperfuse their mitochondria upon starvation (including HBSS/amino acid 
withdrawal) theoretically to preserve mitochondria mass, energy production and therefore survival 
(233,441,442). Here, we do not observe induction of mitophagy-specific cellular signaling and resultant 
mitochondria-specific protein depletion with amino acid starvation using HBSS in C2C12 cells. 
Interestingly, HeLa cells do not express Parkin, and this finding was initially exploited to determine its 
relevance to the molecular regulation of mitophagy (116,117,119,127,132,241). In these experiments, 
CCCP administration depleted most Parkin-positive cells of mitochondria in 48 hours (115). Therefore, 
the specific expression pattern of autophagy- and mitophagy-related genes and receptor proteins 
potentially explain the diverse mitophagic response to starvation stimuli. Interestingly, we make the 
observation that C2C12 cells do not express detectable levels of Parkin protein and that neither CCCP 
administration, HBSS incubation, nor myogenic differentiation of these cells induces Parkin expression 
(Fig. 1 & Appendix B Fig. 6). However, one previous study has shown Parkin in differentiated C2C12 cells 
with stable Hsp72 knockdown (443). Despite this, all other myoblast cell lines we investigated including 
primary mouse, primary human, and L6 immortalized rat cells possessed low Parkin protein levels in 
proliferative cells and drastically increased expression during differentiation (Appendix B Fig. 6). As we 
made the additional novel observation that CCCP administration dramatically reduced while HBSS 
incubation dramatically increased cellular Bnip3 protein levels (Fig. 1), we also wanted to exploit 





Bnip3 is a mitochondrial BH3-containing protein originally described to promote apoptotic cell death by 
interacting with Bcl2 (444,445). Although not appearing to utilize its BH3 domain for its pro-death 
functions (446,447), cells overexpressing Bnip3 were also initially characterized to induce mitochondrial 
autophagy (446). Current understanding indicates Bnip3 regulates autophagy by altering Bcl2-Beclin1 
interaction and by binding to LC3 thereby targeting mitochondria for mitophagy (142,145,146,214). As 
CCCP administration drastically reduced cellular Bnip3 protein levels, we hypothesized that Bnip3 
regulates depolarization-induced mitophagy in C2C12 cells given their lack of Parkin and that its 
reduction represented mitochondrial removal. However, despite observing increased CCCP-induced 
LC3II formation in Bnip3-CRISPR cells compared to controls, there was no difference in mitochondria-
specific protein depletion. This suggests that Bnip3 deficient cells could adapt to maintain functional 
mitochondria removal during depolarization. Interestingly, one feature of CCCP administration that was 
affected by Bnip3 deficiency was PGC1a induction. While C2C12 (Fig. 3) and SCR-CRISPR (Fig. 9) cells 
dramatically increased PGC1a protein levels during CCCP treatment recovery periods, this did not occur 
in Bnip3-CRISPR cells suggesting it is required for this response. In addition to CCCP-induced Bnip3 
depletion, HBSS treatments significantly increased cellular Bnip3 protein content (Fig. 1). Interestingly, 
Bnip3 was identified in an RNA microarray as a target that was significantly increased in the liver of 
fasted mice (448), a finding robustly demonstrated at the protein level (449). Although one study has 
demonstrated autophagy-dependent Bnip3 degradation caused by amino acid starvation (450). 
Nonetheless, its deficiency here did not affect LC3 conversion or p62 degradation during amino acid 
withdrawal in C2C12 cells in this study, suggesting it does not affect autophagic flux in this scenario (Fig. 
9). Furthermore, HB+F-induced resistance to STS was similarly developed in SCR and Bnip3-CRISPR cells, 
also indicating that Bnip3 is not involved with this cellular remodelling effect. This is in contrast to Atg7, 
which we previously demonstrated was required for intermittent amino acid starvation to cause 
resistance to STS-induced cell death (Bloemberg and Quadrilatero, unpublished). Furthermore, although 
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Bnip3 has been shown to promote cell death cause by several stressors, we did not detect an 
independent effect of Bnip3 expression on STS-induced caspase-3 activity and DNA damage, despite 
observing Bnip3 depletion in STS-treated cells (Appendix B Fig. 1). This also suggests the involvement of 
an unidentified mechanism. Lastly, Bnip3 deficiency reduced maximal cellular oxygen consumption in 
various conditions, although it did not affect HB+F-induced elevation in mitochondrial respiration (Fig. 
11). Previously, massive Bnip3 overexpression reduced maximal uncoupled cellular oxygen consumption 
in cultured cells, proposed to be due to degradation of specific mitochondrial proteins involved in 
oxidative phosphorylation (142,451). Additionally, cells from Bnip3-knockout mice have demonstrated 
increased maximal uncoupled cellular oxygen use in basal conditions and attenuated hypoxia-(452) and 
doxorubicin-(451) induced mitochondrial bioenergetic dysfunction. These results suggest a negative 
impact of Bnip3 on mitochondrial function. However, others have hypothesized that Bnip3 is required to 
ensure appropriate mitochondrial removal during stress that prevents accumulation of dysfunctional, 
but still oxygen-using, mitochondria (449). Regardless of Bnip3’s involvement, we demonstrate here that 
repeated autophagy induction increased ADP-stimulated mitochondrial respiration. 
 
Intriguingly, repeated incubation of C2C12 cells in amino acid-free media increased maximal ADP-
stimulated cellular oxygen consumption (OCR) when supplied with electron transport chain (ETC) 
complex-I (pyruvate, malate, glutamate) and complex-II (succinate) substrates (Fig. 8). Furthermore, not 
only did Atg7-deficient cells display significantly reduced complex-I and complex-II supported OCR, 
intermittent amino acid starvation did not increase OCR in these cells. Additionally, while adding 
cytochrome c at the end of the respiration protocol caused a 5-10% increase in OCR in SCR cells, it 
remarkably elevated OCR in shAtg7 cells by several fold. These findings indicate dramatic mitochondrial 
functional impairment with Atg7 deficiency, potentially involving compromised mitochondrial 
permeability and membrane stability, as well as an inability to adapt to autophagy-inducing stimuli. 
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Interestingly, despite observing relatively larger increases in PGC1a protein levels with CCCP compared 
to HBSS, repeated CCCP treatments did not affect maximal mitochondrial respiration or sensitivity to 
ADP-stimulated OCR in SCR or Atg7 deficient cells. This was found despite detecting CCCP-induced 
elevations in mitochondria-specific protein contents in shAtg7. Cumulatively, these results suggest that 
damaged and/or dysfunctional mitochondria accumulate in the absence of autophagy and that despite 
being able to induce mitochondrial biogenesis, mitochondrial functional benefits are not observed 
without functional autophagy. It is well-known that Atg7-deficiency causes mitochondrial dysfunction in 
yeast (453) and alters mitochondrial morphology in mouse cardiomyocytes and hepatocytes (50,454). 
Furthermore, autophagy deficiency also leads to mitochondrial accumulation (384,455-457) while 
simultaneously decreasing maximal mitochondrial respiration kinetics and OCR in various cell types 
(458,459). Therefore, our findings support a role for autophagy providing important contributions to 
maintaining mitochondrial homeostasis. Strangely, these collective results indicate a disconnect 
between PGC1a and mitochondrial respiration: 1) both HBSS/HB+F and CCCP increased PGC1a, 2) only 
HBSS/HB+F elevated maximal OCR, 3) PGC1a did not increase with HB+F or CCCP in Bnip3-KO, 4) but 
Bnip3-KO cells still saw HB+F-induced elevations in OCR. Ultimately, these observations raise the 
question of why mitochondrial functional changes were not induced by CCCP. Possibly, although 30 µM 
CCCP induces mitophagy, this may represent too stressful of a condition to be appropriately adapted to 
in this timeframe, as we typically use CCCP during mitochondrial respirometry protocols to measure 
maximal uncoupled respiration at only 1-2.5 µM (Bradley et al, unpublished). Therefore, despite 
observing CCCP-induced PGC1a expression, this may not have affected expression of downstream 
effectors or mitochondrially-encoded proteins. Notably, constant amino acid starvation for 72 hours was 
previously shown to elevate OCR in HEK cells while potently increasing mitochondrial protein synthesis 
without affect mitochondrial content in general (460). Caloric restriction has also been shown to induce 
PGC1a, Sirt1, eNOS, and select mitochondrial markers in mice in vivo (461,462). Therefore, we suggest 
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that autophagy-dependent recycling of cellular material and promotion of bioenergetically favourable 
mitochondrial adaptations explain the changes to mitochondrial function observed here.   
 
One important finding common to CCCP and amino acid starvation treatments was the development of 
autophagy-dependent mitochondria-specific stress resistance. Although this hypothesis is often made to 
explain the potential longevity-causing effects of various interventions that involve autophagy (311,463), 
explicit demonstration of this occurring is rare. We demonstrate here that not only does intermittent 
amino acid starvation protect from calcium-induced mitochondrial membrane depolarization and 
permeability pore formation, but this effect was eliminated by Atg7 deficiency. This result suggests that 
autophagic degradation specifically is responsible for the HBSS/HB+F- and CCCP-induced development 
of mitochondrial stress resistance. Therefore, these data represent important novel findings that 
substantiate autophagy’s inducible remodelling effects, specifically that of mitochondria. Furthermore, 
as other markers related to cell death execution were generally unaltered by repetitive autophagy and 
mitophagy induction (except perhaps Bcl2, Fig. 6A & 6B), this implicates mitochondria as central 
mediators, effectors, and targets of autophagy-induced cellular remodelling. Notably, and in agreement 
with our previous experiments, intermittent amino acid starvation protected from STS-, but not H2O2- or 
CisPL-induced cell death, indicating the impact of these mitochondrial adaptations are context 
dependent. Although the physiological relevance of these findings is unknown, their observation 
warrants further examination into the impact of autophagy induction on cellular function and tissue 
health. 
 
This study complements our previous investigation into autophagy-induced stress resistance by 
demonstrating specific involvement of mitochondrial adaptations. We show that mitochondrial stress 
resistance and maximal oxygen consumption are increased following intermittent amino acid starvation, 
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and that these adaptations require Atg7. Additionally, despite C2C12 cells’ lack of Parkin, Bnip3 also 
appeared unnecessary for autophagy-induced changes to occur. These findings provide insight into 
autophagy’s role as an inducible mechanism of cellular remodelling and have important implications 
regarding the interaction between autophagy, mitochondria biology, longevity, and aging. 
 
Materials and Methods 
Cell culture 
C2C12 mouse skeletal myoblasts were cultured in growth media (GM) consisting of low-glucose 
Dulbecco’s Modified Eagles Medium (DMEM; Hyclone, ThermoFisher) containing 10% fetal bovine 
serum (FBS; ThermoFisher) and 1% penicillin/streptomycin (ThermoFisher) on polystyrene culture dishes 
(BD Biosciences), as previously performed (369). Cells were appropriately sub-cultured using trypsin 
(0.25% solution with EDTA, ThermoFisher) to ensure all appropriate treatments and analyses were 
performed before cells reached confluence to avoid the potential side-effects of spontaneous 
differentiation. Cells were collected for subsequent experimental analyses via trypsinization and 
centrifuged at 1000g.  
 
Materials 
Cells were treated as indicated with various chemicals/solutions to induce or measure cell stress. These 
include: Hank’s Balanced Salt Solution (HBSS; Gibco formulation: 140mg/L CaCl2, 100mg/L MgCl2-6H2O, 
100mg/L MgSO4-7H2O, 400mg/L KCl, 60mg/L KH2PO4, 350mg/L NaHCO3, 8.0g/L NaCl, 48mg/L Na2HPO4, 
1.0g/L D-glucose, with 1% penicillin/streptomycin), HB+F (HBSS with 1% FBS and 1% 
penicillin/streptomycin), chloroquine (Cq, 50 µM; Sigma-Aldrich C6628), staurosporine (STS, 0.5 or 2.0  
µM; Alexis Biochemicals 380-014-C100), cisplatin (CisPL, 25 µM; Enzo Life Sciences 400-40-M250), 
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hydrogen peroxide (H2O2, 2.5 mM; Sigma Aldrich), carbonyl cyanide 3-chlorophenylhydrazone (CCCP, 30 
µM; Sigma-Aldrich C2759), and the calcium ionophore A23187 (5, 10, or 15 µM; BioVision 1501). 
 
Bnip3 CRISPR Vector 
CRISPR/Cas9 vectors targeting mouse Bnip3 were constructed as follows. The region immediately 
upstream of the transcription start site was searched for candidate guide RNA (gRNA) targets using 
several available online tools including: Zhang Lab, MIT (http://crispr.mit.edu/), CCTop 
(http://crispr.cos.uni-heidelberg.de/), and Off-Spotter (https://cm.jefferson.edu/Off-Spotter/). From 
these, two common gRNA sequences were identified (PAM in brackets): First: 
5’GAGCCACCATGTCGCAGAGC(GGG), and Second: 5’GGAGGAGAACCTGCAGGGTG(AGG). The scramble 
sequence used in Origene CRISPR products was used as a control: 5’GCACTACCAGAGCTAACTCA. 
Corresponding oligonucleotides were constructed (Sigma Aldrich) to allow cloning into the CRISPR/Cas9 
vector pSpCas9(BB)-2A-Puro (PX459) V2.0 (Addgene #62988), which uses a single gRNA. Correct gRNA 
cloning was confirmed by sequencing constructed vectors (The Center for Applied Genomics, Hospital 
for Sick Kids, Toronto, Ontario, Canada). 
 
Transfections and Gene Knockdown 
C2C12 cells were transfected using Lipofectamine 2000 (Life Technologies), optimized according to the 
manufacturer’s instructions, as previously performed (183,369). Briefly, appropriate vector DNA and 
Lipofectamine was diluted in 100 µL Opti-MEM (Gibco) at a ratio of 1µg: 3µL, and incubated for 5 min at 
room temperature. This mixture was added to 50-60% confluent cells with media containing 5% FBS in 
Opti-MEM and incubated for 6 hours, after which cells were washed with PBS and regular growth media 




For generating C2C12 cells with stable knockdown of Atg7, cells grown in 12-well plates were 
transfected with vectors encoding either an shRNA against Atg7 (Origene TG504956) or a scramble 
control sequence (Origene TR30013) using Lipofectamine 2000 (ThermoFisher) as previously performed 
(183). 24 hours later, cells were transferred to 10 cm culture plates and those with stable incorporation 
of each vector were selected by growing cells in GM with 2 µg/mL puromycin (Sigma Aldrich). Surviving 
clones were individually isolated and assessed for Atg7 protein expression using immunoblotting. 
For generating Bnip3 knockout C2C12s, cells grown in 12-well plates were transfected either with the 
aforementioned Bnip3 CRISPR or scramble control vector. 24 hours later, cells were transferred to 10 cm 
culture plates and those with incorporation of each vector were selected by growing cells in GM with 2 
µg/mL puromycin (Sigma Aldrich). Surviving clones were individually isolated and assessed for Bnip3 
protein expression using immunoblotting. 
 
Subcellular Fractionation 
After collection via trypsinization, cells were incubated in digitonin buffer (PBS with 250 mM sucrose, 80 
mM KCl, and 50 µg/mL digitonin, Sigma Aldrich D141) for 5 min on ice. Cells were centrifuged at 1000g 
for 10 min, the supernatant was collected and centrifuged at 16,000g for 10 minutes to pellet any 
mitochondrial contamination, and the supernatant from this spin kept as the cytosolic-enriched fraction. 
The pellet (P1) remaining from the 1000g spin was suspended in PBS, centrifuged at 1000g for 5 min, the 
pellet suspended in lysis buffer (LB, pH 7.4; 20mM HEPES, 10mM NaCl, 1.5mM MgCl2, 1 mM DTT, 20% 
glycerol, and 0.1% Triton-X100), and allowed to sit on ice for 5 min. This was then centrifuged at 1000g 
for 5 min, resulting in a pellet (P2) containing nuclei, and a supernatant (S2) containing mitochondria. S2 
was centrifuged at 1000g for 10 min to pellet nuclear contamination, with the resulting supernatant 
kept as the mitochondrial-enriched fraction. The P2 pellet was suspended in LB, centrifuged at 1000g for 
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Immunoblotting was performed as previously described (357,369). Whole-cell lysates were generated 
by adding ice-cold lysis buffer with protease inhibitors (Complete Cocktail; Roche) to cell pellets 
followed by sonication for 12 seconds. Protein content was measured using the BCA protein assay 
method. Briefly, equal amounts of protein were loaded into and separated using 10-12% SDS-PAGE, 
transferred onto PVDF membranes (Bio-Rad Laboratories), and blocked for 1 hr at room temperature 
with 5% non-fat dry milk in TBS-T. Membranes were then probed with primary antibodies against: ANT 
(sc-9299, 1:100), Bcl2 (sc-7382, 1:200), Bax (sc-493, 1:1000), cytochrome c (sc-13156, 1:2000), parkin 
(sc-32282, 1:500), PARP (sc-7150, 1:200), PGC1 (sc-13067, 1:200), PINK1 (sc-33796, 1:500), p53 (sc-6243, 
1:500), phosphorylated histone H2AX (pH2AX, sc-101696, 1:1000; Santa Cruz), Atg7 (8558, 1:1000), 
Atg4B (5299, 1:1000), Atg12/5 (4180, 1:1000), Beclin1 (3738, 1:1000), LC3 (2775, 1:1000), MnSOD (SOD-
110, 1:4000), Smac (ADI-905-244, 1:2000), XIAP (ADI-AAM-050, 1:1000; Enzo Life Sciences), actin (A-
2066, 1:2000), Bnip3 (B7931, 1:1000), cleaved caspase-3 (C8487, 1:1000; Sigma Aldrich), p62 (PM045, 
1:2000; MBL) overnight at 4oC. Membranes were then incubated with the appropriate horseradish 
peroxidase- (HRP) conjugated secondary antibody (anti-rabbit: sc-2004, anti-mouse: sc-2005, anti-goat: 
sc-2020; Santa Cruz), and bands visualized using ECL immunoblotting substrates (BioVision) or Clarity 
ECL substrates (Bio-Rad) and the ChemiGenius 2 Bio-Imaging System (Syngene). The approximate 
molecular weight for each protein was estimated using Precision Plus Protein WesternC Standards and 




Proteolytic Enzyme Activity 
Enzymatic activity of caspases-3, and -9 was determined using the substrates Ac-DEVD-AFC and Ac-
LEHD-AMC (Enzo Life Sciences), respectively, as previously performed (357,369). Cell lysates were 
prepared using lysis buffer without addition of protease inhibitors and incubated in duplicate with 20 
µM of the appropriate fluorogenic substrate. Caspase activity measurements were performed in an 
assay buffer of 20 mM HEPES, 10 mM DTT, and 10% glycerol. 
 
Lysosomal enzyme activity was measured using the substrate z-FR-AFC (Enzo Life Sciences), generally 
considered to indicate the activities of cathepsins L and B (357,369). Cell lysates were prepared similar 
to caspase assays and analyzed in duplicate with 25 µM of z-FR-AFC in a buffer containing 50 mM 
sodium acetate, 8 mM DTT, 4 mM EDTA, and 1 mM Pefabloc at pH 5.0. For all activities, fluorescence 
was measured at 30oC using a Synergy H1 microplate reader (BioTek) with excitation and emission 
wavelengths of 360 nm and 440 nm for AMC substrates, and 400 nm and 505 nm for AFC substrates, 
respectively. All enzyme activities are presented normalized to total protein content measured using 




Cells were collected as described above and suspended in HBSS. Mitochondrial membrane potential and 
mitochondrial permeability transition pore formation were measured using JC-1 and calcein, 
respectively, as previously performed (369). Mitochondrial membrane depolarization can be monitored 
by changes in the JC-1 red:green fluorescence ratio, where a decreased ratio is indicative of decreased 
mitochondrial membrane potential.  After removing from culture, cells were incubated with 2 μM JC-1 
in 100 µL HBSS for 15 min at 37 °C, washed by centrifugation, and suspended in HBSS. Mitochondrial 
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permeability transition pore (mPTP) formation occurs during mitochondrial-mediated apoptosis prior to 
mitochondrial apoptotic protein release. The fluorescent dye calcein AM accumulates in intact 
mitochondria, but is quenched by cobalt if the mitochondrial membrane becomes permeable to cobalt. 
Thus a decrease in calcein fluorescence indicates mPTP formation. Briefly, cells were incubated with 1 
μM calcein AM and 1 mM CoCl2 in 100 µL HBSS for 15 min at 37°C, washed by centrifugation, and 
resuspended in 500 μl HBSS. Mitochondria-specific resistance to calcium stress was tested by 
concomitantly incubating cells with 2.5, 5, or 10 µM of the calcium ionophore A23187 along with JC-
1/calcein. 
 
Cell Death  
In cell culture experiments, Annexin-V/PI staining was performed to assess the degree and type of cell 
death occurring after various stressors (388). After treatment, cells were removed from culture dishes 
and suspended in Annexin Binding Buffer (10 mM HEPES/NaOH, 150 mM NaCl, 1.8 mM CaCl2, pH 7.4) 
and incubated with 1 µL of Annexin V-FITC (BioLegend, 640906) and 1 µL of 500 µg/mL propidium iodide 
(PI, Sigma Aldrich P-4170). Cells were incubated for 20 min at room temperature, after which they were 
washed and suspended in HBSS. Cells negative for both annexin and PI were classified as healthy, those 
positive for annexin and negative for PI were considered to be in early stages of cell death, and those 
positive for both annexin and PI were considered to be in late stages of cell death. All flow cytometry 




Analyses of C2C12 mitochondrial bioenergetics were performed using high resolution respirometry 
measurement of oxygen consumption (O2K, Oroboros Instruments). After collection via trypsinization, 
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cells were centrifuged at 100g and permeabilized using digitonin buffer (PBS with 250 mM sucrose, 80 
mM KCl, and 50 µg/mL digitonin) for 3 min while agitating at room temperature. After centrifuging once 
more at 200g to remove digitonin, cells were suspended in mitochondrial respiration buffer (Mir06: 0.5 
mM EGTA, 3 mM MgCL2-6H2O, 60 mM lactobionic acid, 20 mM taurine, 10 mM KH2PO4, 20 mM HEPES, 
110 mM sucrose, 1 g/L fatty acid-free BSA, and 100 mg/L catalase; pH 7.1) and transferred into O2K 
chambers. Respiration was performed in Mir06 at 37oC under hyperoxygenated conditions (350 µM) in 
the presence of the complex I substrates glutamate (10 mM), pyruvate (5 mM), and malate (2 mM). The 
sensitivity and maximal response to complex I-supported ADP-stimulated respiration were then 
measured by conducting an ADP titration with the following concentrations: 1.0 µM, 2.5 µM, 5.0 µM, 10 
µM, 20 µM, 50 µM, 100 µM, 200 µM, 500 µM, and 1.0 mM. Succinate was then added in excess (10 mM) 
to determine maximal complex-II supported respiration. Finally, cytochrome c was added (10 µM) after 
achieving maximal respiration to test the integrity of the outer mitochondrial membrane. Data is 
presented normalized to total protein content of the O2K chambers, calculated by aspirating and 
collecting a portion of the chamber volume upon protocol completion. GraphPad Prism was used to 
calculate Vmax and EC50 values on ADP titration curves, using the allosteric sigmoidal enzyme kinetics 
equation:  Y=Vmax*X^h/(Khalf^h + X^h). 
 
Statistics 
Results are presented as means ± SEM, where n=3-6 independent experiments. GraphPad Prism was 
used to perform 1-way and 2-way ANOVA analyses with Tukey post-hoc tests where appropriate with 
significance indicated when p<0.05. Microsoft Excel was used to perform T-tests with significance 






























This thesis contains several experiments testing the impact of autophagy induction on various cellular 
functions. Although much has been learned about autophagy’s molecular regulation and biological 
importance from genetic manipulation studies, relatively less is known regarding the consequences of 
its forced induction. To answer some of these basic biological questions, C2C12 cells were intermittently 
treated with rapamycin, CCCP, or incubated in amino acid-free media. These stimuli were chosen for 
their diverse mechanisms of autophagy induction in an attempt to identify common and/or specific 
resulting phenotypes. The repeated/intermittent nature of these interventions was intentional and is 
fundamental to understanding the relevance of these studies. Importantly, this was done to partly 
mimic the ebb and flow that characterizes cellular stress in vivo, which is punctuated by recovery 
periods that allow responsive and potentially long-lasting adaptations to occur. This is particularly 
relevant to nutritional stresses such as relative and/or short term caloric restriction, given their easily 
inducible nature and strong connection to autophagy, longevity, and aging. Additionally, performing 
these experiments in Atg7-deficient cells allows these observations to be attributed to LC3-dependent 
autophagic degradation specifically, as this enzyme is required for formation of the mature/functional 
LC3II variant. Furthermore, as Bnip3 was recognized as possibly being involved with CCCP- and HBSS-
induced autophagy, experiments were also conducted in Bnip3-deficient cells to better characterize the 
importance of this autophagy- and mitophagy-regulating protein. In doing so, these Projects contribute 
several novel discoveries regarding autophagy’s role as an inducible mechanism of cellular remodeling. 
 
Notably, the specific experiments contain herein diverge from those initially proposed to be done for 
this thesis. In the beginning, I wanted to examine the importance of autophagy in mediating the 
beneficial effects of exercise training on skeletal muscle function and metabolism, made possible as the 
Quadrilatero Laboratory possesses genetically modified mice capable of inducible- and skeletal muscle-
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specific knockdown of Atg7 (Appendix B Fig. 30). In fact, such an experiment would have nicely 
complemented the data presented here by potentially further demonstrating the cellular remodelling 
impacts of autophagy induction; some of these experiments have now been performed by others 
(189,191). With ample foresight, Dr Quadrilatero suggested that some specific cellular aspects of this in 
vivo experiment be investigated, which thus led to the theories and questions tested here in vitro. This is 
relevant for an important reason, because the hypothesis that autophagy does in fact contribute to the 
beneficial effects of exercise training implies several assumptions, primarily that: 1) autophagy is good 
for cells, 2) what is good for cells is good for the organism, and 3) that “good” means keeping cells alive 
and functioning. Importantly, these assumptions were generally held while designing the experiments in 
this this thesis, even though all the results do not necessarily support them. However, whereas keeping 
cells functioning properly seems like a logical way to preserve tissue function and therefore health, 
there are a few caveats to this paradigm. First among them is cancer, where keeping cells alive is not 
good for the organism, thereby violating those second and third assumptions. Similarly, keeping cells 
alive is not the same as keeping them “healthy” and “functional” as demonstrated during senescence 
development. Additionally, although examples of autophagy-induced cell death are rare, they do exist 
and therefore defy the first assumption. Furthermore, it’s been shown that the longevity-inducing 
effects of several interventions, including caloric restriction, are potentially due to increased stress 
resistance development in post-mitotic tissues such as cardiac muscle, but increased cell turnover and 
death in tissues such as the liver (355). Based on current understanding, it is possible that autophagy 
mediates all of these opposing cellular responses, but such information is complex and just beginning to 
be understood. Therefore, it is likely that different assumptions mentioned above hold true in different 
manners for each cell type. These are big theoretical biology questions, but essentially it appears that on 
a cellular level autophagy can promote life and/or death, and that the result of this outcome can be 
good or bad for health! What this means is that any rational design of a drug that impacts health by 
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altering autophagy requires deep understanding of the impact of autophagy induction on specific cell 
types in specific contexts. A number of novel observations regarding the basic biology behind these 























Contributions of Chapter II: Autophagy induction through intermittent amino acid starvation 
does not cause senescence in vitro 
 
Key findings 
− Short-term amino acid and serum withdrawal (HBSS) does not increase caspase-3 activity or 
cause DNA damage in C2C12 cells 
− Low concentration STS administration slightly increases autophagic flux as well as caspase-3 
activity and DNA damage 
− Repeated low concentration STS administration causes senescence in C2C12 cells as 
indicated by: enlarged and misshapen cells and nuclei, G1 growth arrest, SAHF, SA-Bgal, and 
impaired myogenic differentiation 
− Repeated HBSS incubation does not cause any of these phenotypic alterations 
− Senescent cells, but not those incubated in HBSS, display resistance to cisplatin-induced cell 
death 
− P62 protein content is significantly reduced in senescent cells, which also demonstrate 
altered basal autophagic flux and starvation-induced autophagy  
− ROS partly mediate senescence development induced by low concentration STS 
− STS-induced senescence is attenuated in Atg7-deficient cells, likely because they show 
increased sensitivity to STS-induced cell death 
 
Novelty and relevance of these observations 
− Complements recent observations that senescence impairs myogenic potential (252) 
− Demonstrates that autophagy is involved with senescence induced by repetitive toxic stress 
− Despite numerous prior examples of the previous bullet point, this study is among the first 
to show that massive autophagy induction itself does not cause senescence 
 
Conclusions 
− Sub-lethal autophagy induction through amino acid withdrawal does not cause senescence, 
demonstrating that this type of stress (which induces massive autophagy) is fundamentally 
different than those associated with cellular dysfunction 
− Senescence was associated with STS-induced DNA damage, implicating the well-
characterized DDR in mediating senescence development in this context 
− However, despite this, low concentration STS caused too much stress that led to cell death 
in autophagy-null cells and therefore senescence did not occur in the absence of Atg7, 













Contributions of Chapter III: Autophagy mediates stress resistance development caused by 
repeated amino acid starvation 
 
Key findings 
− Atg7-deficient C2C12 cells display significantly increased caspase-3 activity during amino 
acid and serum starvation compared to control cells 
− Shorter time periods of amino acid withdrawal do not decrease p62 protein levels or cause 
LC3II formation in Atg7-deficient cells 
− During the recovery from amino acid starvation, p62 and Atg7 protein contents increase in 
Atg7-containing cells 
− Rapamycin does not increase caspase-3 activity or LC3II formation in the absence of Atg7 
− Repeated incubation in amino acid free media partially protects from subsequent STS-
induced cell death, and this does not occur in Atg7-deficient cells 
− Repeated rapamycin administration increases the subsequent sensitivity to hydrogen 
peroxide- and cisplatin-induced cell death independent of Atg7 
− Protection from STS caused by prior HBSS treatments involves reduced activation of 
caspase-3 and -9 as well as decreased DNA damage, and this effect can be mimicked with 
chemical inhibition of caspase-3 
− Recovering Atg7 protein levels in Atg7-deficient cells with adenovirus restores the 
protection from STS-induced caspase-3 activity and DNA damage caused by prior HBSS 
treatments 
− Intermittent rapamycin administration alters cell cycle and massively increases cell and 
nuclei size 
− Intermittent rapamycin administration completely prevents terminal myogenic 
differentiation, but not induction of Pax7  
 
Novelty and relevance of these observations 
− These findings demonstrate that amino acid starvation remodels cells in a way that causes 
stress resistance, and this depends on autophagy specifically 
− Despite previous hypotheses that autophagy might alter cellular composition in such a way, 
this study is among the first to specifically show that this relationship exists 
− This effect was in stark contrast to that of repeated rapamycin treatments: although 
previous studies have shown that rapamycin can attenuate cell stress/death when 
administered alongside/during the stress, we found that prior intermittent rapamycin 
treatments increased sensitivity to death caused by oxidative stress and DNA damage 
 
Conclusions 
− In the appropriate context forced autophagy induction serves as a pro-active mechanism of 
stress resistance development, thus potentially substantiating the cellular-level factors 
hypothesized to mediate the effects that relative caloric restriction and exercise have on 
health 
− Although it is routinely given to mice and humans, rapamycin has autophagy-independent 
effects that warrant further investigation 
− Additionally, the potential contribution of increased sensitivity to stress caused by 




Contributions of Chapter IV: Autophagy and mitophagy as inducible regulators of 
mitochondrial stress resistance and function 
 
Key findings 
− CCCP administration causes mitophagy as indicated by increased LC3II formation, increased 
LC3II content in mitochondria-enriched subcellular fractions, and reduced mitochondria-
specific protein contents 
− HBSS incubation does not affect mitochondria-specific protein contents 
− CCCP and HBSS dramatically induce PGC1a protein expression 
− CCCP does not cause similar protection from STS-induced cell death as HBSS 
− Both CCCP and HBSS treatments decrease mitochondrial membrane depolarization and 
permeability transition pore formation caused by calcium stress 
− Protection from calcium-induced mPTP formation caused by CCCP and amino acid starvation 
requires Atg7 
− Repeated amino acid withdrawal increases maximal ADP-stimulated cellular oxygen 
consumption when provided with mitochondrial ETC complex-I and complex-II substrates 
− Atg7-deficient cells display dramatically impaired mitochondrial respiration, and neither 
amino acid withdrawal or CCCP affects oxygen consumption in these cells 
− C2C12 cells do not express Parkin, but L6, primary mouse, and primary human myoblasts do 
− CCCP significantly decreases, while HBSS significantly increases Bnip3 protein levels 
− Bnip3 is dispensable for starvation-induced p62 degradation and LC3 dynamics as well as 
CCCP-induced mitochondria-specific protein degradation in C2C12 cells  
− Bnip3 is also not required for HBSS-induced protection from cell death caused by STS or 
increased mitochondrial respiration 
 
Novelty and relevance of these observations 
− These findings demonstrate that repeated autophagy induced by amino acid starvation 
increases mitochondria-specific stress resistance and maximal ADP-stimulated mitochondria 
respiration 
− Despite their lack of Parkin, C2C12 cells are able to execute mitophagy; although apparently 
to a lower extent than Parkin-expressing cell types 
− Although amino acid starvation and CCCP administration alter Bnip3 protein levels, its 
function in mediating autophagy/mitophagy in C2C12 cells may be redundant 
 
Conclusions 
− Autophagy contributes to functional maintenance of mitochondria and is responsible for 
mitochondrial adaptations to starvation  
− Intentional autophagy induction may serve as a mechanism of improving mitochondria 






Autophagy and Mitophagy in C2C12 Cells 
A relevant observation made during preliminary/pilot experiments was that Parkin protein content is 
undetectable in C2C12 cells (Chapter IV Fig. 1 & Appendix B Fig. 6). We initially demonstrated this was 
not an antibody reactivity issue by showing strong Parkin immunoblotting at the correct molecular 
weight in ShSY5Y immortalized human neuroblastoma cells (Chapter IV Fig. 1). As Parkin was also 
detected in differentiated immortalized L6 rat myoblasts and differentiated primary mouse myoblasts 
(Appendix B Fig. 6), we ruled out species-specific reactivity issues thereby validating that C2C12s are in 
fact Parkin-deficient. Although this raises a question regarding the mechanism and even the feasibility of 
depolarization-induced mitophagy in C2C12 cells, many reports of Parkin-independent mitophagy have 
been made (138,156,158,159). Furthermore, our observation that Bnip3 protein levels were 
differentially altered by amino acid starvation and CCCP administration suggested it was involved with 
autophagy and mitophagy regulation in these cells. Although we found that autophagy induced by 
amino acid starvation and mitophagy induced by mitochondrial depolarization were largely unaltered in 
Bnip3-CRISPR cells, several explanations can account for these Parkin- and Bnip3-independent 
responses. Primarily, numerous other mitophagy-regulating proteins that exist were not investigated 
here and these likely mediate autophagy and mitophagy in the absence of Parkin and Bnip3. This 
includes Nix/Bnip3L, a structural and functional homologue to Bnip3, as well as various LC3-interacting 
mitochondrial tagging proteins/factors and proteins which regulate ubiquitination and phosphorylation 
such as FUNDC1, cardiolipin, Bcl2-L-13, TAX1BP1, NDP52, optineurin, TBK1, and FKBP8. Although 
assessing the expression pattern of these in C2C12 and other myoblast cell lines would provide 
interesting mechanistic and functional insight, it is slightly beyond the scope of this thesis. Particularly 
because the experiments presented here focussed on examining the effects of mitophagy induction, 
regardless of how mitophagy was mechanistically executed. Therefore, our observation that CCCP in fact 
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caused mitophagy in C2C12 cells satisfied this requirement. Regardless, these experiments do provide 
some mechanistic insight of Bnip3’s role in C2C12 cells. 
 
Autophagy and Cellular Remodelling 
Although forms of autophagy such as micro-autophagy, chaperone mediated autophagy (CMA), and 
chaperone-assisted selective autophagy (CASA) are known to degrade specific cellular targets, macro-
autophagy mediated degradation is increasingly characterized as demonstrating cargo selectivity. 
Because of this, autophagic degradation is becoming viewed as a cellular remodelling mechanism 
instead of simply a starvation-induced response intended to provide cells with energetic substrates by 
degrading cellular content en masse. Particularly, these molecular interactions frequently suggest that 
autophagy preferentially targets damaged/dysfunctional proteins and organelles in the same way that 
the proteasome is used to degrade damaged proteins identified with ubiquitin tags. As such, autophagy 
is commonly attributed with stress-resistant functions that operate by removing material that might 
subsequently activate programmed cell death mechanisms. This occurrence is well established during 
various modes of chemically-induced stress, DNA damage, loss of mitochondrial membrane integrity, 
accumulated proteins and calcium in ER, and developmentally-encoded stress that occurs during cellular 
differentiation. Additionally, the degradation of specific proteins involved with stress signaling pathways 
has also been demonstrated although far less often. Even rarer are investigations into the cellular 
remodelling associated with autophagy induction in the absence of additional stressors. Although this 
definition is slightly complicated by two points, namely that cells possess a basal level of autophagic flux 
and that anything modulating this could therefore be considered a “stress”, distinctions can be made 
regarding the types and effects of various stressors. With respect to autophagy, these differences can be 
separated by presuming that stresses which activate autophagy may not cause cellular dysfunction and 
cell death, whereas other “toxic” stressors which do cause dysfunction and death may also induce 
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autophagy, with the effect of this response highly context dependent. Therefore, fundamental 
differences likely exist between the types of stresses that activate autophagy but do not cause cellular 
dysfunction and those that do. Importantly, testing the possibility, mechanisms, and relevance of these 
relationships was a central focus of this thesis. Notably, repeated autophagy induction by amino acid 
starvation for periods of time that did not activate cell death signaling was not associated with any type 
of cellular dysfunction, despite massive levels of autophagy. On the other hand, rapamycin 
administration caused dramatic changes to cell morphology, increased sensitivity to cell death, and 
impaired the myogenic capacity of C2C12 cells. Similarly, low-concentration STS increased autophagic 
flux and senescence development was attenuated in Atg7-deficient cells, indicating that functional 
autophagy was required for this response. 
 
Autophagy and Senescence 
The data presented in this thesis therefore indicates that autophagy is involved with a wide variety of 
cellular remodelling mechanisms, and the results of its activation mediate diverse responses to stress. In 
Chapter II, we were specifically interested in two things: 1) whether autophagy induction through 
nutrient stress would cause senescence, and 2) whether autophagy was involved with senescence 
caused by toxic stress. Classically, senescence was thought to simply result from telomere shortening, 
which naturally occurred during replicative exhaustion (259,260,265). However, it is currently 
understood that a senescence-like phenotype results from numerous cellular stressors, typically those 
related to oncogene activation, oxidative stress, and essentially DNA damage (262,264,266). 
Interestingly, whether typical autophagy-inducing stresses themselves, such as nutrient withdrawal, are 
inherently different with respect to stress-induced senescence is relatively unexplored. The results of 
Chapter II indicate that repeated amino acid and serum withdrawal does not cause senescence in C2C12 
cells. This contrasted the senescence phenotype caused by intermittent administration of low 
157 
 
concentration STS, which led to positive identification of each senescence marker we examined. This 
finding implies that these two stresses are fundamentally different, as despite inducing massive levels of 
autophagy, the stress associated with amino acid and growth factor deprivation did not lead to 
senescence.  However, this apparently straight-forward finding does require some explanation and 
context. Importantly, in these experiments HBSS treatments were performed to maximize autophagy 
activation, and as such cells were incubated long enough to observe high levels of autophagy but not 
long enough to cause significant cell death (Chapter II Fig. 1A & 1C; Chapter III Fig. 1B; Chapter IV Fig. 2). 
Of course, this was intentionally done as prolonged starvation could be stressful enough to activate cell 
death signaling mechanisms and damage DNA. In C2C12 cells, DNA laddering occurs after continuous 
incubation in EBSS for 16 hours (464). As the DDR is fundamental to senescence development, it is 
possible that prolonged amino acid withdrawal enough to damage DNA may cause senescence. 
Additionally, this “HBSS does not cause senescence” finding could also be considered a consequence of 
autophagy induction instead of a direct effect resulting from autophagy induction specifically. Although 
amino acid starvation was selected because autophagy is particularly sensitive to this, it is possible that 
this nutrient stress induces autophagy so strongly that other starvation-related stress is attenuated. 
That is, maybe incubation in HBSS and EBSS similarly activate extracellular stress signaling and upstream 
cell death mechanisms, but HBSS induces extra autophagy that counters these. Similarly, it is possible 
that low-concentration STS diluted in HBSS instead of GM would promote additional autophagy that 
would attenutate the senescence-causing effects of STS. Interestingly, this hypothesis not only suggests 
that other types of starvation or autophagy stressors may have different effects on senescence, but also 
that inducing autophagy during or alongside toxic stress may prevent senescence. In fact, in Chapter III it 
was found that rapamycin administration alone caused a cellular phenotype characterized by enlarged 
cells, altered cell cycle, and impaired myogenic differentiation (Chapter III Fig. 7 & Fig. 8). The decision to 
not call this senescence was due to the differences between rapamycin- and STS-treated cells with 
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respect to cell cycle profiles (senescence normally arrests cells in G1: Chapter II Fig. 3F; Chapter III Fig. 
7A), sensitivity to CisPL-induced death (Chapter II Fig. 5A; Chapter III Fig. 3J), and lack of significant SA-
Bgal activity (not shown). Despite these findings, because rapamycin-dependent effects were similar in 
SCR and Atg7-deficient cells, we concluded its effects were autophagy-independent regardless. 
However, evidence for rapamycin-induced senescence has been shown (465). 
 
Separate from the idea that autophagy-associated stressors are fundamentally distinct from those that 
cause dysfunction and senescence is autophagy’s contribution to senescence induced by various 
stressors. As autophagy functions as an important stress-response mechanism, its potential connection 
to senescence is clear. As previously mentioned in this Thesis, studies have generally shown that 
senescence induced by various stressors is attenuated in autophagy-deficient cells or when autophagy is 
inhibited, while others have also indicated that autophagy inhibition causes senescence (283). 
Understanding this relationship is complex as autophagy might be activated alongside but independent 
of senescence, thereby making their correlation meaningless; or, similar to cell death, autophagy may 
simultaneously mitigate and potentiate senescence-related signaling depending on the situation. 
However, mechanisms explaining both positive and negative control of senescence by autophagy have 
been demonstrated. First, autophagy may serve to permit senescence by degrading specific mediators 
of the senescence program, or by generally increasing cellular stress resistance therefore encouraging 
senescence instead of cell death (294,466,467). Alternatively, inadequate autophagy may cause 
accumulation of various cellular insults such as protein aggregates, ER/mitochondria stress, ROS, and 
DNA damage that subsequently results in senescence (288,293). In addition to these studies of stress-
induced senescence, although telomere dysfunction is related to replicative senescence development 
(265), it’s been demonstrated that induced telomere dysfunction stimulates autophagy and that 
inhibiting autophagy does not significantly affect senescence in this scenario (468). This importantly 
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questions the relevance of autophagy’s impact on senescence in vivo. Interestingly, autophagy’s impact 
on senescence has been investigated in other ways where concurrent administration of rapamycin 
partially prevents H2O2-induced senescence in 3T3 cells (293) and p21/p16-induced senescence in (469). 
Furthermore, rapamycin administration may prevent or revert senescence in skeletal muscle satellite 
cells (252) and decrease SASP production in senescent fibroblasts, which was demonstrated to suppress 
the ability of these cells to stimulate prostate tumour growth (470). This Thesis adds to our knowledge 
of the interaction between autophagy and senescence as In Chapter II it was found that low 
concentration STS slightly increased autophagic flux and that senescence was abrogated in the absence 
of Atg7, suggesting that autophagy is required for senescence in this scenario. Additionally, we also 
demonstrate that senescent C2C12 cells display dramatically reduced p62 protein content (Chapter II 
Fig. 7), altered basal and starvation-induced autophagic flux (Chapter II Fig. 7), reduced total ubiquitin 
levels (Appendix B Fig. 27), impaired myogenic differentiation (Chapter II. Fig. 4), resistance to cisplatin-
induced cell death (Chapter II Fig. 5 & 6), essentially unaltered sensitivity to staurosporine-induced cell 
death (Chapter II Fig. 5 & 6), and increased sensitivity to calcium-induced mPTP formation (Appendix B 
Fig. 27). These findings suggest complex interplay between various autophagy and cell death regulating 
mechanisms, and function to further characterize the phenotypic alterations present in senescent cells. 
 
Throughout this thesis senescence has been considered an unwanted cellular response with possible 
pathophysiological implications regarding tissue damage and aging. However, because senescence 
causes relative stress resistance, autophagy and senescence are also thought to be conserved responses 
that function to maintain cell viability and prevent death. Importantly, the physiological impact of this 
effect varies: accumulation of senescent cells would theoretically lead to tissue dysfunction, but 
senescence is also considered anti-oncogenic. Given this complex relationship, the final decision is likely 
determined by the type, timing, and duration of stress stimuli and the cell’s current stress status. 
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Although I have a difficult time delineating 1) autophagy generally helps keeps cell alive (which could be 
senescence) with 2) autophagy targets damaged/damaging material thus keeping cells healthy, it is clear 
that complicated cellular mechanisms control the stress responses that regulate autophagy thereby 
deciding between life, death, or senescence. 
 
Autophagy and Stress Resistance 
In agreement with extensive literature regarding autophagy and resistance to acute stress, we found 
that autophagy-deficient cells displayed increased sensitivity to cell death induced by various insults. 
This includes staurosporine at low (Chapter II Fig. 9) and high (Chapter III Fig. 3) concentrations, 
hydrogen peroxide, cisplatin (Chapter III Fig. 3), and particularly nutrient starvation (Chapter III Fig. 1). 
However, the next central focus of this thesis was examining the impact of autophagy on cellular 
remodelling, specifically whether repeated forced autophagy induction interspersed with recovery 
periods would allow cellular adaptations that conferred stress resistance. Although autophagy is known 
to target dysfunctional and damaged proteins and organelles and in doing so is theorized to act as a 
recycling mechanism that has favourable effects on cellular function, specific demonstration of this 
occurring is rare. While autophagy is suggested to contribute to the beneficial effects of exercise training 
on skeletal muscle (189,191) and to ischemic preconditioning in neural and cardiac tissues (244,342-
344), the specific cellular changes altered by autophagy which mediate these adaptations are not 
known. Additionally, the specific contribution of autophagy to these effects is obscured by the 
complicated nature of physiological stimuli and lack of specific autophagy activation and/or inhibition in 
various experimental protocols. Here, data is presented in all three Projects regarding the impact of 
previous repeated autophagy induction on stress resistance. In Chapter II, it was found that intermittent 
incubation in HBSS decreased subsequent STS-induced caspase activation and DNA damage. In Chapter 
III we demonstrated that this was autophagy-dependent, where Atg7 knockdown removed the 
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protective effect and recovering Atg7 expression in these cells restored it. Finally, data in Chapter IV 
showed that mitochondria-specific stress resistance was increased after multiple treatments with CCCP 
and HBSS, and furthermore that protection from calcium-induced mPTP formation caused by previous 
CCCP and HBSS was eliminated with Atg7 deficiency. These experiments strongly demonstrate that 
autophagy induction through amino acid starvation causes stress resistance, particularly to stress that 
impacts mitochondria. Notably, we show this protection may be limited to mitochondrial stressors. 
Initial characterization of this stress-resistance phenotype consistently indicated that cells were partially 
protected from STS-induced cell death and that this involved reduced caspase-3 and caspase-9 
activation (Chapter IV Fig. 5; Appendix B Fig. 8). In fact, the subsequent focus of these studies on 
mitochondrial-mediated mechanisms was driven by the fact that changes to other cell death regulating 
factors were generally not observed (Chapter II Fig.6; Chapter III Fig. 5; Chapter IV Fig. 6). 
 
This conclusion is further supported by solely observing protection from STS. In our hands, STS-induced 
cell death is characterized by mitochondrial cytochrome c release (369), activation and mitochondrial 
release of AIF (369), caspase-9 activation (388, Chapter III Fig. 4), caspase-3 activation (388, Chapter III 
Fig. 4), p53 activation (Chapter IV Fig. 6), and DNA fragmentation (Chapter III Fig. 5). This contrasts H2O2, 
which causes AIF release (388) and DNA fragmentation (Chapter III Fig. 5) but does not involve caspases 
(388, Chapter IV Fig. 5) or p53 (Chapter IV Fig. 5). Lastly, CisPL administration dramatically induces p53, 
DNA damage, and caspase-3 while significantly reducing XIAP and Bcl2 protein levels (357, Chapter IV 
Fig. 5). Therefore, it appears that stress resistance caused by previous autophagy induction is specific to 
the mitochondrial-mediated caspase activation that occurs with STS, and not oxidative stress (H2O2) or 
direct DNA damage (CisPL). However, although pilot experiments were performed to identify optimal 
doses of these chemicals to cause detectable death-associated changes, it is possible that the 
concentrations used “overpowered” the protective adaptations and that protective effects may have 
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been observed with lower doses. Similarly, these effects may be specific to H2O2 and CisPL, and that 
intermittent autophagy may cause resistance to other inducers of oxidative stress or DNA damage. 
 
As previously alluded to in this thesis, the thought that autophagy may serve as an intentionally 
inducible mechanism of stress resistance shares theoretical similarities to preconditioning and hormesis. 
Although these terms may in fact describe the same cellular phenomenon, in general they describe 
situations where previous exposure to stresses causes subsequent resistance to larger doses. As 
autophagy seems to be sensitive to numerous (and maybe all) cellular stressors, its involvement with 
these phenomena is logical (296). In fact, it is possible that: 1) autophagy represents a novel mode of 
hormesis/preconditioning, 2) autophagy contributes to forms of hormesis/preconditioning, or even 3) 
that hormesis/preconditioning are fundamentally dependent on autophagy and only occur because 
autophagy exists. Although the physiological relevance of hormesis-like effects is debated, there 
appears to be renewed interest in defining these relationships. Importantly, the findings of this thesis 
not only suggests that specific autophagy induction itself may represent and produce preconditioning-
like effects, but also that adaptations to various stressors (STS-induced senescence, starvation-induced 
stress resistance, increased starvation-induced mitochondrial respiration) requires functional 
autophagy.  
 
Interestingly, repeated rapamycin administration caused several unexpected cellular changes. Initially, 
rapamycin-induced autophagy was conducted to complement experiments involving amino acid 
starvation, with the hypothesis that these would have generally similar effects. However, in contrast to 
repeated HBSS incubation, rapamycin exposure did not significantly affect cell death induced by STS and 
actually increased sensitivity to cell death caused by H2O2 and CisPL. As these effects occurred similarly 
in SCR and Atg7-deficient cells, we concluded that this was independent of its autophagy modulating 
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capabilities. This again highlights the numerous other cellular signaling mechanisms and functions that 
mTOR regulates, and justifies further investigation into rapamycin’s effects in vivo. 
 
Autophagy and Mitochondria 
A specific cellular function that was impacted by autophagy deficiency was mitochondrial respiration. In 
Chapter IV, we saw that maximal cellular oxygen consumption was reduced more than 50% in Atg7-
deficient cells when provided with complex I and/or complex II substrates. Furthermore, the addition of 
cytochrome c significantly increased respiration in these cells, suggesting that existing mitochondria 
were damaged without autophagy. It is established that Atg7 knockout causes mitochondrial 
dysfunction in yeast (453) and alters mitochondrial morphology in mouse cardiomyocytes and 
hepatocytes (50,454). Autophagy deficiency also leads to mitochondrial accumulation (384,455-457) 
while simultaneously decreasing maximal oxygen consumption in various cell types (458,459). 
Therefore, our observations in this regard are not surprising. We additionally showed that intermittent 
amino acid starvation increased OCR only in Atg7 competent cells, indicating autophagy is required for 
this effect. However, while this demonstrates that autophagy-dependent degradation is required for 
mitochondrial adaptations in this context, likely through recycling of mitochondrial material, the 
mechanisms which led to increased mitochondrial function are unknown. Although amino acid 
starvation dramatically increased PGC1a, CCCP elevated PGC1a to a greater extent (Chapter IV Fig. 3 & 
Fig. 8) yet OCR did not increase in CCCP-treated cells. Mutual increases in mitochondria-specific protein 
contents were also not observed in HB+F-treated cells, indicating that elevated respiration is not simply 
a function of mitochondrial biogenesis. Possibly, starvation-induced PGC1a could impact specific ETC 
and metabolic enzymes, the expression of which were not measured here, that could account for the 
mitochondrial adaptations. In fact, it is well-established that “mitochondrial biogenesis” does not 
necessarily mean increased mitochondrial mass: functional benefits could result from numerous 
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mechanisms such as increased coupling efficiency (which itself is mediated by several things), increased 
mitochondrial substrate delivery, increased expression of individual/select enzymes (which could be 
thought of as increasing the density of functionally-relevant proteins in the mitochondria), or 
modification of internal mitochondrial degradation mechanisms (which may “clean” mitochondria just 
as autophagy “cleans” cells). Given these possibilities, we nonetheless demonstrate that this response 
was specific to amino acid starvation and requires Atg7. Also noteworthy is that OCR did not increase in 
Atg7-deficient cells despite detecting increased mitochondria-specific protein levels in response to CCCP 
and HB+F treatments, indicating autophagy is required for generation of new and properly functioning 
mitochondria or improvement of existing mitochondria. 
 
Similarly, the precise aspects of mitochondrial biology altered by amino acid starvation that contributed 
to increased stress resistance are also unknown. Although it would be logical to assume that the 
adaptive mechanisms that conferred respiration benefits may also mediate stress resistance, there are 
likely some independent factors. This is highlighted in the finding that repeated CCCP administration 
partially protected mitochondria from calcium stress but did not affect cellular oxygen consumption. 
 
Autophagy-Independent Explanations 
As already mentioned, the most prominent autophagy-independent effect observed here was 
rapamycin-induced cell cycle and morphology alterations and prevention of myogenic differentiation. 
Although this is confounded somewhat because Atg7-deficient cells already show impaired 
differentiation, there were generally no differences in rapamycin-dependent effects between SCR and 
shAtg7 groups. Of course, mTOR affects numerous cellular processes related to general protein 
synthesis, cell cycle, metabolism, and inflammatory responses through its involvement with NF-kB, 
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PPAR, S6K, 4E-BP1, FoXO, SREBP1, and other signaling mechanisms (471). Therefore, the fact that 
rapamycin caused autophagy-independent effects is not that surprising. 
 
Importantly, autophagy induced by amino acid starvation obviously also involves mTOR inhibition, but 
these treatments had dissimilar effects on cell growth, differentiation, and death patterns. Despite this, 
autophagy is regulated by numerous mechanisms other than mTOR, which is the sole autophagy-
relevant target of rapamycin. Therefore, it is not surprising that differences existed between these two 
autophagy stimuli. In particular, an economics difference exists between these two interventions. 
Although rapamycin/mTOR inhibition may stimulate upstream autophagy signaling mechanisms, it does 
this without a biological purpose for autophagy induction. On the other hand, removing amino acids or 
damaging mitochondria provides a robust stimuli/reason for autophagy execution. As a result, this likely 
represents a stronger proxy for actual autophagy induction (ie. degradation of target material) that is 
biologically warranted, as opposed to the simple activation of autophagy-regulating machinery resulting 
from mTOR inhibition.  
 
Although these studies focus on autophagy, there are very few situations presented here in which Atg7 
deficiency completely prevented an effect caused by HBSS, rapamycin, or CCCP. While these 
interventions were chosen due to their ability to stimulate autophagy/mitophagy, only autophagy and 
cell death-related mechanisms were measured here and these treatments alter various other cellular 
processes that regulate stress resistance and mitochondrial metabolism. Among these is antioxidant 
defence, strongly controlled by Nrf2 signaling (472). However, it has been demonstrated that incubation 
in HBSS actually does not activate Nrf2 in human lung epithelial cells (473), which is logical given p62’s 
regulation of Nrf2 function (237,239,399). Despite this, amino acid starvation is known to stimulate NF-
kB (474), Hif1a (475), and FoXO (476), signaling platforms with numerous impacts outside of autophagy. 
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Additionally, while HBSS-induced AMPK activation has been shown (477) and thus an experiment 
involving its inhibition was planned to be conducted here, altered AMPK signaling was not detected in 
C2C12 cells with CCCP or amino acid starvation (Appendix B Fig. 5). 
 
Relevance to Human Physiology and Health 
The relevance that these basic biological mechanisms have on physiology and health has been alluded to 
throughout this thesis. Primarily, these implications concern how cell death and stress resistance on a 
cellular level impact tissue function and therefore health in general. These experiments were designed 
to examine some cellular mechanisms that theories regarding the interaction between autophagy, 
hormesis, and longevity are based upon. 
 
The benefits of healthy eating and regular exercise have literally been known for thousands of years. 
Current scientific understanding of these principles significantly implicates autophagy in mediating some 
of these effects. In fact, relative caloric restriction and/or exercise is widely known to increase longevity 
of biological research animals and in simpler life forms the effect of nutrient deficiency is abolished with 
genetic autophagy impairment (311,356). Therefore, it is very likely this highly conserved biological 
process serves similar functions in human physiology. In fact, a recently published update concluded 
that “caloric restriction without malnutrition...improves health and survival of rhesus monkeys” (320). 
Although this effect can be attributed to many physiological factors (ie. weight gain, numerous other 
biological processes), given autophagy’s sensitivity to nutritional status it is reasonable to assume its 





An often made observation is that animal models of longevity generally display increased stress 
resistance (297,311,354,463). Although the acute interaction between this and autophagy is well-
established, most human diseases involve accumulation of stress or damaging stimuli to manifest and 
become pathological. That is, being able to survive a single insult through increased autophagy may not 
largely impact physiology over an entire lifetime. Therefore, the stress resistance observed in these 
longevity models might not be due to increased acute autophagy induction when encountering a stress, 
but the general development of a stress-resistant phenotype (although whether regular exercise and/or 
caloric restriction affect acute autophagy induction is possible). Importantly, these ideas align with 
autophagy’s purported cellular recycling abilities, where autophagic machinery preferentially targets 
damaged and/or dysfunctional proteins and organelles. Hence, its forced induction is theorized to 
improved cellular composition by decreasing the cell’s current stress level or by allowing adaptation and 
generation of relatively stress-resistance structures. The novel results presented here demonstrate this 
may in fact be true, as repeated autophagy induction through amino acid starvation increased resistance 
to cell death caused by staurosporine and mitochondrial permeabilization caused by calcium.  
 
Although this is a nice thought, it is slightly construed by findings that suggest caloric restriction turns on 
genes related to stress resistance in post-mitotic tissues like cardiac muscle while activating those 
promoting cell death and turnover in the liver (355). If we assume that relative caloric restriction is 
always “good” for human physiology and longevity, then this pro-death response should not be 
considered pathological and therefore has an understandable, evolutionarily-supported reason. In fact, 
the interaction between autophagy and cell death may explain this dichotomy. Among other things, an 
obvious effect of exercise/caloric restriction is reduced body mass, functionally decreasing the amount 
of human being to maintain. If, for example, this means the liver is 25% smaller (ie. is composed of 25% 
less cells) and can adequately perform its function at this size, it should “age” 25% more slowly. 
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Imagined another way, this means that 25% more cells can be lost before the liver ages, essentially 
decreasing the threshold for damage thereby removing cells when they are less dysfunctional than 
before and potentially improving tissue function. Furthermore, increased autophagy induction in 
remaining cells might maintain or improve them as well. However, this is a theory, and one that will not 
be substantiated without research examining more direct mechanisms of autophagy induction. 
Primarily, while autophagy-induced chemoresistance is thought to be a common characteristic of cancer 
cells and partly contributes to the administration of the autophagy/lysosome inhibitor chloroquine 
during therapy (478), the autophagy-inducing chemical rapamycin has well established anti-cancer 
properties (419,420). Therefore, it is possible these cancer-related effects, as well as those related to 
longevity, are unrelated to autophagy and/or actually point towards rapamycin-induced sensitivity to 
cell death. Interestingly, we report here that rapamycin-treated cells showed increased cell death 
induced by DNA damage and oxidative stress. Regardless, it is apparent that the biological purpose of 
autophagy on a cellular level is likely to protect cells, and the result of this role is highly tissue and 
context dependent.  
 
Limitations 
These studies tested a number of general hypotheses regarding autophagy. Despite the conserved 
nature of the assumptions made here, all relevant experiments were performed using C2C12 cells. 
These cells are commonly used to study the mechanisms of skeletal muscle development as well as 
general cell biology, but their individual use here questions the widespread relevance of these findings. 
Although similar results would be expected to occur with other cell lines/types, it is possible that C2C12s 
possess a unique and inherent ability to adapt to stress, particularly given that adaptation to stress is a 




Another shortcoming is using a single Atg7-deficient cell clone for most autophagy-dependent 
experiments. Although numerous stable clones were created (Appendix B Fig. 17), only two (Chapter III 
Fig. 1 & 2, Appendix B Fig. 29) or three (Appendix B Fig. 18 & 19) were tested and compared for 
subsequent use here. Although shAtg7 #1 and #2 appeared to display similar autophagic and cell death 
responses to amino acid starvation and rapamycin (Chapter III Fig. 1 & 2), it is possible that the observed 
effects could be limited to the specific clone (shAtg7 #1) used in following experiments. Additionally, 
current guidelines suggest performing separate experiments where a biological effect is altered by more 
than one essential autophagy gene (ie. Atg5 and Atg7) to fully demonstrate autophagy-dependent 
functions of specific events (103). Given this shortcoming, the observation that adenoviral-mediated 
recovery of Atg7 protein content in shAtg7 #1 re-established the protective effects observed in Chapter 
III strongly implies this finding is conserved and not a clone-related artifact. 
 
We generally observed that prior autophagy induction protected cells from STS-induced cell death. As 
previously mentioned, this may have occurred due to the specific insults and doses employed. For 
example, it is possible that resistance to oxidative stress may have been detected if lower 
concentrations of H2O2 were applied. Similarly, although we concluded that prior autophagy induction 
did not protect from subsequent cell death caused by DNA damage, it is possible an effect would have 
occurred using a chemical other than CisPL. 
 
The measures of cell death utilized here are generally indicators of the apoptotic form of regulated cell 
death: that involving loss of mitochondrial integrity, caspase activation, DNA fragmentation, and outer 
membrane phosphatidyl serine exposure. Of course, numerous other modes of cell death occur, both 
regulated and accidental. Importantly, a central focus in these experiments is that we observed a stress-
resistance phenotype, implying cellular protection in general and not protection specific to apoptotic 
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cell death. In performing the conducted measurements, we thereby assumed any cellular protection 
would manifest as decreased annexin/PI staining, caspase-3 activity, or DNA damage; however, this 
potentially ignores additional protection or death from other cellular processes.   
 
Future Directions 
A logical next step would be to conduct similar experiments in other cells types, including primary 
mouse and human cells, to demonstrate the potential general and conserved nature of these findings. It 
would additionally be interesting to find out if cancerous human cell lines or primary tumour cells 
display similar responses to repeated autophagy induction, particularly given their subversion of cell 
death signaling and use of rapamycin in cancer treatments. Other genetic manipulation techniques 
would also be useful to demonstrate the involvement of autophagy in these results. This could be 
performed by generating additional knockout cell lines using CRISPR/Cas9 or examining primary cells 
isolated from genetic knock out animals of essential autophagy genes other than Atg7. As C2C12 are 
considered muscle precursor cells, the myoblast-specific relevance of these findings could also be 
investigated by generating induced pluripotent stem cell lines from specific autophagy-knockout mice or 
diseased human cells and comparing the effects observed after converting these to cardiomyocytes, 
neurons, myoblasts, etc. Finally, examining the effects of other longevity-associated chemicals 
(resveratrol, spermidine, urolithin A, NAD) on autophagy-dependent remodelling would also further 
define these relationships and perhaps point towards a potential nutritional intervention. 
 
A number of in vivo experiments could also be useful to demonstrate the physiological relevance of 
autophagy-mediated cellular remodelling. This includes the skeletal muscle and exercise study initially 
proposed to be conducted as part of this thesis. Here, to examine if the adaptations associated with 
exercise training in skeletal muscle are autophagy-dependent, mice with inducible skeletal muscle-
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specific knockdown of Atg7 could be exercise trained and examined to see if such adaptations were 
affected. Although some of these experiments have now been performed, a number of specific 
parameters such as metabolic enzyme activity, mitochondrial function, contractile ability, and 
subsequent resistance to stress/atrophy have not been examined. 
 
Another interesting in vivo study would be to examine autophagy in the PolG mouse model of progeria. 
These mice lack the function of an important mitochondrial DNA repair enzyme, and therefore quickly 
accumulate mitochondrial DNA mutations resulting in accelerated aging. Remarkably, forced regular 
endurance exercise (479), but not caloric restriction (480), dramatically attenuates this phenotype. 
Although autophagy’s role in mediating this effect was postulated by these researchers (479), its 
contribution has not been demonstrated. Cross-breeding such PolG mice with those capable of inducible 
autophagy knockdown and exercise training the resulting animals would be a direct way to test this 
hypothesis. 
 
Finally, a particularly interesting idea harnesses a powerful mouse model. In 2005, researchers published 
a study examining the impact of widespread adipocyte cell death on metabolic syndrome by generating 
mice that were engineered to produce and then activate a caspase-8 fusion protein in their adipocytes 
when administered a FK1012-related chemical, which they termed FAT-ATTAC (fat apoptosis through 
targeted activation of caspase-8) (481). Subsequently, another group of researchers modified these mice 
to demonstrate the longevity-inducing and health-prolonging effects that selective removal of senescent 
cells causes by altering them to selectively kill p16-positive cells instead of adipocytes when 
administered the FK1012-related chemical (281,282). However, instead of removing p16-positive cells, it 
would be interesting to induce autophagy in them, which may demonstrate that keeping these cells 




The intention of this Thesis was to examine some relatively unexplored aspects of autophagy’s impact 
on cellular physiology, particularly to further outline and substantiate the thought that all biological 
phenomena are represented by bell curves where dysfunction in either direction can be pathological. 
With respect to cell stress and death, there appears to exist an ideal hierarchy whereby a very minor 
insult activates stress signaling to such an extent that their integration deems no response is necessary 
to continue functioning properly, a slightly stronger insult means that autophagy is activated in defense 
with the intention of repelling and surviving the damage, a stronger insult then surpasses the protective 
functions of autophagy and activates regulated cell death mechanisms so as to ensure homeostatic 
removal of this cell in the tissue/organism, and finally a very strong insult leads to non-regulated cell 
death destruction which may cause additional tissue damage and would therefore not be evolutionarily 
selected against. However, as previously mentioned, keeping cells alive is not always good for the 
organism, as dysfunctional and mutated cells can subvert this paradigm and therapeutic benefit may 
result from “better of two evils” situations. Another interesting idea potentially connecting basic cell 
biology to human physiology and health is that autophagy forms a plausible mechanism explaining the 
idiom “what doesn’t kill you makes you stronger”; but, is this expression actually true? The hormesis 
literature suggests it is always true, but scientific consensus regarding this theory, and even hormesis 
itself, is far from being reached. If forced to answer, I would say the most likely answer is maybe, but it 
depends. Although the stress associated with moderate exercise and relative caloric restriction appear 
to have universally beneficial effects on human health, other types of stress such as UV radiation or 
energy-rich diets are responded and adapted to in less than beneficial ways. Perhaps the drastically 
diverse modulation of autophagy differentiates these types of stresses. In fact, longevity researchers 
indicate that it might be, and that specific autophagy induction in the absence of additional stress (ie. 
ischemia) may provide cellular benefits and avoid potential toxic side effects. In this way, autophagy is 
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imagined as a cellular recycling mechanism instead of a cellular trash disposal mechanism. The 
experiments contained here clearly suggest that the type of stress greatly impacts cell death and 
adaptation responses, and that autophagy differentially regulates these in context-dependent manners. 
In performing such experiments, we attempt to further extend our basic understanding of autophagy, 
with the intention that these findings will help explain complex physiological questions. Ultimately, 
“what doesn’t kill you...” is likely true for specific stresses when your cells are young and can induce 
autophagy properly, thereby providing the additional benefit of being able to adapt to these stresses.  
 
Importantly, assuming that every biological process is represented by a bell curve means that 50% of 
people are worse than average and can therefore be improved. Additionally, although dysfunction in 
either direction may be pathological, it may also be beneficial. Perhaps sensitivity to autophagy 
induction was/will be an evolutionarily advantageous change that we can intervene in. However, before 
progressing past acknowledging the benefits of regular exercise and healthy eating habits to the point of 
handing out autophagy-inducing drugs, several fundamental aspects of autophagy biology require 
further examination. This Thesis illustrates some cellular adaptations resulting from autophagy 
induction, specifically regarding senescence development, stress resistance, and mitochondrial function. 
These results have implications with respect to our basic understanding of the relationship between 
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Appendix A – Complete Methods 
Cell Culture 
C2C12 mouse skeletal myoblasts, L6 rat skeletal myoblasts, NIH 3T3 mouse fibroblasts, MCF7 human 
breast cancer (ATCC), SH-SY5Y human neuroblastoma and HEK 293-A cells (generously provided by Dr. 
Robin Duncan, University of Waterloo) were cultured in growth media (GM) consisting of low-glucose 
Dulbecco’s Modified Eagles Medium (DMEM; Hyclone, ThermoFisher) containing 10% fetal bovine 
serum (FBS; ThermoFisher) and 1% penicillin/streptomycin (ThermoFisher) on polystyrene culture dishes 
(BD Biosciences), as previously performed (369). For microscopy experiments, cells were grown on 
Cultrex-coated (3432-005-001; R&D Systems) glass coverslips. Coverslip-coating was performed by 
thawing Cultrex on ice, diluting the stock 1:100 (resulting in a concentration of 120-180 µg/mL) in high-
glucose DMEM, incubating coverslip surfaces in an appropriate volume of this diluted solution for 1 hour 
at room temperature, and plating cells immediately after aspirating the coating solution. C2C12 and L6 
cells were appropriately sub-cultured using trypsin (0.25% solution with EDTA, ThermoFisher) to ensure 
all appropriate treatments and analyses were performed before cells reached confluence to avoid the 
potential side-effects of spontaneous differentiation. In appropriate situations, myogenic differentiation 
was induced by switching 80-90% confluent C2C12 or L6 cells to differentiation media consisting of 
DMEM with 2% horse serum (ThermoFisher) and 1% penicillin/streptomycin. Cells were collected for 
subsequent experimental analyses via trypsinization and centrifuged at 1000g.  
 
Materials 
Cells were treated as indicated with various chemicals/solutions to induce or measure cell stress. These 
include: Hank’s Balanced Salt Solution (HBSS; Gibco formulation: 140mg/L CaCl2, 100mg/L MgCl2-6H2O, 
100mg/L MgSO4-7H2O, 400mg/L KCl, 60mg/L KH2PO4, 350mg/L NaHCO3, 8.0g/L NaCl, 48mg/L Na2HPO4, 
1.0g/L D-glucose, with 1% penicillin/streptomycin), chloroquine (Cq, 30-200 µM; Sigma-Aldrich C6628), 
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leupeptin (Leu, 250 µM; Sigma Aldrich L2884), staurosporine (STS, 15 nM, 125 nM, 0.5  µM or 2.0 µM; 
Alexis Biochemicals 380-014-C100), cisplatin (CisPL, 25 µM; Enzo Life Sciences 400-40-M250), hydrogen 
peroxide (H2O2, 2.5-5 mM; Sigma Aldrich), the caspase inhibitor z-VAD-FMK (10 or 25 M µM; Enzo Life 
Sciences ALX-260-020-M005), N-acetyl-L-cysteine (NAC, 10, 20, or 50 µM; Sigma Aldrich A-7250), tiron 
(1, 2, or 5 mM; Sigma Aldrich), 2',7'-dichlorodihydrofluorescein diacetate (DCF, 25 µM; Sigma Aldrich 
D399), carbonyl cyanide 3-chlorophenylhydrazone (CCCP, 30 µM; Sigma-Aldrich C2759), rapamycin (Rap, 
0.5-10 µM; Enzo Life Sciences BML-A275-0005), mdivi-1 (20 µM; Enzo Life Sciences BML-CM127-0050), 
the calcium ionophore A23187 (5, 10, or 15 µM; BioVision 1501), oligomycin (oligo, 2.5 µM; Cayman 
Chemical Company 11341), and doxorubicin (Doxo, 10 µM; Sigma Aldrich D1515). 
 
Vectors, Cloning, and Adenovirus 
Vectors encoding shRNA against mouse Atg7 were used as previously described (183). Vectors were 
purchased from Origene containing an shRNA sequence targeting Atg7 (TG504956) or a scramble control 
sequence (TR30013). 
 
Adenovirus coding for human Atg7 protein (adAtg7) was generously provided by Dr. Gokhan S. 
Hotamisligil, Department of Genetics and Complex Diseases, T.H. Chan School of Public Health, Harvard 
(424). Control adenoviral constructs encoding GFP (adAVH6/adGFP) were a gift from Dr. Robin Parks, 
Ottawa Hospital Research Institute (425). Virus were amplified using HEK 293A cells and viral particles 
were isolated/concentrated through repeated freeze-thaw cycles as indicated in the ViraPower 
Adenoviral Expression System protocol (Life Technologies). AdAtg7 stock volumes were titred to recover 





CRISPR/Cas9 vectors targeting mouse Bnip3 were constructed as follows. The region immediately 
upstream of the transcription start site was mined for candidate guide RNA (gRNA) targets using several 
available online tools including: Zhang Lab, MIT (http://crispr.mit.edu/), CCTop (http://crispr.cos.uni-
heidelberg.de/), and Off-Spotter (https://cm.jefferson.edu/Off-Spotter/). From these, two common 
gRNA sequences were identified (PAM in brackets): First: 5’GAGCCACCATGTCGCAGAGC(GGG), and 
Second: 5’GGAGGAGAACCTGCAGGGTG(AGG). The scramble sequence used in Origene CRISPR products 
was used as a control: 5’GCACTACCAGAGCTAACTCA. Corresponding oligonucleotides were constructed 
(Sigma Aldrich) to allow cloning into the CRISPR/Cas9 vector pSpCas9(BB)-2A-Puro (PX459) V2.0 
(Addgene #62988), which uses a single gRNA. Correct gRNA cloning was confirmed by sequencing 
constructed vectors (The Center for Applied Genomics, Hospital for Sick Kids, Toronto, Ontario, Canada). 
 
For visualization of mitochondrial morphology and autophagic puncta, cells were co-transfected with 
the vectors pDsRed2-Mito and pGFP-LC3, generously provided by Dr. D. R. Green (St. Jude’s Children’s 
Research Hospital, Memphis, Tennessee) and Dr. Terje Johansen (Department of Medical Biology, UiT, 
Tromso, Norway), respectively. 
 
Transfections and Gene Knockdown 
C2C12 cells were transfected using Lipofectamine 2000 (Life Technologies), optimized according to the 
manufacturer’s instructions, as previously performed (183,369). Briefly, appropriate vector DNA and 
Lipofectamine was diluted in 100 µL Opti-MEM (Gibco) at a ratio of 1µg: 3µL, and incubated for 5 min at 
room temperature. This mixture was added to 50-60% confluent cells with media containing 5% FBS in 
Opti-MEM and incubated for 6 hours, after which cells were washed with PBS and regular growth media 




For generating C2C12 cells with stable knockdown of Atg7, cells grown in 12-well plates were 
transfected with vectors encoding either an shRNA against Atg7 or a scramble control sequence using 
Lipofectamine 2000 (ThermoFisher) as previously performed (183). 24 hours later, cells were transferred 
to 10 cm culture plates and those with stable incorporation of each vector were selected by growing 
cells in GM with 2 µg/mL puromycin (Sigma Aldrich). Surviving clones were individually isolated and 
assessed for Atg7 protein expression using immunoblotting. 
 
For generating Bnip3 knockout C2C12s, cells grown in 12-well plates were transfected either with the 
aforementioned Bnip3 CRISPR or scramble control vector. 24 hours later, cells were transferred to 10 cm 
culture plates and those with incorporation of each vector were selected by growing cells in GM with 2 
µg/mL puromycin (Sigma Aldrich). Surviving clones were individually isolated and assessed for Bnip3 
protein expression using immunoblotting. 
 
Subcellular Fractionation 
Cells were additionally separated into cytosolic-, mitochondrial-, and nuclear-enriched fractions (369). 
After collection via trypsinization, cells were incubated in digitonin buffer (PBS with 250 mM sucrose, 80 
mM KCl, and 50 µg/mL digitonin, Sigma Aldrich D141) for 5 min on ice. Cells were centrifuged at 1000g 
for 10 min, the supernatant was collected and centrifuged at 16,000g for 10 minutes to pellet any 
mitochondrial contamination, and the supernatant from this spin kept as the cytosolic-enriched fraction. 
The pellet (P1) remaining from the 1000g spin was suspended in PBS, centrifuged at 1000g for 5 min, the 
pellet suspended in lysis buffer (LB, pH 7.4; 20mM HEPES, 10mM NaCl, 1.5mM MgCl2, 1 mM DTT, 20% 
glycerol, and 0.1% Triton-X100), and allowed to sit on ice for 5 min. This was then centrifuged at 1000g 
for 5 min, resulting in a pellet (P2) containing nuclei, and a supernatant (S2) containing mitochondria. S2 
was centrifuged at 1000g for 10 min to pellet nuclear contamination, with the resulting supernatant 
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kept as the mitochondrial-enriched fraction. The P2 pellet was suspended in LB, centrifuged at 1000g for 
10 min, the pellet again suspended in LB, sonicated for 12 seconds on ice, and kept as the nuclear-
enriched fraction.  
 
Immunoblotting 
Immunoblotting was performed as previously described (357,369). Whole-cell lysates were generated 
by adding ice-cold lysis buffer with protease inhibitors (Complete Cocktail; Roche) to cell pellets 
followed by sonication for 12 seconds. Protein content was measured using the BCA protein assay 
method. Briefly, equal amounts of protein were loaded into and separated using 10-12% SDS-PAGE, 
transferred onto PVDF membranes (Bio-Rad Laboratories), and blocked for 1 hr at room temperature 
with 5% non-fat dry milk in TBS-T. Membranes were then probed with primary antibodies against: ANT 
(sc-9299, 1:100), Bcl2 (sc-7382, 1:200), Bax (sc-493, 1:1000), cytochrome c (sc-13156, 1:2000), parkin 
(sc-32282, 1:500), PARP (sc-7150, 1:200), PGC1 (sc-13067, 1:200), PINK1 (sc-33796, 1:500), p21 (sc-397, 
1:1000), p53 (sc-6243, 1:500), phosphorylated histone H2AX (pH2AX, sc-101696, 1:1000; Santa Cruz), 
Atg7 (8558, 1:1000), Atg4B (5299, 1:1000), Atg12/5 (4180, 1:1000), Beclin1 (3738, 1:1000), LC3 (2775, 
1:1000), AMPKa (5831, 1:1000), pAMPKa Thr172 (2535, 1:1000), AMPKb1/2 (4150, 1:1000), pAMPKb1 
Ser108 (4181, 1:1000), ACC (3676, 1:1000), pACC Ser79 (11818, 1:1000; Cell Signaling Technologies), 
histone H2B (07-371, 1:2000; Millipore), MnSOD (SOD-110, 1:4000), Smac (ADI-905-244, 1:2000), XIAP 
(ADI-AAM-050, 1:1000; Enzo Life Sciences), actin (A-2066, 1:2000), Bnip3 (B7931, 1:1000), cleaved 
caspase-3 (C8487, 1:1000; Sigma Aldrich), myosin (MF-20, 1:2000), myogenin (F5D, 1:200), Pax7 (PAX7, 
1:200; Developmental Studies Hybridoma Bank), or p62 (PM045, 1:2000; MBL) overnight at 4oC. 
Membranes were then incubated with the appropriate horseradish peroxidase- (HRP) conjugated 
secondary antibody (anti-rabbit: sc-2004, anti-mouse: sc-2005, anti-goat: sc-2020; Santa Cruz), and 
bands visualized using ECL immunoblotting substrates (BioVision) or Clarity ECL substrates (Bio-Rad) and 
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the ChemiGenius 2 Bio-Imaging System (Syngene). The approximate molecular weight for each protein 
was estimated using Precision Plus Protein WesternC Standards and Precision Protein Strep-Tactin HRP 
Conjugate (Bio-Rad Laboratories).  
 
Proteolytic Enzyme Activity 
Enzymatic activity of caspases-3, -8,  and -9 was determined using the substrates Ac-DEVD-AFC , Ac-
IETD-AMC, and Ac-LEHD-AMC (Enzo Life Sciences), respectively, as previously performed (357,369). 
Calpain activity was determined similarly, using the substrate Suc-LLVY-AMC. To account for 
proteasomal cleavage of this substrate, each sample was also analyzed with 25 µM of the calpain 
inhibitor Z-LL-CHO and the difference in fluorescence was taken as calpain activity. Cell lysates were 
prepared using lysis buffer without addition of protease inhibitors and incubated in duplicate with 20 
µM of the appropriate fluorogenic substrate. Caspase and calpain activity measurements were 
performed in an assay buffer of 20 mM HEPES, 10 mM DTT, and 10% glycerol. 
 
Lysosomal enzyme activity was measured using the substrate z-FR-AFC (Enzo Life Sciences), generally 
considered to indicate the activities of cathepsins L and B (357,369). Cell lysates were prepared similar 
to caspase/calpain assays and analyzed in duplicate with 25 µM of z-FR-AFC in a buffer containing 50 
mM sodium acetate, 8 mM DTT, 4 mM EDTA, and 1 mM Pefabloc at pH 5.0. For all activities, 
fluorescence was measured at 30oC using a Synergy H1 microplate reader (BioTek) with excitation and 
emission wavelengths of 360 nm and 440 nm for AMC substrates, and 400 nm and 505 nm for AFC 
substrates, respectively. All enzyme activities are presented normalized to total protein content 







Cell morphology was visualized using Giemsa staining, as previously performed (357). Briefly, after fixing 
in ice-cold methanol for 10 min and air-drying, cells were incubated with 1:20 dilution of 0.45 µm 
filtered Giemsa staining solution (Sigma Aldrich 48900) in PBS (pH 6.0) for 45 min at room temperature. 
Cells were then washed with distilled water and mounted with Permount (ThermoFisher). 
 
Immunofluorescence 
Cell and nuclear morphology was also determined using immunofluorescent identification of actin and 
DAPI. After fixing in 4% formaldehyde for 5 min and permeabilizing in 0.5% Triton-X 100 in PBS for 5 min, 
cells were blocked in 5% goat serum for 1 hr and incubated with an anti-actin antibody (A-2066, 1:200; 
Sigma Aldrich) overnight at room temperature. Cells were then incubated with anti-rabbit AlexaFluor 
488 secondary antibody for 1 hr (ThermoFisher A-11008), counterstained in 300 nM DAPI 
(ThermoFisher), and mounted with Prolong Gold (ThermoFisher). ImageJ was used to analyze cell and 
nuclear shape parameters, with at least 100 cells measured per trial. After masking nuclei by colour 
threshold, Area and Shape Descriptors measurements were performed. Calculations of these 
measurements can be found under the Analyze heading of the ImageJ user guide. 
 
b-galactosidase Staining 
Senescence-associated b-galactosidase activity staining (SA-Bgal) was performed as previously indicated 
by others (263). After washing with PBS, cells were fixed in 2% formaldehyde for 5 min at room 
temperature, washed again with PBS, and then incubated at 37oC for 48 hours in the staining solution 
consisting of PBS with 1 mg/mL X-gal, 40 mM citric acid, 5 mM potassium ferrocyanide, 5 mM potassium 
ferricyanide, 150 mM NaCl, and 2 mM MgCl2 at pH 6.0. For all microscopy experiments, cells were grown 
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on Cultrex- (R&D Systems) coated glass coverslips. All fluorescent microscopy was performed using a 
Zeiss Laser Scanning Microscope (LSM) 780. All light microscope images were acquired with a Nikon 




Cells were collected as described above and suspended in HBSS. Mitochondrial membrane potential and 
mitochondrial permeability transition pore formation were measured using JC-1 and calcein, 
respectively, as previously performed (369). Mitochondrial membrane depolarization can be monitored 
by changes in the JC-1 red:green fluorescence ratio, where a decreased ratio is indicative of decreased 
mitochondrial membrane potential.  After removing from culture, cells were incubated with 2 μM JC-1 
in 100 µL HBSS for 15 min at 37 °C, washed by centrifugation, and suspended in HBSS. Mitochondrial 
permeability transition pore (mPTP) formation occurs during mitochondrial-mediated apoptosis prior to 
mitochondrial apoptotic protein release. The fluorescent dye calcein AM accumulates in intact 
mitochondria, but is quenched by cobalt if the mitochondrial membrane becomes permeable to cobalt. 
Thus a decrease in calcein fluorescence indicates mPTP formation. Briefly, cells were incubated with 1 
μM calcein AM and 1 mM CoCl2 in 100 µL HBSS for 15 min at 37°C, washed by centrifugation, and 
resuspended in 500 μl HBSS. Mitochondria-specific resistance to calcium stress was tested by 
concomitantly incubating cells with 2.5, 5, or 10 µM of the calcium ionophore A23187 along with JC-
1/calcein. 
 
Cell Death  
In cell culture experiments, Annexin-V/PI staining was performed to assess the degree and type of cell 
death occurring after various stressors (388). After treatment, cells were removed from culture dishes 
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and suspended in Annexin Binding Buffer (10 mM HEPES/NaOH, 150 mM NaCl, 1.8 mM CaCl2, pH 7.4) 
and incubated with 1 µL of Annexin V-FITC (BioLegend, 640906) and 1 µL of 500 µg/mL propidium iodide 
(PI, Sigma Aldrich P-4170). Cells were incubated for 20 min at room temperature, after which they were 
washed and suspended in HBSS. Cells negative for both annexin and PI were classified as healthy, those 
positive for annexin and negative for PI were considered to be in early stages of cell death, and those 
positive for both annexin and PI were considered to be in late stages of cell death. 
 
Cell Cycle 
After collection, cells were fixed by slowly suspending them in ice-cold 70% ethanol in PBS. Following at 
least 24 hr fixation, cells were washed with PBS and suspended in PI staining solution containing 40 
µg/mL PI, 0.1% Triton-X, and 20 µg/mL RNAse in PBS for 30 minutes at room temperature. For each flow 
cytometry analysis, the cells from 1 well of a 12-well plate were measured. All flow cytometry analyses 




Analyses of C2C12 mitochondrial bioenergetics were performed using high resolution respirometry 
measurement of oxygen consumption (O2K, Oroboros Instruments). After collection via trypsinization, 
cells were centrifuged at 100g and permeabilized using digitonin buffer (PBS with 250 mM sucrose, 80 
mM KCl, and 50 µg/mL digitonin) for 3 min while agitating at room temperature. After centrifuging once 
more at 200g to remove digitonin, cells were suspended in mitochondrial respiration buffer (Mir06: 0.5 
mM EGTA, 3 mM MgCL2-6H2O, 60 mM lactobionic acid, 20 mM taurine, 10 mM KH2PO4, 20 mM HEPES, 
110 mM sucrose, 1 g/L fatty acid-free BSA, and 100 mg/L catalase; pH 7.1) and transferred into O2K 
chambers. Respiration was performed in Mir06 at 37oC under hyperoxygenated conditions (350 µM) in 
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the presence of glutamate (10 mM), pyruvate (5 mM), and malate (2 mM). The sensitivity and maximal 
response to complex I-supported ADP-stimulated respiration were then measured by conducting an ADP 
titration with the following concentrations: 1.0 µM, 2.5 µM, 5.0 µM, 10 µM, 20 µM, 50 µM, 100 µM, 200 
µM, 500 µM, and 1.0 mM. Succinate was then added in excess (10 mM) to determine maximal complex-
II supported respiration. Finally, cytochrome c was added (10 µM) after achieving maximal respiration to 
test the integrity of the outer mitochondrial membrane. Data is presented normalized to total protein 
content of the O2K chambers, calculated by aspirating and collecting a portion of the chamber volume 
upon protocol completion. GraphPad Prism was used to calculate Vmax and EC50 values on ADP 
titration curves, using the allosteric sigmoidal enzyme kinetics equation:  Y=Vmax*X^h/(Khalf^h + X^h). 
 
Reactive Oxygen Species 
ROS production was assessed by measuring DCF fluorescence. The day before the experiment, 20,000 
cells were plated in each well of a black-walled 96-well cell culture plate. The following day, cells were 
pre-loaded with dye by incubating them in HBSS with 25 µM DCF for 45 minutes at 37oC/5% CO2. Cells 
were then washed twice with warmed PBS and treated as indicated with or without HBSS, STS, NAC, and 
tiron for 4 hours. After washing again in PBS, HBSS was added to all wells and fluorescence was 
measured at 37oC using a Synergy H1 microplate reader (BioTek) with excitation and emission 
wavelengths of 395 nm and 528 nm, respectively. Data is reported as arbitrary fluorescence units after 
subtracting treatment-specific background fluorescence of wells which did not receive DCF.  
 
Cell Counting 
A Beckman-Coulter Z2 particle analyzer was used to assess cell numbers. Events from 12-23 µm were 





Results are presented as means ± SEM, where n=3-6 independent experiments. GraphPad Prism was 
used to perform 1-way and 2-way ANOVA analyses with Tukey post-hoc tests where appropriate with 
significance indicated when p<0.05. Microsoft Excel was used to perform T-tests with significance 



























Figure 1. Autophagic signaling induced by various stressors in subconfluent and differentiated C2C12 
cells. Subconfluent (A & B) and differentiated (C & D) C2C12 cells were treated as indicated and 
immunoblotted for autophagy-related proteins. Day 1 = 24 hours after inducing differentiation, CCCP = 
30 µM 4 hours, STS = 2 µM 4 hours, H2O2 = 2.5 mM (A & B) or 5 mM (C & D) 6 hours, HBSS = 6 hours, 















Figure 2. Characterizing autophagy induced by CCCP and HBSS. C2C12 cells were treated with 30 µM 
CCCP in GM, HBSS, and/or 30 µM chloroquine (Cq) for 3 hours (A) or 6 hours (B) and collected for 
assessing autophagic flux by p62 and LC3 immunoblotting. (C & D) C2C12 cells were similarly treated 
with CCCP or HBSS and immunoblotted for various autophagy-related proteins. Apart from the 
predicted changes to LC3 and p62 protein contents, HBSS decreased Atg4B while Bnip3 was reduced by 









Figure 3. Autophagy flux analyses with various lysosomal enzyme inhibiting chemicals. C2C12 cells were 
treated as indicated and immunoblotted for LC3 and p62 to quantitatively analyze autophagic flux. (A) 
Initial assays were performed with 10 µM chloroquine (Cq, which impairs degradative enzymes by 
altering lysosomal pH levels), although this concentration was unable to prevent p62 and LC3II 
degradation during HBSS treatments, presumably due to the high amount of autophagy induction. (B) 
Up to 200 µM Cq was unable to fully prevent HBSS-induced p62 and LC3II degradation during a 3 hour 
treatment. (C) Leupeptin (Leu, a serine and cysteine protease inhibitor that doesn’t affect pepsin or 
cathepsins A/D) and Complete Cocktail (a proprietary collection of serine, cysteine, metalloproteinase, 
and calpain inhibitors) were tested for their ability to prevent p62 and LC3II degradation caused by 3 
hours of HBSS. (D) A combination of 50 µM Cq and 250 µM Leu was able to prevent HBSS-induced LC3II 
degradation during shorter time periods. Note that the “gold standard” for performing an LC3/p62 
autophagic flux assay is to treat cells with 1-10 µM pepstatin (aspartic protease inhibitor) and 1-10 µM 
























Figure 4. Assessing autophagy-related signaling induced by CCCP and HBSS in subcellular fractions. 
Subconfluent C2C12 cells and those on Day 3 of differentiation were treated with 30 µM CCCP or HBSS 
for 6 hours and separated into mitochondrial and cytosolic fractions prior to immunoblotting. A trial of 































Figure 5. AMPK-related signaling is not induced by HBSS or altered by Atg7 deficiency. (A) C2C12 cells 
were treated as indicated with 30 µM CCCP or HBSS for 3 or 6 hours and collected immediately or after 
spending 3 additional hours in regular GM (+3 hr recovery). Immunoblotting of phosphorylated AMPKa 
was performed to assess AMPK signaling activation. (B) Control (SCR) and Atg7-deficient cells (shAtg7) 
were treated as indicated with HB+F for 1.5 hours and cells were collected immediately or after 
spending 3 or 6 additional hours in regular GM. Immunoblotting of various AMPK-related targets was 
performed to assess AMPK signaling. There were no significant changes in any protein content, 




















Figure 6. Comparing autophagy signaling in C2C12, L6, SHSY5Y, mouse primary, and human primary 
myoblasts. (A) L6 myoblasts were treated as indicated with 30 µM CCCP or HBSS for 3 or 6 hours and 
C2C12 and L6 cells were collected during various time points during differentiation and collected for 
immunoblotting. Notably, PINK1 demonstrates massive induction in C2C12 but not L6 cells on Day 1 of 
differentiation. Surprisingly, C2C12s possessed undetectable levels of Parkin protein. (B) Despite this, 














Figure 7. Mitochondria and autophagosome visualization during CCCP and HBSS treatments. C2C12 cells 
were co-transfected with LC3-GFP and mito-DsRed vectors and imaged live using fluorescent 




















Figure 8. Determining appropriate conditions for repeated treatments in various cell types. Cells were 
administered CCCP or incubated in HBSS, treated with STS to induce cell death, and assessed for 
caspase-3 activity to determine whether repeated treatments led to cyto-protection. (A) Differentiating 
C2C12 cells were administered 10 or 30 µM CCCP for 3 hours per day for 3 consecutive days and given 
2.0 µM STS 20 hours following the final treatment. (B) Similar experiment to (A) performed in 
proliferative C2C12 cells. (C) Proliferative C2C12 and NIH3T3 cells were administered the indicated 
concentrations of CCCP for 5 hours per day for 3 consecutive days and given 1 µM STS 20 hours 
following the final treatment. (D) Proliferative C2C12 cells were administered 30 µM CCCP or incubated 
in HBSS for 5 hours per day for 3 consecutive days and given 0.5 µM STS 20 hours following the final 

















Figure 9. Cell death signaling caused by individual CCCP and HBSS treatments. (A) C2C12 cells were 
treated as indicated and assessed for caspase-3 activity. +3/6 hours refers to cells given regular growth 
media following treatments and allowed to “recover” for 3 or 6 hours. (B) C2C12 cells were treated as 


























Figure 10. Effect of repeated CCCP and HBSS treatments on cell death and autophagy signaling. C2C12 
cells were administered 30 µM CCCP or incubated in HBSS for 5 hours per day for 3 consecutive days 
and collected 20 hours following the final treatment. (A) Quantitative analyses of Bcl2 and p62 protein 
expression. (B) Representative immunoblots. (C) Enzyme activity of caspase-3 and caspase-9. (D) As the 
changes depicted in (A, B, & C) can be explained by CTRL cells being over-confluent and HBSS cells being 
under-confluent, immunoblotting of myogenin was performed to determine the onset of myogenic 
















Figure 11. Effect of repeated CCCP and HBSS exposure on proteolytic enzyme activity and select stress-
related protein markers. C2C12 cells were treated as in the previous Figure, but seeded at treatment-
specific densities that resulted in similar confluence between groups after 3 days of repeated CCCP or 
HBSS. (A) Quantitative analyses of PGC1a, Hsp70, and MnSOD protein expression. (B) Representative 























Figure 12. Generating C2C12 cells with stable Atg7 knockdown: Attempt #1. C2C12 cells were 
transfected with vectors coding for either an shRNA against Atg7 (KD) or a scramble control sequence 
(Scr), stably-incorporated colonies were selected using puromycin, and individual clones were isolated 


























Figure 13. Generating C2C12 cells with stable Atg7 knockdown: Attempt #2. (A) Cells were transfected 
and isolated similar to Figure 6. (B) Select clones were re-plated into culture and differentiated to 























Figure 14. Generating C2C12 cells with stable Atg7 knockdown: Attempt #3. Phoenix helper-free 
retrovirus-producing cells were used to package virus particles containing either Atg7-targeting or 
scramble shRNA vectors. After isolation, viral particles were introduced into C2C12 cultures with 
Polybrene (Santa Cruz), and individual cell clones with stable vector incorporation were selected using 
puromycin as in previous Figures. Atg7 protein content was then assessed using immunoblotting. 


























Figure 15. Evaluating Atg7 expression in cell clones from Attempt #3. Select clones were re-plated into 
culture and administered HBSS to confirm Atg7 protein knockdown. C2 represents non-transfected, low-



















Figure 16. Generating C2C12 cells with stable Atg7 knockdown: Attempt #4. Using fresh vector DNA, 
C2C12 cells were transfected with either Atg7 or scramble vectors and clones were isolated as in 
Attempts 1 and 2. This time, numerous clones transfected with Atg7-specific shRNA demonstrated 










Figure 17. Selecting experimental Atg7 knockdown cell lines. (A) Immunoblot demonstrating reduced 
Atg7 and LC3II protein content in several knockdown clones compared to low-pass non-transfected 
C2C12 and scramble control cells (SCR). (B) To select clones with “effective” Atg7 protein knockdown, 
the relative expression of Atg7 was plotted against the LC3II/I ratio, with the intention of selecting 
clones in which these two parameters were related: decreased Atg7 should result in less LC3 lipidation. 
As can be seen, clones 12, 18, and 52 have drastically lower Atg7 levels and LC3II/I ratios. In other parts 














Figure 18. Effect of Atg7 knockdown on caspase activity during myogenic differentiation. To corroborate 
previous findings regarding the role of autophagy during myogenic differentiation (183), several 
knockdown clones were differentiated. Cells were assessed for caspase-3 (A) and caspase-9 (B) activity 
at several time points during the differentiation process. Area under the curve (AUC) calculations 
highlight increased caspase-3 (C) and caspase-9 (D) activation during differentiation in the absence of 


























Figure 19. Effect of Atg7 knockdown on myogenic differentiation. Similar to Figure 18, several Atg7-
knockdown cell lines were differentiated and collected at various time points. (A) Quantitative analysis 
of myosin protein content. (B) Quantitative analysis of myogenin protein content. Knockdown clones #1 
and #2 demonstrate significantly reduced expression of these two myogenic-specific proteins. (C) 




































Figure 20. Adenoviral recovery of Atg7 protein content in Atg7-deficient C2C12 cells. Adenovirus coding 
for human Atg7 (adAtg7) was generated in two batches, each of which was titred for its ability to induce 
Atg7 protein expression. The indicated volumes of virus stock was incubated on 40-50% confluent 
shAtg7 cells in 12-well plates for 24 hours, cells were washed in PBS and grown in regular GM for 48 
hours, and cells were collected and analyzed for Atg7 protein content using immunoblotting. Note that 
the human Atg7 protein created by adAtg7 is 2 kDa larger than endogenous mouse Atg7. Recovery of 






















Figure 21. Generating C2C12 cells with stable Bnip3 knockdown: Attempt #1. C2C12 cells were 
transfected with vectors coding for either an shRNA against Bnip3 (K) or a scramble control sequence 
(S), stably-incorporated colonies were selected using puromycin, and individual clones were isolated and 


















Figure 22. Generating C2C12 cells with stable Bnip3 knockdown: Attempt #2. (A & B) C2C12 cells were 
transfected with one of three vectors coding for shRNA against Bnip3 (K) or a vector targeting a 
scramble control sequence (S), stably-incorporated colonies were selected using puromycin, and 
individual clones were isolated and assessed for Bnip3 protein expression using immunoblotting. (C) 






Designing Bnip3 CRISPR gene knockout targets in mouse 
Zhang Lab’s tool: http://crispr.mit.edu/ 




Basically, these programs allow you to analyze DNA sequences for CRISPR targets. Each works by 
searching for 20mer targets (this is standard CRISPR sgRNA (single guide RNA) size used by Zhang’s 
px330 family of CRISPR/Cas9 vectors) with correct PAM locationality (-NGG) in your given sequence. 
 
 Note that the E-CRISP tool can accept GeneID/FASTA information and then pull the sequence 
data to be analyzed from NCBI’s gene database, while the other programs have to be manually 
provided relatively smaller (up to 250-500bp) DNA sequences. 
 
After potential target sequences are attained, the programs essentially “BLAST” these identified 
sequences against the rest of the genome (from NCBI) to determine how specific they are to your gene 
of interest. Each then provides some sort of “score” informing how good/useful the identified targets 
are. 
 
The Zhang lab also suggests the following when using CRISPR to target things specifically for knock-out 
experiments: aim for a protein coding region of the genome near the beginning of the resulting mRNA 
sequence, have your target sequence begin 5’-G...-3’. 
 
To make confirming these designs more complicated, it’s important to note that since we’re making a 
double-strand break, it doesn’t matter which direction or which “side” of the DNA sequence is targeted: 
we just want to make a cut. Additionally, Bnip3 is actually positioned “backwards” on the genome (it 
uses the reverse complement DNA strand according to NCBI’s sequencing direction). 
 
Anyways, I inserted the following 50bp of genomic DNA located roughly around the transcriptional start 




This is in the forward direction according to NCBI around the transcriptional start site, noting that Cas9 
should make cuts 3-4 bp upstream (towards the 5’ end) of the PAM. The sequence is described here: 
 
NCBI forward 
5’-C TGC CTC ACC CTG CAG GTT CTC CTC CCC GCT CTG CGA CAT GGT GGC TCG G-3’ 
 
Reverse complement (in the direction that Bnip3 is made) 
5’-C CGA GCC ACC ATG TCG CAG AGC GGG GAG GAG AAC CTG CAG GGT GAG GCA G-3’ 
 
Bold = start. Gray = exon. Green = protein coding. Yellow = intron. 
 





Off-Spotter: 10  
E-CRISP: 60 (but, 5084 potential targets were identified across the entire 18,683 bases that 
make up the Bnip3 mouse gene, 561 hit a specific target, and 501 were removed for being 
redundant). 
 
So, 3 or 10 is not a lot of targets. In fact, 1 of CCTop’s actually targets 4 other regions of the genome, and 
only 2 of Zhang’s are classified as “good” and they’re only different by a single base. But, all four 
programs identified two similar target sequences with the best chances of working (PAM in brackets): 
 
First: GAGCCACCATGTCGCAGAGC (GGG) 
Second: GGAGGAGAACCTGCAGGGTG (AGG) 
 
Both of these sequences in the same direction as Bnip3 is made: 
 
5’-C CGA GCC ACC ATG TCG CAG AGC GGG GAG GAG AAC CTG CAG GGT GAG GCA G-3’ 
1st:   GA GCC ACC ATG TCG CAG AGC(GGG) 
2nd:                                G GAG GAG AAC CTG CAG GGT G(AG G) 
 
 
Alrighty then. Now we need oligos to insert into the spCas9 vectors we have. Note these have small 
overhangs for cloning: as specified by Zhang Lab’s cloning protocol. 
 
First forward: 5’- CACC GAGCCACCATGTCGCAGAGC -3’ 
      reverse: 5’- AAAC GCTCTGCGACATGGTGGCTC -3’ 
 
Second forward: 5’- CACC GGAGGAGAACCTGCAGGGTG -3’ 
       reverse: 5’- AAAC CACCCTGCAGGTTCTCCTCC -3’ 
 
 
Here is a scramble sequence for control. This is actually the sequence that Origene uses in their control 
CRISPR products. According to the gRNA design tools, there is a greater chance of an off-target hit with 
either of the above Bnip3 sequences than with this scramble sequence: 
 
Scramble forward: 5’- CACC GCACTACCAGAGCTAACTCA -3’ 
Scramble reverse: 5’- AAAC TGAGTTAGCTCTGGTAGTGC -3’ 
 
 
Well, it looks like we need a few things yes to do this: two restriction enzymes (Robin doesn’t have 
these) and a nucleotide phosphorylating kinase (the annealed oligos need to be phosphorylated for 
ligating). New England BioLabs or ThermoFisher/Invitrogen/Fermentas has this stuff (NEB is cheaper). 
- BbsI 
- AgeI  
- T4 Polynucleotide Kinase (PNK) 
 
 
And maybe two for mouse Atg7? (we didn’t end up getting these – they are great gRNA according to the 
design tool guidelines): 
 
First: forward: 5’- CACC GGCCTCACCACTGTGCTCGT -3’  




Second: forward: 5’- CACC GAAAATTCCCACGAGCACAG -3’ 













































Zhang Lab Target Sequence Cloning Protocol 
 
PX330-based plasmids, including PX458-462 – SpCas9 (or SpCas9n D10A nickase) + single guide RNA: 
 
The Quadrilatero Lab has pSpCas9(BB)-2A-Puro(px459) which makes double-strand  
breaks and pSpCas9n(BB)-2A-Puro(px462) which makes single-strand nicks 
 
To clone the guide sequence into the sgRNA scaffold, synthesize two oligos (Standard de-salted oligos 
are sufficient) of the form: 
 
                     5’ – CACCGNNNNNNNNNNNNNNNNNNN     – 3’ 
                     3’ –     CNNNNNNNNNNNNNNNNNNNCAAA – 5’ 
 
PX260 and PX334 – SpCas9 (or SpCas9n D10A nickase) + CRISPR array + tracrRNA: 
 
To clone the guide sequence into the sgRNA scaffold, synthesize two oligos of the form: 
 
            5’ – AAACNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNGT     – 3’ 
            3’ –     NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNCAAAAT – 5’ 
 
Oligo annealing and cloning into backbone vectors: 
 
1.  Digest 1ug of plasmid with BbsI for  
 30 min at 37°C: 
 
  1 ug Plasmid 
  1 ul FastDigest BbsI (Fermentas) 
  1 ul FastAP (Fermentas) 
  2 ul 10X FastDigest Buffer 
  X ul ddH2O    
  20 ul total 
 
2.  Gel purify digested plasmid using  
QIAquick Gel Extraction Kit and elute in EB. 
 
3. Phosphorylate and anneal each pair of oligos: 
 
  1 ul oligo 1 (100mM) 
  1 ul oligo 2 (100mM) 
  1 ul 10X T4 Ligation Buffer (NEB) 
  6.5 ul ddH2O 
  0.5 ul T4 PNK (NEB)    
  10 ul total 
 
Anneal in a thermocycler using the following 
parameters: 
 
  37oC 30 min 
  95oC 5 min and then ramp down to 
25oC at 5oC/min 
 
4. Set up ligation reaction and incubate at room 
temperature for 10 min: 
 
  X ul BbsI digested plasmid 
   from step 2 (50ng) 
  1 ul phosphorylated and annealed  
   oligo duplex from step 3 (1:200  
   dilution) 
  5 ul 2X Quickligation Buffer (NEB) 
  X ul ddH2O     
  10 ul subtotal 
  1 ul Quick Ligase (NEB)   






Bnip3 CRISPR vectors 












Sequencing from The Center For Applied Genomics 
 
Overlapping region 
Cloned-in restriction site 
CRISPR sgRNA 
Edited per FinchTV 
 




















































































Anti-Bnip3 Antibody from Sigma 
 
Our antibody’s epitope 
 
Bnip3 mouse amino acids 
MSQSGEENLQ GSWVELHFSN GNGSSVPASV SIYNGDMEKI LLDAQHESGR SSSKSSHCDS 
PPRSQTPQDT NRAEIDSHSF GEKNSTLSEE DYIERRREVE SILKKNSDWI WDWSSRPENI 
PPKEFLFKHP KRTATLSMRN TSVMKKGGIF SADFLKVFLP SLLLSHLLAI GLGIYIGRRL 
TTSTSTF 
 
Nix mouse Amino Acids 
MSHLVEPPPP LHNNNNNCEE GEQPLPPPAG LNSSWVELPM NSSNGNENGN GKNGGLEHVP 
SSSSIHNGDM EKILLDAQHE SGQSSSRGSS HCDSPSPQED GQIMFDVEMH TSRDHSSQSE 
EEVVEGEKEV EALKKSADWV SDWSSRPENI PPKEFHFRHP KRAASLSMRK SGAMKKGGIF 
SAEFLKVFIP SLFLSHVLAL GLGIYIGKRL STPSASTY 
 
Bnip3 Human Amino Acids 
MGDAAADPPG PALPCEFLRP GCGAPLSPGA QLGRGAPTSA FPPPAAEAHP AARRGLRSPQ 
LPSGAMSQNG APGMQEESLQ GSWVELHFSN NGNGGSVPAS VSIYNGDMEK ILLDAQHESG 
RSSSKSSHCD SPPRSQTPQD TNRASETDTH SIGEKNSSQS EEDDIERRKE VESILKKNSD 

































Figure 23. Generating Bnip3-knockout C2C12 cells using CRISPR/Cas9: Attempt #1. (A) C2C12 cells were 
transfected with CRISPR/Cas9 vectors containing one of two gRNAs targeting Bnip3 (1.N or 2.N) or a 
scramble control sequence (S) and more successfully transfected clones were selected with puromycin 
and individually isolated for assessment of Bnip3 protein content using immunoblotting. (B) Select 
clones were immunoblotted again to facilitate protein expression comparisons. C2 represents non-












Figure 24. Evaluating Bnip3 expression in cell clones from CRISPR Attempt #1. Select clones from Figure 
18 were re-introduced into culture and left untreated (CTRL), differentiated for 4 days (Diff), or treated 


























Figure 25. Selecting experimental Bnip3-knockout cell clones. Select Bnip3-CRISPR clones were 
incubated in HB+F or 30 µM CCCP for 1.5, 3, or 6 hours and collected immediately or after spending an 






































Figure 26. Preventing STS-induced caspase-3 activity with iMAC2. To implicate mitochondrial-mediated 
mechanisms involved in autophagy-induced protective cellular remodelling, the mitochondrial pore 
inhibiting chemical iMAC2 was tested for its ability to prevent STS-induced caspase-3 activity. Although 
caspase-3 activity was slightly reduced by 0.5 µM iMAC2, this was not significant enough to justify 
performing a full experiment. However, “iMAC2-mediated reduction in STS-induced caspase-3 
activation” is the exact experiment performed when initially developing this chemical, where its IC50 
was observed to be 2.5 µM (482). In an additional study, these researchers conducted similar 
























Figure 27. Repeated HBSS treatments protect mitochondria from while senescent cells are sensitized to 
Ca2+ stress. (A) To specifically test the stress-resistance of mitochondria, mitochondrial permeability 
transition pore (mPTP) formation was measured with flow cytometry analysis of calcein fluorescence 
after inducing calcium stress with the Ca2+ ionophore A23187. Here, increasing concentrations of 
A23187 caused progressive drops in calcein fluorescence (p<0.05), indicating mitochondrial 
permeabilization. However, cells repeatedly given HBSS displayed relatively smaller (p<0.05) decreases 
in fluorescence compared to CTRL, signifying partial protection from Ca2+ stress. This contrasts the 
response of STS-treated cells, as 125 nM STS administration let to larger (p<0.05) decreases in calcein 
fluorescence compared to CTRL. Bars represent SEM, n=4, comparisons made with 2-way ANOVA. (B) 




















Figure 28. Repeated rapamycin administration prevents C2C12 myogenic differentiation. In this pilot 
experiment, C2C12 cells were grown in regular GM (CTRL) or administered 1.0 µM rapamycin (Rapa) for 
8 hours per day for 3 consecutive days and myogenic differentiation was induced 20 hours following the 
final treatment by switching to low growth-factor DM. Cells were collected at the media-switching 
moment (D0) as well as after spending 2 days (D2) and 4 days (D4) in DM and subsequently 
immunoblotted for various myogenic factors. While expected transient p21 and progressive myosin 





















Figure 29. Proteolytic enzyme activity assessment in Atg7-deficient C2C12 cells repeatedly incubated in 
HBSS or rapamycin and subsequently killed with STS or CisPL. Full panels of caspase-3 (A), caspase-8 (B), 
caspase-9 (C), and cathepsin (D) activity measurements as previously depicted in Chapter II, Figure 4, 

















Figure 30. Assessing autophagy signaling alterations 10 weeks after inducing skeletal muscle-specific 
knockdown of Atg7 in mice. Mice with floxed Atg7 genomic regions (Fl/Fl) with/without additional 
skeletal muscle-specific (driven by human skeletal muscle actin promoter) tamoxifen-inducible Cre-
recombinase expression (Fl/Fl/Cre) were intraperitoneally-injected with 2 mg of 10 mg/mL tamoxifen 
dissolved in sunflower seed oil once per day for 5 consecutive days. 10 weeks later, mice were 
sacrificed, soleus, plantaris, and left ventricle muscles were dissected and snap-frozen in liquid nitrogen, 
and tissues were assessed for Atg7, LC3, p62, and actin protein expression using immunoblotting. As 
expected, Fl/Fl/Cre mice displayed reduced Atg7 but increased LC3I and p62 protein levels compared to 























Figure 31. Effect of endotoxin/LPS on skeletal muscle cell death, antioxidant, and autophagy signaling 
protein contents and proteolytic enzyme activity. C57 mice were intraperitoneally-injected with the 
indicated concentrations of endotoxin/LPS, sacrificed 24 hours later, and select hindlimb skeletal 
muscles were dissected and snap-frozen in liquid nitrogen. (A) Mixed-type gastrocnemius muscles were 
used for immunoblotting analyses of several stress-related proteins. Proteolytic enzyme activity 
measurements were performed in soleus (B) and extensor digitorum longus (EDL) (C) muscle 








Figure 32. Morphological assessment of C2C12 cells repeatedly incubated in amino acid starvation 
media or administered rapamycin. Cells were incubated in HB+F for 3 hours or given 1.0 µM rapamycin 
in GM for 8 hours per day for 3 consecutive days and immunofluorescently stained for actin (green) and 
DAPI (blue). Note these images were acquired with the same microscope objective: this highlight the 
odd/enlarged morphology caused by repeated rapamycin administration. 
